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The General Introduction (Chapter One) provides the background and rationale for the work 
contained within the thesis. Within this Chapter, there is justification for the specific approach 
taken within the thesis, guided by an early review of the literature and discussions with experts 
in the field. Given the novelty of the research topic, a narrative review of the available literature 
is contained in Chapter Two which explores considerations relevant to the topic area and the 
available literature pertaining to the role of nutrition, specifically the intake of collagen-
containing proteins, in the synthesis of collagen within ligaments and tendons. Chapter Three 
consists of the extended methods section and explores the data collection involved in all four 
experimental studies. Chapter Four contains the first experimental study which investigated 
the variability in the amino acid composition of different sources of bone broth, a food 
commonly promoted for the health of collagenous tissues, with special attention to those 
purported to promote collagen synthesis in ligaments and tendons. Chapter Five contains the 
second experimental study which aimed to assess whether a metabolite of proline 
(hydroxyproline) could be used as a biomarker of collagen intake. Chapter Six contains the 
third experimental study which investigated plasma kinetics of amino acids purported to have 
a role in the synthesis of collagen following the consumption of various protein sources. The 
final experimental study; Chapter Seven investigated the effects of consuming different 
protein sources (hydrolysed and non-hydrolysed collagen protein, and a hydrolysed leucine-
rich dairy protein) on collagen synthesis using an in vitro engineered ligament model modified 
by the inclusion of a diluted media aimed to meet fasting physiological serum levels.  These 
studies are followed by a general discussion chapter (Chapter Eight), which provides a 
summary of the findings, the practical implications, limitations and future directions of the 




research process and PhD progression and challenges. Chapter Ten and Chapter Eleven 
contains references, the candidate’s research portfolio and appendices.  
Chapters Four, Five and Six are presented as they appear in published peer reviewed journals, 
with reformatting to maintain consistency throughout the thesis. Chapter Seven is presented 
within the manuscript as it has been submitted in the peer-reviewed journal. Due to journal 
requirements, there may be some language discrepancies (e,g. US vs AUS spelling 
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Sporting success is determined by a multitude of factors and their interactions. Physical 
function is a major determinant of the athlete’s ability to train optimally and with consistency, 
as well as to achieve the work requirements of their competitive event. Ligaments and tendons 
are types of dense connective tissue which play a major role in locomotion and stability. These 
tissues are at risk of being injured, interfering with the athlete’s training and competition 
availability. Furthermore, due to their slow rate of turnover, the management of injuries to these 
tissues requires a significant rehabilitation period at the expense of both the athlete and/or 
sporting team. Practical strategies that reduce the injury risk by enhancing the strength of these 
tissues and/or lessen the rehabilitation period by enhancing the healing process are of 
understandable interest to the sporting community as well as other populations. However, 
determining the impact of nutritional interventions on whole body collagen synthesis provides 
considerable challenges, including the lengthy intervention period needed to observe 
meaningful changes in the structure and function of ligaments and tendons. Additionally, the 
many gaps within the current literature prevent researchers from identifying candidate 
treatments that would justify the necessary levels of investment, time and resources needed to 
undertake such a study. Consequentially, this thesis aimed to gather background data and 
address methodological considerations that would assist in the future implementation of a well-
designed intervention study. Specific questions were identified: 
 Which food sources and/or supplements are most likely to provide precursors that 
support the synthesis of new collagen? 
 Can a purported biomarker of the intake of these precursors be validated as tool to 
assess recent or habitual intakes of collagen-promoting foods and assist 




 What are the key characteristics of the absorption and digestion after the consumption 
protein sources proposed to be implicated in the synthesis of collagen?  
 
The first study in the series (Study 1) sought to determine whether bone broth, a presently “in 
vogue” source of collagen protein, is able to provide adequate, and consistent levels of the 
amino acids (AAs) purported to support the synthesis of new collagen. A variety of 
“standardised” and “non-standardised” preparations of bone broth was prepared and/or 
obtained. The main outcome of this study was that AA concentrations in bone broth were too 
inconsistent to provide a therapeutically beneficial amount of the key AAs of interest.  
 
The second study (Study 2) aimed to determine whether urinary excretion of hydroxyproline, 
a component of collagenous tissue, is suitable as a biomarker of collagen intake in free-living 
individuals. However, this biomarker was only present within the urine for up to 6 h after the 
consumption of a 20 g serve of collagenous protein and was not substantially elevated through 
usual dietary intake. These findings, in conjunction with the large inter-individual variability 
in urinary hydroxyproline concentrations, underpin the conclusion that it is an unsuitable 
biomarker of habitual dietary intake of collagen. 
 
Ligaments and tendons are poorly vascularised tissues, which may require exercise-induced 
stimulation of blood flow to transport nutrients such as AAs that may be implicated in collagen 
synthesis. Exercise may provide a further integral component of this process by upregulating 
the machinery for protein synthesis. Therefore, the intake of nutritional support for collagen 
synthesis must be coordinated so that peak blood concentrations of AA coincide with exercise-




necessitates an understanding of the AA responses to intake of different collagen protein 
sources. Study 3 involved obtaining serial plasma samples from individuals over the three 
hours following the consumption of a 20 g serve of various protein sources (including both 
collagen and dairy proteins), and a 300 mL serve of bone broth. The main finding was the 
variability in the timing and magnitude of peak concentrations of various AAs according to the 
type of protein that was consumed. Specially, collagen-containing proteins provided the 
highest source of glycine, whilst dairy proteins provided the highest source of leucine. 
Meanwhile, although hydrolysed forms of dairy proteins produced higher peak concentrations 
of AAs than their non-hydrolysed counterparts, this was not the case for the collagen proteins.  
 
The final study within the series (Study 4) built upon previous in vitro work by our group 
(Shaw et al., 2017) in which a 15 g dose of gelatin was found to increase the content and 
mechanical properties of collagen in an engineered ligament model. Information on the timing 
of plasma AA peaks gained from prior studies in the thesis informed when the blood samples 
would be collected for treatment of engineered ligaments. A further addition to the 
methodology involved the manipulation of the media used to prepare the ligaments to more 
closely reflect physiological concentrations of AA in fasted individuals. While we failed to 
find an effect of the treatments, this study facilitates further questioning around key 
methodological considerations of this model, and highlights the challenges of undertaking 
research on ligaments and tendons.  
 
In summary, this body of work identified supplementation protocols that merit investigation 
for the support of collagen synthesis and the health/functioning of dense connective tissues and 








Participation in physical activity and/or sport carries a number of benefits including lowering 
the risk of chronic disease, improved mental health, improved tissue strength and improved 
injury protection (Warburton et al., 2017). In children and/or adolescents, physical activity 
plays an integral role in coordination, balance, flexibility, tissue development and social 
wellbeing (Janssen et al., 2010). In later life, the maintenance of tissue strength is particularly 
important given the age related declines in muscle mass (i.e. sarcopenia), which can contribute 
to an increased risk of falls, resulting in a significant amount of morbidity and mortality 
(Siracuse et al., 2012). Physical activity is therefore important throughout all life-stages and is 
a necessary consideration for the maintenance of health and general wellbeing. For the select 
few (e.g. elite athletes), participation in sport is a profession and their predominant source of 
personal income, which further supports a much larger group of other people employed within 
the sports industry. Although there is an obvious benefit to participation in sports both for 
recreational and elite populations, participation in sport comes with risk. Within Australia, as 
at 2011-12, soft tissue (e.g. muscle, tendon and ligament) injuries were the second most 
common type of injury sustained (AIHW: Kreisfield et al., 2011-12). In regard to dense 
connective tissues specifically, a recent study over a 5 year period reported that Australia had 
one of the highest incidences of ACL reconstructions globally (Janssen et al., 2012). 
Meanwhile, the number of primary ACL reconstructions in young Australians increased by 
43% from 2000-01 to 2014-15 (Zbrojkiewicz et al., 2018). The direct monetary cost of ACL 
reconstruction surgery as at 2014-15 was estimated to be $142 million, with further indirect 
costs such as income lost due to time off work, and the future development of chronic disease 
such as osteoporosis (Zbrojkiewicz et al., 2018). More widely, it is estimated that 5.2 million 
Australians sustain sport injuries each year, with an increasing monetary cost, last estimated 





Connective tissues are the most widely abundant and diverse set of tissues present within the 
human body and are involved in a vast array of functions ranging from organ support to the 
transportation of blood and nutrients (Ovalle et al., 2013). Ligaments and tendons are a 
particular type of dense, regular connective tissue, predominantly responsible for stability and 
locomotion, and when functioning optimally, also play an important role in injury prevention 
(Birch et al., 2013). Specifically, ligaments connect bone to bone and prevent abnormal 
movement occurring within the joints, while tendons connect muscle to bone, and are 
responsible for the transmission of force from the muscle to the bone, thereby facilitating 
movement (Birch et al., 2013). Although ligaments and tendons have distinct roles, they are 
structurally similar tissues with a composition dominated by collagen protein (principally Type 
I), followed by elastin, proteoglycans and binding proteins (Kjær, 2004). Collagen is the key 
tensile element that contributes to the strength and structure of these tissues, allowing for the 
resistance of tensile, compressive and shear forces (Muiznieks et al., 2013). Research suggests 
that tissues with larger and/or more densely packed collagen fibrils have a greater ability to 
withstand force, thereby providing better protection against injuries such as tendinopathies and 
ligament tears (Galloway et al., 2013; Magnusson et al., 2016). By contrast, conditions which 
cause a reduction in collagen synthesis and/or disruptions to collagen processing (e.g. heritable 
disorders of connective tissue or genetic polymorphisms), result in weak tissues prone to 
injuries such as fractures, tendon ruptures and ligament tears (Grahame, 2000; Vaughn et al., 
2017). Although these disorders are uncommon, amongst healthy individuals, current literature 
suggests that smaller tendons, presumably with a lower collagen content and/or disruptions to 
mechanical properties are accompanied by a higher injury risk (Arya et al., 2010; Couppe et 
al., 2013; Kongsgaard et al., 2010), thus illustrating the importance of collagen for the optimal 





Contrary to the historical belief that ligaments and tendons are relatively inert tissues with little 
capacity for hypertrophy post puberty, literature suggests that the collagen protein within 
ligaments and tendons share the characteristics of myofibrillar protein, in being responsive to 
exercise, which results in distinct changes to morphological, material and mechanical 
properties (Tardioli et al., 2012; West et al., 2015; Wren et al., 2000). Indeed, it has recently 
been shown that basal protein synthetic rates within tendons and ligaments, are within the same 
range as skeletal muscle protein synthetic rates at 0.06 ± 0.01%/h, 0.04 ± 0.01%/h and 0.04 ± 
0.01%/h, respectively (Smeets et al., 2019). While researchers are endeavouring to establish 
the key mechanisms responsible for the biochemical response of mechanical load to ligaments 
and tendons, others have focused on the potential supportive role that nutrition may play in the 
synthesis of new collagen (Scott et al., 2016; Tack et al., 2018). Despite the lack of a clear 
evidence base, several recommendations have surfaced with the aim of minimising injury risk 
in athletes and/or assisting their “return to play”. These include the pre-exercise consumption 
of protein derived from collagenous animal tissue to enable the provision of key AAs to the 
target tissues at a time when blood flow is optimised and synthetic machinery is upregulated 
(Baar, 2017). Even though such recommendations are appealing to both the athlete and their 
support team, a systematic process of developing such recommendations (such as that outlined 
in Figure 1.1) is needed. Thus, the initial aim of the thesis was to work through a progression 
of “steps” to bridge any identified gaps with the end goal of implementing a valid and reliable 
intervention study to consolidate current recommendations. In particular, we wanted to explore 
considerations, such as AA availability, and the impact of the ingestion of various proteins 
(including both whole foods and supplemental sources) on collagen synthesis in vitro prior to 
implementing an in vivo study. However, due to early investigations, supported by discussions 
with experts in the field, a number of challenges were identified in tackling the full scale of 




feasible and ethical approach to measure the synthesis and incorporation of collagen into 
ligaments and tendons and the functional outcomes of this increased collagen content (Phase 
5), reducing our confidence in the likelihood of being able to identify whether any intervention 
would achieve real-world benefit. Because of the need for a lengthy intervention period for a 
final study (Phase 6), requiring significant resources and effort from a research team, and a 
high level of interest and/or compliance of the subject population, it was deemed unethical, or 
at least wasteful, to embark on a study with minimal chance of achieving the desired endpoint.  
 
In addition to the current lack of consensus on the optimal dietary interventions that are 
important for collagen synthesis (Phase 1 and 2), we recognised that the poor vascularisation 
of ligaments and tendons created a need to interrogate whether key dietary factors are able to 
reach the target tissue before implementing a chronic intervention (Phase 4). Preliminary in 
vitro data, produced by members of our research group, suggested both a rationale for interest 
in the topic and a working model for Phase 3 of the systematic series of studies. However, the 
invasiveness and required expertise involved in conducting the micro-dialysis or biopsy 
techniques needed to confirm whether any favourable conditions in vitro can be achieved in 
vivo placed further emphasis on the need to quantify dietary sources of potentially important 
precursors to collagen synthesis. On this basis, the current research program undertook a 
deliberate focus on the first steps (Phases 1-3) in the development and validation of dietary 
strategies to improve the health and function of collagenous tissues. By providing a robust 
interrogation of the early phases of this pathway, this program aimed to create a foundation of 
information that others could leverage to continue further investigation into the role of nutrition 
support for collagen synthesis in ligaments and tendons. The research program underpinning 




 Can a putative food source of collagen precursors, currently being used by athletes 
and/or their support teams for injury prevention/treatment, provide a proposed 
therapeutic dose of AAs? 
 Is urinary hydroxyproline, a previously identified biomarker of collagen intake, a valid 
and reliable option to assess the dietary intake of collagen in free-living individuals, 
which can be used to enable greater rigor in implementing acute or chronic 
interventions utilising dietary and/or supplemental forms of collagen (or 
epidemiological approaches to the effect of dietary collagen sources on the health and 
function of collagenous tissues)?  
 What are the key kinetics around the intake of protein sources proposed to be involved 
in collagen synthesis which will inform consumption protocols to coincide with 
exercise (e.g. when synthetic machinery is upregulated and tissue perfusion is 
supported)?  
 Can an in vitro model, reflective of physiological conditions, provide evidence that the 






Figure 1.1: Theoretical model of studies required to optimise nutrition support for collagen synthesis in 










The following literature review will summarise the function and structure of ligaments and 
tendons before moving to a discussion of the role of nutrition in their health and function. 
Themes that will be covered include: the importance of collagen protein; the biosynthesis of 
fibril-forming collagen; challenges in the measurement of collagen turnover, and the role of 
exercise in the synthesis of collagen. In addition, sex differences for connective health will be 
discussed, which ultimately led to the decision to exclude female participants from the ensuing 
data collection. Finally, the last section of the literature review will include the potential 
sources of collagen precursors in the Australian diet, and the background measurement of 
collagen intake. Whilst it is acknowledged that there are several nutrition strategies that may 
be associated with connective tissue repair (Curtis, 2016), including the provision of protein to 
prevent tissue atrophy (Berg et al., 1992; Farup et al., 2014) and the adequate intake of vitamins 
A and D (Berg et al., 1992), this literature review focused predominantly on nutritional 
strategies aimed to increase collagen synthesis within ligaments and tendons. Given the novel 
subject area and the availability of literature, the review will take on a narrative format, and 
include studies undertaken in animals and cell-culture models, where relevant. It is 
acknowledged that there are considerable differences in collagen turn-over between species 
(e.g. higher rates of growth in rodents), and challenges in the transferability of cell-culture 
models to in vivo outcomes (which will be further discussed in section 2.6.3). The literature 
included in this review was sourced from a number of databases including, but not limited to: 
PubMed, Medline via Ovid, and SPORTDiscus. Keywords used included: ligament, tendon, 






Although ligaments and tendons are predominantly composed of water, the majority of the dry 
weight of these tissues is made up of the structural protein, collagen (Magnusson et al., 2016). 
Collagen is the key tensile element in ligaments and tendons, and is responsible for the 
considerable strength that is necessary for their roles in locomotion and the stability of 
surrounding tissue (Gelse, 2003). The dominant type of collagen, known as fibril-forming 
collagen (principally type I), is composed of non-essential AAs (NEAA); chiefly proline and 
glycine (Kadler et al., 1996).  Given its importance in the health and functioning of ligaments 
and tendons, there is an obvious interest in factors, including nutrition that may assist in 
collagen synthesis and integration within these tissue types. Skeletal muscle is often used as a 
reference point for the emerging interest in collagen health; indeed, there is considerable 
research on nutrition and myofibrillar protein synthesis (Stokes et al., 2018), and in particular, 
the pivotal role of essential AAs (EAA), particularly leucine (Dodd et al., 2012). However, 
similar research on dense connective tissue is made difficult by the challenges of measuring 
collagen turnover and incorporation into the insoluble pool of collagen in ligaments and 
tendons (Smith et al., 2007). Unlike other major collagen containing tissues in the body (e.g. 
skin, and bone), ligaments and tendons are notoriously slow to turnover, requiring a lengthy 
intervention period in order to detect any meaningful changes (Babraj et al., 2005a; Babraj et 
al., 2005b; Shoulders et al., 2009; Smith et al., 2007). Additionally, it remains difficult to 
determine actual changes to the turnover and integration of collagen in these tissues without 
causing long term damage, which may be considered both unethical and unfeasible in athletic 
populations (Movin, 2000). Finally, lengthy and difficult intervention studies may be 
considered superfluous to these population groups as some experts consider ligaments and 




Despite these challenges, a number of studies have provided insight into the role of exercise in 
the synthesis of collagen, and have established that ligaments and tendons are indeed dynamic 
tissues that respond to loading with a change in both material and mechanical properties (Kjaer 
et al., 2015; Kjaer et al., 2009). This process is driven by “mechanotransduction”, a signalling 
cascade that occurs in response to a physical stimulus on the tissue, resulting in a biochemical 
milieu that enhances the synthesis of collagen (Chiquet et al., 2009; West et al., 2015). In 
addition to its role in the upregulation of collagen synthesis, exercise is also thought to enhance 
blood flow to these tissues which are otherwise poorly vascularised, thus assisting in the 
availability of nutrients when synthetic machinery is “turned on” (Bray et al., 2002). These 
issues may help to explain why previous studies have shown that nutrition alone appears unable 
to meaningfully increase collagen synthesis in tendons and ligaments (Babraj et al., 2005a).  
 
While emerging research on the potentially supportive role of nutrition in the synthesis of 
collagen is still predominately limited to cell-culture work and/or animal models, it is 
speculated that, similar to other protein fractions, key AAs may have both a stimulatory 
function and provide the framework for collagen protein to be incorporated into ligaments and 
tendons (Baar, 2017). In response to the extensive study of skeletal muscle tissue growth, initial 
studies of nutrition interventions and changes to the material properties of ligaments and 
tendons have followed a similar interest in the potential role of leucine in the synthesis of 
collagen (Barbosa et al., 2012; Dideriksen et al., 2011; Kato et al., 2016). However, the 
available literature suggests that, in a fed state, leucine intake beyond that of dietary sufficiency 
does not appear to have any additional benefit (Barbosa et al., 2012; Kato et al., 2016). 
Furthermore, these findings may be confounded if an increase in muscle tissue in response to 
a leucine intervention increases the physical stimulus to neighbouring tendons and ligaments, 




2005). Therefore, although leucine has strong physiological anabolic, and anti-catabolic effects 
on muscle tissue, which likely influences the synthesis of collagen in ligaments and tendons, 
its direct influence on collagen protein in ligaments and tendons remains inconclusive.   
 
More recently, attention has been focussed on the role of non-essential amino acids (NEAA) 
in the synthesis of collagen, particularly when combined with an appropriate exercise stimulus 
(Baar, 2017). Although these AAs are considered, by definition, “non-essential”, they are 
known to be the predominant AA within collagen protein. Furthermore, studies have suggested 
that NEAA may be required in higher amounts when endogenous production is inadequate to 
meet increased needs, such as during wound healing or where there are higher rates of turn-
over (Meléndez-Hevia et al., 2009; Mussini et al., 2017; Stechmiller et al., 2005). It is possible 
that athletic populations have a higher turn-over rate of collagen protein within ligaments and 
tendons compared to their sedentary counterparts due to the effect of consistent high-level 
exercise. Furthermore, as injury to these tissues is common among sporting populations and is 
often accompanied by surgery, there may be an increased requirement for NEAAs during post-
operative and/or rehabilitation periods. Whilst it is tempting to fortify individual AAs into the 
diet, the safety of this in humans is questionable, and may lead to AA imbalances, which has 
been shown in animal models to lead to adverse effects (Kurpad, 2018). 
 
Despite the potential benefits of collagen intake on the health/function of connective tissues, a 
lack of information on the collagen content of foods within the Australian food supply prevents 
the ability to quantify the dietary intake of collagen-derived proteins within various 
populations. It is speculated that it is likely to have reduced in the modern era, given current 
consumer preferences for lean meats, void of collagenous tissues (e.g. cartilage and bone) 




potentially consume greater amounts of dietary collagen sources; this includes followers of the 
Palaeolithic diet for whom bone broth is a staple food choice because of its purported collagen 
content and alleged support for collagenous tissues in the body (MacSharry, 2012). In addition, 
collagen supplements are commercially available and are being marketed at athletes for the 
same purpose. These products include hydrolysed collagen formulas containing di- and tri-
amino acid sequences (e.g. Pro-Hyp and Gly-Pro-Hyp). It has been suggested that these 
peptides have physiological functions beyond that of the intact or partially hydrolysed protein, 
and are able to reach the target tissue in their peptide form in a more rapid and pronounced 
manner (Aito-Inoue et al., 2007; Ichikawa et al., 2010; Iwai et al., 2005; Matsuda et al., 2006; 
Schunck et al., 2013). Such formulations have been shown to produce benefits to a range of 
collagen containing tissues with various outcomes including reduced inflammation, reduced 
tendon/joint pain and improved body composition within the elderly (Bello et al., 2006; Clark 
et al., 2008; Dressler et al., 2018; Oertzen-Hagemann et al., 2019; Oesser et al., 2016; Praet et 
al., 2019; Schunck et al., 2013; Zdzieblik et al., 2015). Although manufacturer claims promote 
these formulas as being more effective at increasing collagen synthesis than intact or partially-
hydrolysed collagen proteins, these claims have not yet been substantiated within the literature.  
 
2.3 The Function and Structure of Ligaments and Tendons, and the 
Importance of Collagen 
 
Collagen is the most widely abundant protein present in the human body, accounting for ~ 1/3 
of total body protein (Shoulders et al., 2009). Acting as the key tensile element of tissues, it 
contributes to strength and rigidity, and is a regulator of mechanical forces (Birch et al., 2013). 
Whilst 28 different types of collagen are currently known, type I, a fibril-forming collagen, is 
the main type present in the extra-cellular matrix (ECM) of ligaments and tendons (Shoulders 




influenced by the degree off cross-linking within collagen fibrils (Magnusson et al., 2016), 
provide another important feature (Hansen et al., 2006; Muiznieks et al., 2013). Indeed, cross-
linking of collagen molecules gives rise to tissues that are considerably strong and stable, as is 
necessary given their role in locomotion and stability of surrounding tissues (Rumian et al., 
2007). Specifically, tendons are responsible for the transfer of force from the muscle to bone, 
enabling movement (Birch et al., 2013), while ligaments connect bone to bone and prevent 
excessive movement occurring within joints (Frank, 2004). The extracellular matrix (ECM) of 
dense connective tissues plays a pivotal role in their load bearing capacity (Chiquet et al., 
2009). Within the ECM of ligaments and tendons there are different quantities of proteins, 
elastin, glycans and water, which is also distinctive to the tissue location (Table 2.1). Despite 
these differences, collagen protein predominates in all tissue types, accounting for ~55 – 80% 
of their dry weight (Rumian et al., 2007). 
 
Table 2.1: Matrix composition differences within ligaments and tendons. Mean ± SD (n=3) Adapted from 
Rumian et al. (2007). 













LCL 65.5 ± 3.9 126  ± 17 63.1 ± 1.0 5.1  ± 1.6 68.6  ± 5.3 
MCL 67.8  ± 3.0 157  ± 22 59.9  ± 1.8 4.3  ± 0.6 71.4  ± 7.9 
PCL 67.6  ± 2.9 197  ± 13 67.7  ± 0.7 34.3  ± 3.2 55.6  ± 4.3 
ACL 67.1  ± 2.5 181  ± 14 64.6  ± 1.0 7.4  ± 1.3 58.9  ± 4.1 
LDET 76.3  ± 2.6 187  ± 16 56.8  ± 1.0 6.2  ± 2.5 73.2  ± 3.6 
SDFT 77.6  ± 2.7 240  ± 6 56.2  ± 1.0 1.7  ± 0.3 78.8  ± 13.4 
PT 72.9  ± 3.6 202  ± 7 53.1  ± 0.8 2.3  ± 0.3 73.7  ± 1.4 
Collagen Fibril Index (CFI); Mass-Average Diameter (MAD); Glycosaminoglycans (GAG); Lateral Collateral 
Ligament (LCL); Medical Collateral Ligament (MCL), Poster Cruciate Ligament (PCL), Anterior Cruciate 





2.4 The Biosynthesis and Formation of Fibril-Forming Collagen 
 
Fibroblasts are the major cells involved in the production of collagen within ligaments and 
tendons (Gelse, 2003). The biosynthesis of collagen is a complex, multi-step process (outlined 
in Figure 2.1), and commences with the typical process of gene transcription and translation 
within the cell nucleus of the fibroblast, before being transferred to the rough endoplasmic 
reticulum. This results in a pre-procollagen molecule with repeating units of Gly-X-Y; whereby 
Gly is occupied by glycine, while X and Y can be occupied by any other AA acid but generally 
consist of proline and hydroxyproline, respectively (Ramshaw et al., 1998). These pre-
procollagen molecules then undergo hydroxylation of proline and lysine residues by the 
enzymes prolyl 3-hydroxylase, prolyl 4-hydroxylase and lysl hydroxylase. This is the first 
enzymatically-derived cross-linking process which utilises ascorbic acid (vitamin C) as a key 
co-factor (Gelse, 2003). The hydroxylated pre-procollagen molecules are then glycosylated 
with the addition of a sugar and disulphide bonds are formed. The pre-procollagen strands then 
wrap around each other to form a triple helical structure, through hydrogen bonding. The 
resulting molecule, known as procollagen, has the terminal ends: procollagen N terminal 
propeptide (PINP) and procollagen C terminal propeptide (PICP). The assembled procollagen 
chains are excreted into the ECM where they are cleaved at the terminal ends by N and C 
procollagen peptidases to form tropocollagen. Once this process is complete, collagen fibril 
assembly commences involving the maturation of the collagen molecule through covalent 
bonding, a copper-dependent hydroxylation of lysine residues utilising the key enzyme lyslyl 
oxidase (LOX) (Gelse, 2003).  Finally, collagen molecules assemble in a hierarchical manner 
to form fibrils (~10-300 nm in diameter), then fibres (~1-20 µm), and may further associate 




Figure 2.1: Schematic representation of collagen synthesis starting with transcription and translation 
within the fibroblast, followed by post-translational modifications, secretion, and finally extra cellular fibril 




2.5. Sex Differences for Connective Tissue Health 
 
Women are said to be up to 10 times more likely to sustain an ACL rupture than men (Arendt 
et al., 1999; Gwinn et al., 2000). Although there remains no definitive consensus on factors 
that contribute to this increased risk, dynamic movement patterns appear to be the main 
contributing factor (Stijak et al., 2015). However, several studies have shown an association 
between the menstrual cycle phase and injury risk. It has been illustrated that the ACL is an 
androgen responsive tissue (Lovering et al., 2005), and although not yet fully understood, 
several studies have shown that fluctuations in circulating sex hormones such as progesterone, 
oestrogen and testosterone may play either a protective or non-protective role (Beynnon et al., 
2005; Chidi-Ogbolu et al., 2018; Lee et al., 2015; Lovering et al., 2005; Stijak et al., 2015). It 
has been suggested that an increase in oestrogen results in an increased tissue laxity, which in 
turn increases knee displacement leading to a higher risk of injury (Beynnon et al., 2005; Chidi-
Ogbolu et al., 2018). In a recent study by Lee et al. (2015), utilising a cell culture model, it was 
shown that oestrogen inhibited the activity of LOX, without changing LOX expression or the 
amount of collagen present within the graft (Lee et al., 2015). Given the role of LOX on the 
cross-linking of collagen molecules (section 2.4), this was found to reduce the mechanical 
function of the engineered ligaments (Lee et al., 2015). Although the increased risk of 
connective tissue injury in women and the influence of sex hormones on connective tissue 
health presents an important area for future investigations, there remains a lack of consensus 
within this area (Ireland, 2002; Stijak et al., 2015). Nonetheless, it can be said that differences 
in the hormonal milieu due to the menstrual cycle phase or contraceptive pill use, is a 
confounding factor in research exploring the impact of nutritional interventions on dense 
connective tissue health/performance, and as such it was decided to exclude females from the 




2.6 Challenges Associated with the Measurement of Collagen Turnover in 
Ligaments and Tendons 
 
Presently, there is no “gold-standard”, non-invasive technique to directly measure collagen 
metabolism within human dense connective tissue. Therefore, research within this particular 
field remains challenging. Furthermore, considerations such as the time period required for the 
turnover of ligaments and tendons in order to illustrate measurable change needs to be 
considered for reasons such as compliance, budget and participant/staff burden. As a result, 
researchers often use an assortment of techniques, including a number of direct and indirect 
approaches, dependant on the research question, the time and budget available, and the skill 
level of the research team (Smith et al., 2007). The following section will discuss a number of 
approaches currently utilised to measure collagen metabolism within human dense connective 
tissue. The challenges and/or considerations will be discussed, and are summarised in Table 
2.2. Direct approaches will include those which determine the fractional synthetic rate (FSR) 
of collagen protein fractions within the target tissue utilising biopsy (Smith et al., 2007; 
Wilkinson et al., 2015; Wilkinson et al., 2014). Indirect approaches will include markers of 
collagen synthesis and breakdown within bodily fluids (e.g. procollagen monomers), and 
morphological changes measured through imaging techniques such as magnetic resonance 
imagining (MRI) and ultrasound (Hodgson et al., 2012). A more recent development, which 
utilises an in-vitro model to replicate human in-vivo conditions (3D cell culture) will also be 
discussed (Hagerty et al., 2012; Handsfield et al., 2017; Paxton et al., 2010; Paxton et al., 2012; 





2.6.1 Direct measures of collagen synthesis  
 
Currently, tissue biopsy is the only direct way to measure collagen synthesis and incorporation 
within various collagen containing tissues in humans (Smith et al., 2007). The incorporation of 
isotopically labelled AAs (e.g. AAs containing 2H, 18O, 15N or 13C) into the tissue has 
traditionally been utilised to measure the FSR of various protein fractions in a range of 
musculoskeletal tissues (Babraj et al., 2005a; Babraj et al., 2005b; Dideriksen et al., 2013; 
Dideriksen et al., 2011). However, this technique has been criticised for its complex 
experimental procedure, required including bed rest, intravenous cannulation and the use of 
expensive tracers. Furthermore, the technique is limited in its ability to track changes in protein 
synthesis and AA incorporation over periods greater than 12 hrs. A time frame which may fail 
to truly capture the slow and transient nature of collagen synthesis in dense connective tissue 
(Movin, 2000; Wilkinson et al., 2015).  
 
More recently, orally administered deuterium oxide (D2O), in combination with biopsy, has 
been utilised to quantify the day-to-day metabolism of multiple protein fractions (Wilkinson et 
al., 2014), and acute measures of MPS in as little as~3 h (Wilkinson et al., 2015). Consumed 
orally, D2O equilibrates rapidly in body water (~1-2 h), which creates a homogenous labelled 
precursor pool with a slow-turnover rate (half-life of ~9-11 days). The deuterium is exchanged 
with hydrogen and can be incorporated into metabolic pools and tissues, and thus provides a 
way to measure the FSR of various protein fractions (Wilkinson et al., 2017). This technique 
is less invasive, more cost effective, can be utilised in “free-living” individuals and can assess 
changes in collagen synthesis over periods > 12 h, thus being able to determine more chronic 
outcomes of interventions than isotopically labelled AAs (Wilkinson et al., 2015; Wilkinson et 
al., 2014). Despite advancements to this technique, biopsy remains an invasive protocol and 




time associated with such a procedure. Finally, the site of measurement may impact on the 
findings. For example, a recent study investigating levels of the 14-carbon isotope (14C) 
remaining in the core of the tendon in individuals born during periods of high atmospheric 
levels (~ 20 – 40 years ago, following the explosion of atomic bombs) led to the belief that 
such tissues do not turnover after pubertal development (Heinemeier et al., 2013). However, 
given that there is substantial evidence to suggest that ligaments and tendons are in fact 
dynamic and respond to multiple exercise modalities (see section 2.7.), others have suggested 
that ligaments and tendons grow at other regions of the tissue (e.g. periphery, proximal and/or 
distal ends) and therefore a biopsy of the tissue core may not appropriately reflect these changes 
(Kjaer et al., 2015; Mackey et al., 2008). 
 
2.6.2 Indirect measures of collagen synthesis 
 
There are several biomarkers that can be obtained from biological fluids to indicate collagen 
turnover. Collagen monomers (e.g. PINP and PICP), resulting from the formation of 
tropocollagen (see section 2.4), are commonly utilised to measure collagen synthesis (Koivula 
et al., 2012; Smith et al., 2007). Meanwhile, type I collagen fragments (e.g. Cross-linked C-
telopeptide of type I collagen and Cross-linked C-telopeptide of type I collagen: ICTP and 
CTX), derived during the process of cross-linking to stabilise collagen fibrils, have been used 
to indicate collagen breakdown (Eyre et al., 2008; Smith et al., 2007). Finally, hydroxyproline, 
a metabolite of proline, unable to be re-incorporated into newly synthesised collagen, may also 
be utilised to measure collagen breakdown (Prockop et al., 1961). While these techniques offer 
useful information with regard to the turnover of collagen protein, there are several 
considerations in utilising these measures. First, it has been suggested that there are two “pools” 
of collagen including an immature, soluble, fast pool, and an insoluble, mature, slow-turnover 




into the tissue, thus overstating the impact of an increase in collagen synthesis (Smith et al., 
2007). To overcome this issue, the measurement of markers of both collagen synthesis and 
breakdown may be warranted. Although this does not conclusively determine whether newly 
synthesised collagen is indeed incorporated into the target tissue, it allows for consideration of 
whether there is a net change in collagen metabolism within the body. However, it is also stated 
that serum measures are more likely indicative of bone collagen turnover given that bone has 
a higher rate of turnover (Eyre et al., 2008; Koivula et al., 2012). In order to overcome 
uncertainty around metabolic fates, obtaining dialysate from directly around the target tissue 
(e.g. peritendinous fluid) may be useful (Langberg et al., 2001; Langberg et al., 2000; Henning 
Langberg et al., 1999). However, this technique is also limited in its application due to greater 
invasiveness of procedure and the need for specialised equipment and/or personnel.  
 
Other indirect measures of collagen turnover include the measurement of morphological 
changes to the tissue through magnetic resonance imaging (MRI) and/or ultrasound, and have 
been utilised by a number of researchers for longer term investigations into the synthesis and 
incorporation of collagen into dense connective tissues (Couppe et al., 2008; Couppe et al., 
2013; Hodgson et al., 2012; Westh et al., 2008; Wiesinger et al., 2015; Zhang et al., 2015). 
Imaging techniques can illustrate tissue hypertrophy resulting from an increase in collagen 
content and are currently utilised to measure changes to collagen organisation or changes to 
tissue size which may imply an increase in collagen content or changes to fibril organisation 
associated with improved tissue health (Hodgson et al., 2012; van Schie et al., 2010). However, 
there are several limitations in the use of these techniques including high incidence of operator 
error and poor reproducibility (Hodgson et al., 2012). Moreover, morphological changes to 
tissue size necessitate a considerable time period to illustrate any measurable change given the 




equate to an increase in collagen integration. Indeed, an acute response of the tissues to injury 
(i.e. reactive tendinopathy) can result in a conditional hypertrophy due to an accumulation of 
water and ground substance (Cook et al., 2009). Thus imaging techniques should be used in 
conjunction with other measures of collagen turnover.  
 
2.6.3 Cell-culture models 
 
The use of 3D cell cultures, such as engineered ligaments and tendons have shown recent 
promise  (Baar, 2017; Handsfield et al., 2017; Paxton et al., 2010; Paxton et al., 2012; West et 
al., 2015). Developed from primary fibroblast cells isolated from a human donor, or established 
cell lines, this model provides a way to determine the response of these tissues to various 
interventions, in a well-controlled environment, without the need for invasive techniques (Ravi 
et al., 2015). This model has recently been utilised to provide information about biochemical 
changes that may occur as a result of exercise and/or nutrition interventions (Handsfield et al., 
2017; Paxton et al., 2010; Paxton et al., 2012; Shaw et al., 2017; West et al., 2015). After the 
3D cell culture model is grown to a particular strength, it is then treated for a period of time 
with the specific intervention, which may include human serum and/or plasma obtained after 
an exercise or nutrition intervention. The treated engineered ligaments are then tested for 
material (e.g. collagen content) and mechanical properties (e.g. modulus, ultimate tensile 
strength, and maximal tensile load). Although this approach offers several benefits as outlined 
above, it is unlikely that this in vitro work truly reflects in vivo conditions. For example, cell 
culture requires above-optimal levels of various components (e.g. hormones and/or nutrients) 
in order to facilitate and support the growth of cells (Yao et al., 2017). In real-world conditions, 
tendons and ligaments are known to be poorly vascularised (Bray et al., 2002; Tempfer et al., 
2015), and therefore nutrient delivery is likely sub-optimal in comparison to engineered tissues 




the engineered tissues contains supra-physiological levels of AAs which means results 
obtained from this technique may not be directly translatable to in vivo conditions (Bray et al., 
2002; Fenwick et al., 2002; Yao et al., 2017).  
 
While each of these techniques offer their own distinct advantages and disadvantages, it could 
be argued that there is indeed no “gold standard” technique in which to monitor the whole 
tissue response both acutely and chronically to interventions aimed at increasing collagen 
metabolism within dense connective tissues in human subjects. Presently, tissue biopsy is the 
only direct way to measure collagen metabolism within dense connective tissues, however, 
even with advancements to this technique, it remains invasive and potentially unsuitable for 
use in athletic populations. Whilst a number of indirect markers are able to be utilised which 
are less invasive than tissue biopsy, there are several complications with the interpretation of 
these markers. This includes the consideration that biomarkers of collagen metabolism are only 
able to give a “snap-shot” of the acute whole body response. Whilst imaging techniques may 
be utilised as an adjunct to give an indication of changes to tissue size over the longer-term, an 
increase in collagen content of the tissue can only be inferred from such measures. Regardless 
of the intervention(s) chosen, the slow turnover rate of dense connective tissues must be taken 
into consideration as this will have implications in regards to cost, and participant compliance 
to nutritional interventions. Lastly, whilst cell culture models provide a way to measure the 
potential response of dense connective tissues to various interventions in a well-controlled 
laboratory environment, this model is not necessarily reflective of in vivo conditions, and 




Table 2.2: Comparison of measurement techniques of collagen turnover in ligaments and tendons.  
Measure Rationale Considerations 
Direct 
FSR measured utilising biopsy 
Direct measure of the synthesis and 
incorporation of collagen into the target 
tissue.  
- Invasive. 
- Anecdotal reports of ongoing tissue pain, and the slow turnover rate of these tissues means its 
use needs to be considered in specific populations whom rely on the functioning of these 
tissues (e.g. athletes). 
The incorporation of isotopically 
labelled AAs 
Acute measure. 
- Only able to be used acutely (up to 12 h) given the complex experimental procedure (i.e. bed 
rest, cannulations, laboratory control).  
- Multiple cannulations required for infusion of AAs. 
- Significant cost. 
- Cannot be utilised in “free-living” individuals. 
Orally administered D2O Acute and chronic measure. 
- Able to be utilised acutely (~ 3 h), and more chronically (up to 8 days), thus may illustrate 
changes which would not yet be picked up by imaging techniques.  
- More suitable for use in “free-living” populations. 
- Although less biopsies required compared to above, still invasive in nature. 
Indirect 
Biomarkers of collagen synthesis in 
body fluids: 
 
- Multiple measures may strengthen the validity of outcomes and give an indication of collagen 
synthesis and incorporation, rather than just synthesis. 
Procollagen monomers e.g. PICP and 
PINP within the blood 
Involved in the process of collagen 
synthesis (refer to section 2.4). 
- Only semi-quantitative due doubts surrounding origin, site of processing and efficiency of the 
rates of transfer to sites of measurement i.e. tissue fluid, plasma, serum or urine. 
- PINP thought to be mainly reflective of bone turnover. 
- Reflects sum of whole body collagen turnover.  
Serum or urine cross-linked 
telopeptides C or N terminal (CTX, 
NTX), pyridium crosslinks, Type I 
collagen fragments (ICTP) within the 
blood 
Measurements of collagen breakdown or 
resorption. 
- Little known about the metabolic fate or relationship between production and appearance.  
- More likely reflect acute changes in fast-turnover collagen pool. 
Hydroxyproline excretion in urine  
Hydroxyproline not re-utilized as there is 
no hydroxy-prolyl- tRNA. 
- May be influenced by several other factors e.g. dietary intake, exercise, collagen related 
disease. 
Micro dialysis of above 
Measured closer to the site of the target 
tissue. 
- Less likely to be contaminated with collagen synthesis of other tissues.  
- May still only be indicative of collagen synthesis and not necessarily integration into the tissue.  




Imaging techniques Magnetic 
resonance imaging (MRI) and 
ultrasound 
Changes in size of tissue may be as a result 
of an increased collagen content. 
- Only gives qualitative information. 
- May not give indication of collagen content, particularly at the injured tissue due to reactive 
tendinopathy: accumulation of ground substance. 
- Potentially expensive. 
- Can only infer changes to collagen content and/or fibril organisation; not a direct measure. 
Cell culture 
Engineered ligaments/tendons 
- Ability to measure outcome of 
interventions without the need for 
invasive techniques. 
- Collagen content of the tissue 
determined through measurement of 
hydroxyproline content as it accounts 
for ~ 13% of the collagen monomer. 
- Tissue mechanics (e.g. ultimate tensile 
strength, modulus etc.) measured by 
custom built force transducer. 
- Cell donor may impact on tissue mechanics (e.g. post mortem cells may be weaker than those 
obtained during tissue reconstruction surgery).  
- For the cells to have the best chance of survival, conditions need to be “above optimal” e.g. 
media used to develop and treat ligaments contains up to four times fasting physiological levels 
of AAs. 
- Not likely to reflect in vivo conditions e.g. nutrient availability at the site of the tissue due to 





2.7 The Impact of Exercise on the Synthesis of Collagen in Ligaments and 
Tendons 
 
Whether there is capacity to influence the growth of ligaments and tendons beyond that of 
initial stages of development remains a topic of dispute. A study by Heinemeier and colleagues 
observed high levels of 14C in the core of the tendon in individuals born at a time of high 
atmospheric levels but not within skeletal muscle tissue, suggesting substantially slower 
turnover of tendons (Heinemeier et al., 2013). However, within the same study, some 
individuals of a similar age were found to have low tendon 14C levels, suggesting a variable 
capacity for tendon tissue turnover. In line with these findings, several others have found that 
tendons and ligaments respond both acutely and chronically to physical stimulus (Kjaer et al., 
2015). Thus, it plausible that these responses may have been as a result of higher physical 
stimulus over the individuals’ lifetime. By contrast, immobilisation has been shown to lead to 
atrophy of collagen containing tissues, via a marked reduction in circulating growth factors 
with a resultant reduction in collagen synthesis and further tissue mechanical properties 
(Boesen et al., 2013; de Boer et al., 2007; Kannus et al., 1997; Wren et al., 2000). Thus, it 
would appear that ligaments and tendons are in fact dynamic tissues that respond to loading.  
 
2.7.1 Mechanotransduction and fibroblast response to exercise  
 
It has been well documented that connective tissues respond to training through alterations to 
tissue mechanics (e.g. stiffness) and increased tissue size. Conversely, the absence of physical 
load results in tissue atrophy through a marked reduction of collagen synthesis (Magnusson et 
al., 2016). Mechanical stimulus (e.g. compression, tension and sheer) results in the activation 
of several intracellular signalling pathways and the expression of mechanosensitive genes 
leading to protein synthesis within the ECM of connective tissue (Figure 2.2) (Ackermann et 




integrin receptors act as the major transmembrane proteins. The matrix adhesions are 
responsible for the transmission of forces from the ECM to the intra-cellular environment, 
which results in a signalling cascade, known as “mechanotransduction” thought to drive 
collagen synthesis (Chiquet et al., 2009). Integrins, and integrin-associated proteins (e.g. 
collagen XII and tenascin-C), at the cell surface are believed to be key sensors of mechanical 
strain, and are important in linking the ECM to the cytoskeleton (Gauthier et al., 2018). 
Although several intracellular signalling pathways have been suggested to play a role in 
mechanotransduction, mitogen-activated protein kinase (MAPK) is said to be crucial in the 
conversion of mechanical stimulus to tissue adaptation (Kjær, 2004). Meanwhile, cell culture 
studies have illustrated that fibroblasts respond to mechanical stimulus by increasing their 
production and secretion of several growth factors and hormones, with a corresponding 
increase in mRNA expression of type I collagen (Kjaer et al., 2015). Growth factors and 
hormones believed to be involved in the process include transforming growth factor-1 (TGF-
β1), connective tissue growth factor (CTGF), insulin-like growth factor (IGF-1) and growth 









2.7.2 The response of ligaments and tendons to exercise  
 
While the exact mechanisms responsible for the adaptation of connective tissue in response to 
mechanical stimulus are complex and remain poorly understood, several studies have shown 
that dense connective tissue responds both acutely and chronically to exercise. Indeed, an 
increase in type I collagen biomarkers (e.g. ICTP, PICP) and/or growth factors (e.g. GH, TGF- 
β1) in response to acute exercise have been illustrated in several studies (Dideriksen et al., 
2013; Heinemeier et al., 2003; Kjaer et al., 2014; Miller et al., 2005; Moerch et al., 2013). 
Meanwhile, these biomarkers have also been illustrated to be present in the peri-tendinous fluid 
surrounding the Achilles tendon in response to both acute (Langberg et al., 2001; Henning 
Langberg et al., 1999) and prolonged exercise (Langberg et al., 2000). Utilising a 3D cell 
culture model, Paxton and colleagues illustrated that mechanical stimulus resulted in an 
increased collagen content, interface strength and sinew modulus compared to control (Paxton 
et al., 2010). Furthermore, West and colleagues used a similar technique to show that 
engineered ligaments treated with serum obtained from young, healthy men after exercise 
resulted in more collagen and improved tensile strength compared to serum obtained from 
resting men (West et al., 2015). Although, as outlined in section 2.6.3, these models are not 
necessarily reflective of in vivo conditions. Moore and colleagues, utilising a tracer, biopsy 
method, were able to show an increase in muscle collagen synthesis after an acute bout of 
resistance exercise (Moore et al., 2005). Although the same outcome was not found in a similar 
study looking at patellar tendon collagen synthesis after an acute bout of resistance exercise 
(Dideriksen et al., 2013). As outlined in section 2.6.1, the component of connective tissue 
biopsied may have affected these findings. Finally, others have shown that habitual loading of 
tendons results in an increased CSA across varying sections of the tendon which is presumably 
as a result of an increased collagen content (Wiesinger et al., 2015; Zhang et al., 2015). 




collectively, this evidence suggests that it is highly plausible that exercise plays a pivotal role 
in the synthesis, and incorporation of collagen protein within ligaments and tendons. 
 
2.7.3 The role of exercise in nutrient delivery to ligaments and tendons 
 
Adequate blood flow to tissues is necessary for the delivery of oxygen and nutrients (Pittman, 
2011). Although variability occurs with the tissue location, ligaments and tendons are said to 
be poorly supplied by blood, and therefore the delivery of nutrients are suboptimal, particularly 
at rest (Fenwick et al., 2002; Petersen et al., 1999; Tempfer et al., 2015; Yang et al., 2013). 
Poor blood supply can lead to a reduced healing capacity, and in the case of ligaments and 
tendons results in an increased length of time to heal, in comparison to other tissue types 
(Tempfer et al., 2015). Post-surgery, blood flow to the tissue is essential, and an inadequate 
supply can lead to cell and tissue necrosis. It should be noted that,  under some conditions (e.g. 
chronic tendinopathy and degeneration), there is an increased vascularity, the purpose of which 
is currently unknown but does not appear to be associated with tendon healing, and may in fact 
play a role in pain presentation, potentially as a result of tissue inflammation (Fenwick et al., 
2002). In addition to blood supply, synovial fluid has also been proposed to play a major role 
in the delivery of nutrients to dense connective tissue (Fenwick et al., 2002). Therefore, 
increasing blood flow and synovial fluid through exercise, improves tissue perfusion and 




2.8 The Role of Nutrition in the Synthesis of Collagen in Ligaments and 
Tendons 
 
As outlined in section 2.4, there are several processes which require adequate nutrition for the 
formation of fibril-forming collagen within ligaments and tendons. First, as a substrate for the 
protein synthetic machinery that elongate and synthesise collagenous protein (i.e. AAs), 
second, as co-factors in key enzymatic processes necessary for the formation of collagen cross-
links, resulting in a strong and rigid tissue (e.g. ascorbic acid and copper) (Scott et al., 2016). 
Adequate nutrition support is vital for the optimal functioning of all tissues in the human body, 
while malnutrition, such as inadequate dietary protein intake, can promote and/or accelerate 
losses to the integrity and structure of tissues (McCormick, 1989). Although recent research 
exploring the potential for nutrition to increase the synthesis and incorporation of collagen is 
scarce, it is well established that nutrition deficiencies can disrupt collagen synthesis and lead 
to poor wound healing and weak connective tissues (McCormick, 1989; Mussini et al., 2017). 
Indeed, given the role of ascorbic acid in the synthesis and stability of collagen molecules, its 
deficiency results in a loose ECM of collagen containing tissues, leading to the symptoms 
characteristic of scurvy such as bleeding gums, poor wound healing and retardations to normal 
tissue development (Boyera et al., 1998; Gelse, 2003). While it appears highly plausible that 
exercise plays a central role in the synthesis of collagen in ligaments and tendons (refer to 
section 2.7), the role of nutrition is still being determined beyond that of initial growth and 
development, and in states of malnutrition. The relevant studies are summarised in Tables 2.3-
2.6.  
 
Indeed, the effect of feeding on collagen synthesis remains inconclusive and appears to differ 
dependant on the tissue type (± the addition of exercise). In muscle, it has been illustrated that 




Similarly, Babraj et al. illustrated that, unlike bone collagen, collagen synthesis within the ECM 
of connective tissues is not upregulated post-prandially by nutrition alone (Babraj et al., 2005a; 
Babraj et al., 2005b). However, Moore et al., 2005 illustrated that an increased EAA 
availability, through the consumption of a protein supplement drink, every 30 min (0.1g/kg/h 
of carbohydrate and protein) in addition to resistance exercise led to an increased collagen 
synthesis in muscle (Moore et al., 2005). Meanwhile, Miller and colleagues have illustrated a 
coordinated response of skeletal muscle and tendon collagen synthesis following a combination 
of exercise and nutrition support every 30 min over 4 h (Miller et al., 2005). By contrast, a 
more recent study by Holm et al., 2010 found that although there was a clear effect of exercise 
on skeletal muscle collagen synthesis, intermittent feeding had no additive effect (Holm et al., 
2010). Thus, although not conclusive, it would appear that nutrition alone is unable to stimulate 
collagen synthesis within muscle and the ECM of dense connective tissue, and likely plays a 
supportive, rather than central, role.  
 
2.8.1 Essential, non-essential and conditionally essential amino acids  
 
Amino acids are necessary for the synthesis of all protein fractions within the human body, and 
have historically been defined as either EAAs or NEAAs, determined through nitrogen balance 
and growth (Rose, 1967). EAAs are those unable be endogenously synthesised and therefore 
exogenous sources are required to sustain tissue integrity via the consumption of suitable 
dietary protein sources. NEAAs, on the other hand, are synthesised endogenously, and 
therefore are not reliant on exogenous sources for adequate supply (Rose, 1967). It has been 
well documented that EAAs are necessary to support muscle protein synthesis (MPS) with 
inadequacies in the consumption of EAA resulting in atrophy of muscle tissue (Kumar et al., 
2009). Meanwhile, the EEA, leucine, has received considerable attention for its ability to 




Venne et al., 2012). The mechanism of action for leucine is thought to be the mammalian target 
of rapamycin (mTOR), which causes a signalling cascade resulting in MPS (Dodd et al., 2012).  
Given the important role of leucine in the synthesis of myofibrillar protein, some research 
groups have explored whether leucine may also play a role in the synthesis of collagen. Barbosa 
et al. (2012) illustrated that, although malnourished rats fed a leucine rich diet had a higher 
collagen content and improved tissue mechanics of the digital flexor tendon, which was further 
amplified by exercise, the high leucine diet failed to have the same effect in rats that were not 
malnourished (Barbosa et al., 2012). Meanwhile, Kato and colleagues showed that the 
ingestion of leucine-enriched EAA after exercise did not result in increased muscle collagen 
protein synthesis in rats (Kato et al., 2016). This suggests that leucine may be beneficial to 
maintain protein synthesis and tissue integrity in a malnourished state, however under 
conditions of dietary adequacy, there may not be any added benefit to the intake of additional 
leucine. Although leucine has not yet been established as a key player in the synthesis of 
collagen, recent research has suggested that AAs, such as those that predominate in collagen 
(e.g. proline and glycine) (see Figure 2.3.), may play a more distinctive role in its synthesis 












Although proline and glycine have previously been considered NEAAs, emerging evidence 
suggests that some NEAA may be conditionally essential (CEAA) and are required in higher 
amounts under certain conditions. An example of this is L-arginine, which has been shown to 
be required in higher amounts in situations where endogenous production does not meet the 
requirements for synthesis (e.g. during periods of metabolic stress and growth/development) 
(Demling, 2009; Mussini et al., 2017; Russell, 2001). L-arginine is utilised to synthesise nitric 
oxide, which, in dermal wound healing, has been shown to stimulate fibroblast proliferation 
and collagen synthesis, essential for scar formation (Fujiwara et al., 2014; Schaffer et al., 1996).  
 
Glycine occupies one third of the AA residues in collagen, and has traditionally been thought 
of as a NEAA (Wang et al., 2013). However, increasing evidence suggests that glycine may, 
in fact, be a CEAA, and similar to L-arginine, its requirements may not be able to be met 
endogenously under certain conditions (de Paz-Lugo et al., 2018; Li et al., 2018; Meléndez-
Hevia et al., 2009; Wang et al., 2013). Furthermore, glycine is thought to have a strong anti-
inflammatory influence, which may also play a role in maintaining tissue integrity under certain 
conditions (e.g. tendinopathy) (Wang et al., 2013). Indeed, a study by Vieira et al. (2015) found 
the inflamed tendons in rats which were fed a diet containing glycine achieved a higher 
hydroxyproline content, and GAG concentrations than those of an inflamed group fed a glycine 
free diet, and values similar to that of an un-inflamed control group (Vieira et al., 2015). 
However, whether the administration of glycine under normal conditions results in an increased 
synthesis of collagen in ligaments and/or tendons is yet to be explored.  
 
After glycine, proline (or its derivative, hydroxyproline) is the next most prevalent AA in 
collagen, comprising ~ 23% of AA content of collagen (Albaugh et al., 2017). Proline is a 




and hydroxyproline are essential for collagen structure and strength (Barbul, 2008). The 
hydroxylation of proline occurs post-translationally, utilising oxygen, iron and ascorbate as 
cofactors; once hydroxylated, it cannot be resynthesised into new collagen (Albaugh et al., 
2017). For wound healing, there are several pathways in which proline can be metabolised, 
through the utilisation of other AAs, including arginine (Albaugh et al., 2017). However, it has 
been shown that supplementation with either proline or hydroxyproline does not result in 
increased wound breaking strength or increased collagen deposition, likely due to the tight 
regulatory control of proline availability and the inability of hydroxyproline to be incorporated 
into new collagen (Barbul, 2008). With regard to dense connective tissue, several researchers 
have shown the importance of proline in the synthesis of collagen. Indeed, Dideriksen et al. 
(2011) found a trend towards a higher fractional synthetic rate of muscle collagen in elderly 
individuals after the consumption of casein, compared to whey protein. It is possible that this 
is due to casein providing a higher source of proline at 10.0 grams compared to 4.6 grams per 
100 grams for whey protein (Dideriksen et al., 2011). In support of these findings, recent in 
vitro work by Paxton and colleagues was able to illustrate that the treatment of engineered 
ligaments with proline (50 µM), in addition to ascorbic acid (50 µM) resulted in an increased 
collagen content, interface strength and sinew modulus compared to untreated ligaments 
(Paxton et al., 2010).  
 
Utilising a combined in vitro and in vivo design Shaw et al. (2017) illustrated that the ingestion 
of 15 grams of gelatin (denatured collagen containing high levels of both glycine and proline), 
equating to a concentration of 40 – 45 µM of proline in growth media, in addition to 48 mg of 
vitamin C increased the collagen content and mechanical properties of an engineered ligament 
in vitro. Meanwhile, the in vivo arm of the study showed a doubling of blood concentrations of 




of gelatin ingestion, one hour prior to 6 minutes of skipping (Shaw et al., 2017).  
 
Of course, as is previously outlined (section 2.6), there are several challenges with the 
interpretation of this data such as uncertainty around metabolic fates, and the challenges in 
transferring in vitro models, or animal studies, to human applications. Nonetheless, taken 
collectively, these studies illustrate that there is indeed potential for collagen precursors to 
support exercise in the synthesis of collagen in ligaments and tendons. Furthermore, it is also 
possible that during periods of increased metabolic demand and/or tissue turnover, the 
endogenous production of some AAs involved in the synthesis of collagen may be inadequate 
to meet requirements, and therefore may be required in the diet in higher amounts, however 
further investigations are required to confirm this hypothesis. Finally, more work needs to be 
done to determine the benefit of the intake of essential AAs (i.e. leucine) for ligaments and 




 Table 2.3: The impact of dairy derived proteins on collagen synthesis and mechanical properties of dense connective tissues: Animal models. 
Author/Year/Title Subjects and design Intervention Measures Outcomes Commentary 
  Nutrition Exercise    
Barbosa et al., 2012. A 
Leucine-rich diet and 
exercise affect the 
biomechanical 
characteristics of the 
digital flexor tendon in rats 
after nutritional 
recovery   
Male Wistar rats, 21 days 
old (n=56), maintained in 
collective cages at 22 ± 2 
°C, under 12 h light/dark 
cycles.  
 
Evenly separated into the 
following groups:  
 
 Control diet only: C 
 Control diet + 5 
weeks swim exercise: 
CT 
 Malnourished only: M 
 6 weeks malnourished 
+ 5 weeks control 
diet: MRC 
 6 weeks malnourished 
+ 5 weeks control diet 
+ swim exercise: 
MRT 
 6 weeks malnourished 
+ 5 weeks leucine rich 
diet: MRL 
 6 weeks malnourished 
+ 5 weeks leucine 
enriched diet + swim 
exercise: MRLT 
 
Free access to semi 
purified diets + water 
 
 Control diet: 18% 
protein. 
 Malnourished diet: 
6% protein. 
 Leucine rich diet: 




Swimming after 6 weeks 
for 5 days starting with 15 
min and progressively 
increasing 5 min per day 
until reaching 1 h of 
exercise per day. 
 Mechanical tensile 
strain (maximal load, 
displacement, stress 
and strain).  
 Cross-sectional area 
(CSA). 
 Collagen content of 







 Malnutrition produced 
a significant reduction 
in tendon CSA. 
 Exercise, especially 
when associated with 
nutritional recovery, 
increased the diameter 
of the tendon fibres as 
compared with the 
control group  
 Higher collagen 
content in leucine 
treated groups 
compared to 
sedentary and trained 
groups in tension 
region of the DDFT.  
 Higher collagen 
content in groups M 
and all nutritional 
recovery animals 
compared C in 
compression region of 
the DDFT. 
 In nutritional recovery 
groups, mechanical 
tensile strain were 
comparable to C.  
 Trained nutritionally 
recovered groups 
presented similar 
values to CT group.  
 Malnutrition possible 
lead to reduced CPS, 
and in turn CSA.  
 Exercise increased 
CPS, leading to 
increased CSA. 
 Different regions of 
the DDFT appeared to 
be affected differently 
by nutrition states.  
 Nutritional recovery 
and/or exercise lead to 
improved tensile 
strain compared to 
control groups. 
 Appears that LEAA 
administration in the 
fed state does not lead 
to increased CPS. 
Kato et al., 2016. Leucine-
Enriched Essential Amino 
Acids Augment 
Mixed Protein Synthesis, 
But Not Collagen Protein 
Synthesis, in Rat Skeletal 
Muscle after 
Downhill Running 
Female Wistar rats, 7 
weeks old, housed in a 
temperature-controlled 





 Sedentary (n=30) 
 Orally administered 
distilled water (Con), 
immediately, 3 h, 1 
day, 2 days, 4 days, 
and 7 days after 




 Intermittent running 
on a motor-driven 
treadmill, speed = 17 
m/min, for a total of 
130 min on downhill 
tracks.  
 During the exercise, 
26 repetitions of five -
min running bouts 
30 min after oral 
administration, rats were 
injected with flooding dose 
of proline for 30 min at 
which time vastus lateralis 
muscle was removed and 
used for analysis. 
 Collagen protein 
synthesis (CPS) in 
vastus lateralis muscle 
was elevated 1 and 2 
days after the 
exercise, compared to 
the sedentary group. 
 LEAA administration 
did not further 
Although CPS increased 
by exercise, increased 
EAA availability does not 




 Active (n-64) 
 
 
mixture (1 g/kg) 
immediately and 1 
day after the exercise. 
 The LEAAs mixture 
consisted of: histidine, 
2%; isoleucine, 11%; 
leucine, 40%; lysine, 
17%; methionine, 3%; 
phenylalanine, 7%; 
threonine, 9%; 
tryptophan, 1% and 
valine, 11%.  
 Except for the 
elevated leucine, this 
mixture contains the 
ratio of EAAs found 
in whey Protein. 
were separated by 2-
min intervals. 
increase CPS 1 h or 1 





Table 2.4: The impact of dairy derived proteins on collagen synthesis and mechanical properties of dense connective tissues: In vivo studies. 
Author/Year/Title Subjects and design Intervention Measures Outcomes Commentary 
  Nutrition Exercise    
Babraj et al., 2005. 
Collagen synthesis in 
human musculoskeletal 
tissues and skin 
 
EAA group: 
 Healthy young men, 
28 ± 6 y, BMI 24 ± 3 
kg/m2 (n=8). 
 Healthy elderly men, 
70 ± 6 y, 26 ± 4 kg/m2 
(n=8) 
 
Mixed nutrient drink 
group:  
 Healthy young men 25 
± 1 y, 22 ± 2 kg/m2 
 20 g of EAA  
 Mixed nutrient 
Drink: 15% Protein, 64% 
carbohydrate, and 21% fat 
over 280 min to provide the 
equivalent of 1.4 BMR 
 
Nil  Musculoskeletal 
collagen FSR 
measured by the 
incorporation of 
isotopically labelled 
proline or leucine. 
 Muscle biopsies at rest 
and 3 h post ingestion. 
 Patella tendon 
biopsies 2 h post 
flooding dose. 




 No difference on 
muscle collagen 
synthesis. 
 No difference on 
tendon collagen 
synthesis. 
 Similar tendon and 
ligament collagen 
synthetic rates, which 
were higher than 





previously thought.  
 Compared to similar 
study in bone tissue 
(Babraj et al., 2005) 
feeding independent 
of exercise had no 
effect. 
Dideriksen at al., 2011. 
Stimulation of muscle 
protein synthesis by whey 
and caseinate 
ingestion after resistance 
exercise in elderly 
individuals 
24 healthy elderly men (n = 
15) and women (n = 9) 




1. Casein pre: 71 ± 3 y, 
80.5 ± 6.5kg 31.1 ± 
3.0 % body fat (BF) (n 
= 6). 
2. Casein post: 70 ± 2 y, 
75.8 ± 6.1 kg, 27.6 ± 
4.0 % BF (n = 6). 
3. Whey post 64 ±1 y, 
76.1 ± 4.4 kg, 26.2 ± 
0.6 % BF (n = 6). 
4. Control: 68 ± 2 y, 71.9 
± 5.2 kg, 23.0 ± 3.2 % 
BF (n = 6). 
 
Labelled protein dissolved 
in 300mL water was 0.45 
g/kg lean body mass 
(LBM), resulting in 
individualized drinks with 
a total content of 15.6–30.4 
g Protein, 7.8–14.6 g 
EAAs, and 1.5–3.4 g 
leucine 
 
1. Calcium caseinate 
ingestion 30 min 
before exercise. 
2. Calcium caseinate 
immediately after 
exercise. 
3. Whey immediately 
after exercise 





5 sets of 8 x 80% 1 RM 
unilateral knee-extension 
and bilateral leg-press with 
3 min rest between sets 
 Muscle myofibrillar 





 Muscle biopsy 30 + 
390 min after exercise 
 Venous blood samples 
to evaluate changes in 
insulin and AA 
concentrations. 
 Myofibrillar protein ↑ 
after pre-casein 
ingestion. 
 Tendency for ↑ 
myofibrillar protein 
for post-casein and 
post-whey ingestion.  
 Insignificant tendency 
for ↑ muscle collagen 
synthesis for pre and 
post casein compared 
to post-whey ingestion 
and control. 
 
 Trend toward a higher 
FSR with ingestion of 
casein compared to 
whey protein, possibly 
due to proline content 




Farup et al., 2014. Whey 
protein hydrosylate 
augments tendon and 
muscle hypertrophy 
independent of resistance 
exercise contraction mode. 
Healthy recreationally 
active males: 23.9 ± 0.8 y, 
78.1 ± 1.8 kg, 181.5 ± 1.5 
cm, 16.0 ± 0.9% BF (n = 
22) 
 
Equally allocated to the 
following groups:  
 
1. Placebo (PLA) (n = 
11). 




Drinks (consumed ½ pre 




(CHO): 663 KJ; 19.5 
g whey protein. 
hydrolysate + 19.5 g 
CHO. 
 Placebo: 39 g CHO. 
 
 
Knee extensions training 
program 3 x per week for 
12 weeks (1 leg concentric 
+ 1 leg eccentric): 
 
Exercise progression: 
 Week 1 6 x 10-15 
repetition max (RM) 
 Week 2-3 8 x 10 – 15 
RM 
 Week 6-8 10 x 10-15 
RM 
 Week 8-10, 12 x 6–10 
RM 
 Week 11-12, 8 x 6-
10RM (2 sec tempo 
and 2 min rest 
between sets). 
 Quadriceps muscle 
and patella tendon 
magnetic resonance 
imaging (MRI) CSA. 




 PLA group ↑ CSA of 
quadriceps muscle 
independent of mode 
(but to a lesser extent 
than WHD). 
 WHD group ↑ CSA of 
patellar tendon. 
independent of mode 
 PLA group ↑ CSA of 
eccentric leg, but not 
concentric. 
 Significant correlation 
between quadriceps 
CSA and patella 
tendon CSA and 
quadriceps CSA and 
patella tendon CSA 
(when combining 
distal, mid and 
proximal levels).  
Given the correlation 
between quadriceps muscle 
increase and patella tendon 
increase in CSA, the impact 
that whey protein has on 
MPS, and that load has on 
increased collagen 
synthesis and tendon 
hypertrophy, it is likely that 
the increased loading of the 
muscle on the tendon led to 
the increased CSA. 
Miller et al., 2005. 
Coordinated collagen and 
muscle protein synthesis in 
human patella tendon and 
quadriceps muscle after 
exercise.  
Healthy young men. 
Separated into two groups: 
 
Group 1. 25±1 y, 186±9 
cm, 76±8 kg (n=8). 
Group 2 2. 29±1 y, 181±9 
cm, 76±6 kg (n=8). 
Consumed every 30 min 
for 3 hours: 
 Nutrient drink: 15 % 
protein, 64 % 
carbohydrate, 21 % 
fat. 
 Energy = 1.4 x 
Cunningham BMR 
 Feeding started with a 
double dose to bring 
subjects rapidly into a 
fed state.  
Group 1: 1 of 1 legged 
kicking at 67% Wmax vs 
Resting leg 
 
Group 2: 1 h of 1 legged 
kicking at 67% Wmax. R and 
L legs separated by 18 h.  
 
One leg: 6 x 10 max 
lengthening contractions w/ 
2.5 min rest b/w sets. 
 
Other leg: 6 x 10 max 
shortening contractions + 
extra to match workload w/ 
2.5 min rest b/w set. 
 Incorporation of 
isotopically labelled 
AAs (proline and 
leucine) into patella 
tendon, and 
quadriceps muscle. 
 Muscle biopsy at 24, 
48 and 72 h post 
exercise. 
 Muscle collagen at 
rest, 48 and 72 h after 
exercise 
 Tendon collagen 
synthesis at rest, fell 
thereafter but still 
significantly elevated 
72 h after exercise. 
 ↑ In muscle collagen 
synthesis at 6 and 24 
h, return to BL by 72 
h. 
 ~1.7 fold ↑ in tendon 
collagen synthesis at 6 
and 24 hours, which 
continued at 72 h.  
Increase in collagen 
synthesis in tendon 
potentially as a result of an 
increase in quadriceps size 









Table 2.5: The impact of collagen derived proteins on collagen synthesis and mechanical properties of dense connective tissues: Cell culture models. 
Author/Year/Title Subjects and design Intervention Measures Outcomes Commentary 
  Nutrition Exercise    
Paxton et al., 2010. 
Engineering an In Vitro 
Model of a Functional 




embryonic chick fibroblast 
cells. 
Constructs fed every 2-3 
days with DMEM media 
supplemented with 10% 
fetal bovine serum, and 
then supplemented with 
ascorbic acid (50 µM) , 
proline (50 µM), and/or 
TGF-β1 (2.5 ng/mL) on 
day 7 after plating for 2 
and 4 weeks. Groups 
included: 
 
 Constructs untreated 
at 2 and 4 weeks. 
 Constructs treated 
with ascorbic acid + 
proline at 2 weeks. 
 Constructs treated 
with ascorbic acid + 
proline + TGF-β1 at 2 
weeks. 
TGF-β1 acts as an exercise 
stimulus as it is 
upregulated after resistance 
training.  










 Collagen content: 
1.45 ± 0.32 
Ascorbic acid + proline: 
 Collagen content: 
8.34 ± 0.90, 
 22 fold increase in 
young’s modulus 
compared to untreated 
controls. 
Ascorbic acid + proline + 
TGF-β1:  
 Collagen content: 
11.25 ±0.82  
 34 fold increase in 
young’s modulus. 
 DMEM media utilised 
to develop and treat 
ligaments are at 
supra-physiological 
levels for some AAs 
particularly proline 
and leucine, whilst 
tendons/ligaments are 
poorly supplied by 
blood so unlikely that 
these levels world be 
reflective of in vivo 
conditions. 
 The vitamin C added 
to constructs was 
considerably high, 
and therefore led to 
high tissue mechanics. 







recreationally active males: 
27 ± 6 y, 79.6 ± 12 kg 
(mean ± SEM). 
 
Engineered ligaments 
developed utilising human 
ACL cells. 
 
0, 5 or 15 grams of gelatin. 
Consumed 1 h before each 
rope skipping session.  
6 min of skipping rope and 
then rest for 4 h. After 
leaving lab instructed to 
complete 3 sessions of 6 
min skipping, with at least 
6 h between each bout of 
exercise. 
 Blood draws at -1h 
and 0 h time points 
(before exercise) were 
used for engineered 
ligament treatment. 
 Bloods draws at 24, 
48 and 72 h after the 
initial bout of exercise 
were used to assess 
PINP. 
 Blood draws at -1, -
0.5 h, 0, 0.5, 1, 2 and 
4 h for AA analysis 
 Mechanical. 
properties: ultimate 
tensile stress (UTS), 
maximal tensile load 
(MTL). 
 Proline and glycine 
peaked at 1 h within 
the blood. 
 There was an 
increased collagen 
content corresponding 
to dose of gelatin. 
 There was an 
increased collagen % 
of dry mass. 
corresponding to dose 
without a change in 
CSA suggesting 
increased density of 
collagen fibrils. 
 MTL of ligaments 
increased for all 
treatment groups. 
 As a collagenous food 
source was utilised 
within the study, 
unable to ascertain 
which AA exactly had 
an impact. 
 PINP is more 
reflective of bone 
collagen synthesis. 
 As above re DMEM 




 Increased UTS and 
tensile strength.  
 Increase in PINP for 
treatment groups, 





Table 2.6: The impact of collagen derived proteins on collagen synthesis and mechanical properties of dense connective tissues: Animal models. 
Author/Year/Title Subjects and design Intervention Measures Outcomes Commentary 
  Nutrition Exercise    
Vieira et al., 2015. Glycine 
Improves Biochemical and 
Biomechanical Properties 
Following 
Inflammation of the 
Achilles Tendon. 
Young adult male (60 days 
old) Wistar rats, housed 
under 12 h light/dark cycle 
with free access to standard 
chow and water prior to 
treatment with glycine, and 
control diet. 
The animals were divided 
into five groups:  
 
 C: Control group                                                                                
 G1 and G3: Inflamed 
and control diet, and; 
 G2 and G4: Inflamed 




Tendinitis induced via 
injection into Achilles 
tendon 









 Greater concentration 
of hydroxyproline in 
G4 compared to other 
inflamed and treated 
groups: similar to 
control group. The 
effect of glycine on 
collagen content 
occurred within the 
first 7-21 days as there 
was no differences in 
the first 7 days of 
treatment 
 G4 withstood a larger 
load than other 
groups: similar to 
control 
 No differences in CSA 
between groups in 21 
days.  
 Epitenon of G2 was 
thicker than other 
groups. 
 No difference in MPa 
These results indicate that 
the glycine rich diet may 
rectify the degradation and 
disorganisation associated 
with inflammation results 
in biomechanics and 
collagen content similar to 
non-inflamed tendons. 
However, there was no 
non-inflamed glycine diet 
group, thus it is not 
possible to determine the 
impact of glycine in a 





2.8.2 Potential sources of collagen precursors in the Australian diet  
 
It has been estimated that American populations consume between 5.3 - 22.6 and 3.3 - 12.7 
grams of collagen protein per day for males and females respectively, which is predominantly 
provided through the intake of highly processed meats (Paul et al., 2019). Meanwhile, there is 
no reliable information available within Australia in regard to the collagen content of naturally-
occurring or processed foods, and as such, the average consumption cannot be estimated. As 
collagen contributes to a large proportion of protein found in animal tissues, dietary collagen 
is be obtained through the consumption of meat, particularly those with the skin, bone or 
connective tissue still attached (Eastoe, 1955) (Table 2.7). However, recent trends in Australia 
in regards to meat and poultry consumption has prompted a move towards isolated, lean cuts 
at the expense of the purchase and intake of whole carcasses or “lower quality” cuts that are 
often a valuable source of collagen (i.e. bone and cartilage) (Williams et al., 2010; Wong et al., 
2013).  
Table 2.7: Amino acid composition of the 5 major mammalian collagens and gelatin in comparison to 
human collagen. 
 Animal Collagen  Human Collagen 
Amino Acid Ox-hide Gelatin Pig skin Ox-bone Bone Tendon 
Alanine 11.0 11.3 10.7 10.5 10.9 10.3 
Glycine 27.5 27.2 26.4 25.3 25.8 25.4 
Proline 16.4 15.5 16.2 14.7 15.3 15.2 
Glutamic acid 11.4 11.6 11.3 11.9 11.4 11.1 
Hydroxyproline 14.1 13.3 13.5 14.1 14.1 12.6 






Although, there is no information regarding the collagen content of processed meats in 
Australia, it seems reasonable that a higher processed meat consumption would also result in a 
higher dietary collagen intake. However, processed meats are associated with an increased risk 
of several forms of cancer, and therefore, excess consumption is not recommended (Australian 
Government, 2015). Data from 2011-12 from the Australian Government indicated a typical 
average daily intake of 14.5 and 9.7 grams of processed meats for males and females 
respectively (Australian Government, 2017). This is in comparison to an average daily intake 
of 31.2 and 17.0 grams for males and females respectively, in America in 2001-04 (Paul et al., 
2019). Thus, within Australia there is a lower consumption of processed meat, potentially 
leading to a lower consumption of collagen compared to American populations. Another 
dietary source of collagen is gelatin which is commonly utilised in processed foods as a 
thickening or gelling agent; this is manufactured from ground animal collagen, most commonly 
porcine (Gomez-Guillen et al., 2011). Unfortunately, the gelatin content of foods such as ice-
cream, yoghurt and other desserts, or jelly confectionary is generally not specified since 
Australian labelling laws do not require amounts to be stated (Australian Government, 2016). 
Thus, the typical dietary intake of collagen in the contemporary Australian diet is thought to 
be low, or mostly unknown. This contrasts with increasing interest within some lifestyle and 
diet philosophies (e.g. the Paleo diet) which promote the intake of collagen-containing food 
sources, but supports the potential need for specialised food products, such as hydrolysed 
collagen powders (refer to section 2.8.3). Although there may be increasing interest 
surrounding supplemental sources of collagen, a food source may be preferential provided it 
supplies the potential collagen precursors without exposing the individual to known harmful 
dietary constituents often found within highly processes meats. The use of a food source of 
dietary collagen has the potential to tackle a number of sports nutrition and general health goals 






One particular food source of collagen to receive considerable attention in lay literature and 
alternative health circles is bone broth. Bone broth differs from meat stock and broth in that it 
is made by simmering bones, and other collagen-containing tissues, such as cartilage for 
lengthy periods (usually in excess of 24 hours) to enable the collagen protein that predominates 
in these tissue types to be leeched into the liquid (MacSharry, 2012). Bone broth is claimed to 
have several health benefits including boosting the immune system, treating disease including 
cancer, arthritis and inflammatory bowel disease, and addressing malnutrition (MacSharry, 
2012). It is also said to be beneficial for ailments affecting connective tissues (MacSharry, 
2012). However, there is a lack of evidence to substantiate these claims. Although bone broth 
is suggested to be a constant source of dietary collagen (and therefore the AAs that 
predominate), it may in fact describe a range of products including those that are home-made 
or commercially produced, and in varying forms including liquid and dehydrated powder. In 
addition, recipes may differ according to the source of the collagenous tissues (e.g. beef or 
chicken), the type of bone (e.g. standard soup/butcher bones, or marrow bones), the duration 
of cooking and the addition of acidic components such as vinegar which anecdotally, improves 
the solubility of bone and other collagenous tissue. As a result, it is likely that there is 
considerable variation in the amount and type of AAs present in bone broth (Murphy et al., 
2000). Therefore, while there has been increasing interest, and potentially increased intake of 
collagenous food sources within some lifestyle groups, it remains difficult to quantify intake 
due to a lack of information within food composition databases, a lack of labelling 





2.8.3 Hydrolysed proteins and bioactive peptides  
 
Supplemental forms of dietary proteins provide convenient, specific and timely sources of key 
nutrients, and may be of benefit when the consumption of whole foods cannot meet therapeutic 
requirements. Hydrolysed collagen and/or “bioactive peptide formulas” are steadily increasing 
on the market and are accompanied by claims that they are superior to other forms of dietary 
and supplemental collagen. Furthermore, due to the hydrolysis of cross-linking bonds, 
hydrolysed collagen powders are highly water soluble, which may result in increased 
palatability compared to partially hydrolysed formulations (i.e. gelatin). Additionally, recent 
research by Paul et al., (2019) suggested that it was possible to supplement the diet with a level 
as high as 36% of collagen peptides as a protein substitution without impacting on the overall 
protein quality of the diet (Paul et al., 2019). Some studies have shown that the ingestion of 
peptide formulas may be beneficial in a range of situations including a reduction of joint and 
tendon pain (Clark et al., 2008; Oesser et al., 2016; Praet et al., 2019) and improved body 
composition (Zdzieblik et al., 2015). The superiority of hydrolysed collagen and/or “bioactive 
peptide formulas” is proposed to be due to the high percentage of two and three hydroxyproline 
containing AA peptide sequences (e.g. Pro-Hyp and Pro-Hyp-Gly) which have the ability to 
rapidly pass the mucosal barrier, and are in turn suggested to have a higher bioavailability at 
the tissue matrix after their ingestion (Aito-Inoue et al., 2007; Ichikawa et al., 2010; Iwai et al., 
2005; Wang et al., 2016). However, these peptides have also been shown to appear in the blood 
after the ingestion of gelatin (Wang et al., 2015). In addition, it has also been suggested that 
peptide formulas have bioactive properties which influence physiological functions, including 
the upregulation of collagen synthesis, beyond that of the partially hydrolysed or intact proteins 
(Edgar et al., 2018; Paul et al., 2019; Rutherfurd-Markwick, 2012). Indeed, a number of studies 
have shown that the ingestion of hydrolysed collagen leads to an increased collagen synthesis 




et al., 2003; Schunck et al., 2013). In support of this, a recent study by Oertzen-Hagemann et 
al., (2019) identified that resistance exercise, in combination with the consumption of 
hydrolysed collagen, resulted in a higher upregulation of collagen related proteins and 
pathways, compared to a placebo control (Oertzen-Hagemann et al., 2019). Thus, the 
consumption of hydrolysed and/or bioactive peptide formulas may have several beneficial 
influences on collagen containing tissues compared to non-hydrolysed and/or intact proteins, 
although more work is necessary to confirm this.  
 
2.8.4 Quantifying habitual intake of collagen 
 
Given the lack of information on the collagen content of various food stuffs in Australia, it is 
difficult to account for background dietary intake of collagen in both epidemiological and 
intervention studies (Weaver et al., 2017). As outlined in section 2.6.2, hydroxyproline is a 
metabolite of proline, and cannot be incorporated into the synthesis of new collagen (Albaugh 
et al., 2017). Hydroxyproline constitutes ~14% w/w of collagenous protein, and its measurement 
in bodily fluids (e.g. blood and urine) can be used to assess the breakdown of collagen protein 
as a result of collagen related disease and/or disorders (e.g. Marfan’s syndrome) (Eastoe, 1955; 
Sjoerdsma, 1965). In such protocols, the intake of dietary collagen is restricted prior to testing, 
to prevent this source of hydroxyproline in bodily fluids from influencing the interpretation of 
data (Prockop et al., 1961; Sjoerdsma, 1965). Indeed, early studies by Prockop et al., (1961) 
found a four- to five-fold increase in excretion of urinary hydroxyproline when 28 grams of 
gelatin (containing 4 grams of Hyp) was consumed (Prockop et al., 1961). More recent research 
has shown that the consumption of 30 grams of gelatin led to the urinary excretion of 14 mg of 
hydroxyproline, while a parallel study by the same author showed an increase in 




µM after the consumption of 10 grams of gelatin) (Knight et al., 2006). Given that the intake 
of collagenous proteins lead to an increased excretion of hydroxyproline in the urine, it may be 
possible to use urinary hydroxyproline as a biomarker for collagenous intake in healthy 




2.9 Summary and Conclusion 
 
The capacity for nutrition to influence collagen synthesis in ligaments and tendons is of obvious 
interest as it may play a role in the health/functioning, injury prevention and supporting the 
rehabilitation of these tissues. The limited, but accumulating, data suggest that nutrition 
interventions may support exercise in increasing the synthesis and integration of collagen into 
ligaments and tendons. However, there are challenges and/or gaps within the current literature 
that need to be considered prior to embarking on a lengthy, costly, and challenging nutrition 
intervention study. These include determining the optimal food source and/or supplement 
containing AAs that may support collagen synthesis, and the bioavailability of various collagen 
food sources and/or supplements, including hydrolysed vs. non-hydrolysed formulations. 
Finally, determining a suitable biomarker to assess collagen intake may provide rigidity to 
nutrition intervention studies by accounting for background intake of collagen proteins. The 
studies contained within this thesis will attempt to address some of the gaps unearthed within 











As is outlined in Chapter One, this body of work involved a series of studies aimed at 
progressing the knowledge gained in each, with the goal of “filling in” literary gaps prior to 
the future implementation of a well-designed in vivo intervention study (see Figure 1.1). 
Detailed methods of each study are available in the respective chapters. Study 1 was completed 
independently of Studies 2-4, with a comprehensive outline of the methods available in Chapter 
Four. The data collection process for Studies 2-4 was undertaken over two phases; this section 
will give an overview of the rationale, process and timeline of this data collection. 
 
3.2 Rationale for Data Collection Process  
 
Given that there are several benefits of utilising food over supplemental sources of nutrients, 
Study 1 “Bone broth unlikely to provide reliable concentrations of collagen precursors used in 
collagen research” investigated whether bone broth is a reliable source of AAs that may be 
involved in the synthesis of collagen in amounts that are equivalent to supplemental sources. 
These data informed the decision not to utilise bone broth in the final study, as it was found to 
be an unreliable source of AAs. Study 2 “Urinary hydroxyproline is only suitable as a 
biomarker for acute intake, up to 6 hours post ingestion of collagen proteins in free living, 
healthy active males” was developed to determine whether urinary hydroxyproline could be 
used as a reliable biomarker for background dietary collagen intake, to ultimately enhance the 
robustness of nutritional intervention studies. Study 3 “Plasma amino acid responses after the 
ingestion of dairy and collagen protein, in healthy active males” was developed to characterise 
the plasma AA response to the intake of collagen and dairy protein sources that might be used 
to support the synthesis of collagen in ligaments and tendons. Study 4 “The consumption of 




ligaments treated with a media reflective of fasting physiological amino acids” represented the 
culmination of information derived from previous studies, utilising serum obtained after the 
consumption of dairy and collagen proteins to treat engineered human ligaments in vitro.  
 
Data collection for Study 3 was undertaken in two phases (see Figure 3.1). Part A, was 
undertaken during September/October 2017 and also included the data collection for Study 2. 
Part B data collection occurred during February/March 2018 and also gathered samples for 
Study 4, with the information from Part A used to inform the optimal timing (i.e. time of peak 
concentrations of AAs of interest) for the blood draw used in the treatment of engineered 
ligaments. This sequencing of data collection allowed sufficient time to analyse the relevant 
samples to inform the methodology of the subsequent study, while also providing an efficient 












A total of 15 healthy, active males (30 ± 5 years; 80 ± 8 kg BM) were recruited for Studies 2, 
3 and 4, with data collection occurring over two phases (as outlined above). The following 
exclusion criteria was specified:  
 Females: As is outlined in section 2.5, variations in serum oestrogen concentrations 
associated with female reproductive function have been suggested to influence the 
mechanical properties of engineered ligaments via its action on LOX (Lee et al., 2015). 
This would add a confounding variable to the study and therefore we decided to control 
for this by excluding female subjects.  
 Individuals with allergy/intolerance to porcine and/or bovine gelatin, milk and/or milk 
products and/or chicken/beef/seafood. 
 Individuals with diabetes: Increased blood glucose has been shown to influence non-
enzymatic cross-linking in collagen (Couppe et al., 2016). 
 Individuals with a history of recent (< 1 month) or current tendinopathies: Inflammatory 
cytokines have been shown to influence fibroblast activity and collagen synthesis and 
subsequent cross-linking (Kjaer et al., 2013). 
 
The sample size (of n = 15) for Study 3 was chosen using power estimation determined in 
previous, similar studies of the AA response to dietary protein intake (Burke et al., 2012; van 
Loon et al., 2000). Sample size estimates for Study 4 were informed by previous work by our 
group utilising a similar protocol. With the goal of being able to detect a 2.4 µg change in 
engineered ligament collagen content, and assuming a SD of 1 µg with 80% power at the 0.05 
level, a sample size of eight subjects was deemed appropriate (Shaw et al., 2017). The first data 




3. The second period of data collection (Part B) involved recruiting the final seven participants 
for Study 3 (to reach a total of n = 15 as determined by power calculations) and eight 
participants for Study 4 (with one participant re-recruited from Part A). The data collection 
protocol was submitted to the Australian New Zealand Clinical Trials Registry 
(ANZCTR12617000923369), and approval was granted by the Australian Institute of Sport 
Ethics Committee (20170607). 
 
3.4 Protein Food Source or Supplement 
 
Four collagen and two dairy protein sources were selected for Study 3 and administered in a 
counter-balanced order. These included a hydrolysed collagen peptide powder (Tendoforte, 
Gelita, Eberbach, Germany); a non-hydrolysed collagen powder (Gelatin, McKenzies, VIC, 
Australia); a hydrolysed dairy protein powder (Hydrolysed casein) and a non-hydrolysed dairy 
protein powder (Calcium Caseinate) (both from Professional whey, NSW, Australia); a liquid 
collagen supplement (GBR nutrition, Lancashire, UK), and a bone broth (Elemental Café, 
Braddon, ACT, Australia) sourced for Study 1, and frozen until needed for use in the relevant 
studies (refer to Table 4.1, for further details). We chose a standard dose of 20 g protein for all 
powdered supplements and 60 mL of liquid collagen (equivalent to 20 g of collagen protein as 
per manufacturer information). This dose was chosen to build on previous work (Shaw et al., 
2017), with a slightly higher dose to increase AA availability (Imaoka et al., 1992; Iwai et al., 
2005). As we found substantial variability in the AA content of bone broth (Alcock et al., 
2018), we decided on a 300 mL serve, as we deemed this to be an acceptable amount to 
consume with the prescribed 5 minutes. To maintain consistency all other protein sources were 




3.5 Data Collection Protocol 
 
3.5.1 General protocol 
 
For each data collection (Part A and B); a total of six trials were undertaken with the ingestion 
of a different test protein food source/supplement, in a counter-balanced order, with a minimum 
of 48 h between trials. Participants arrived to the laboratory (The Australian Institute of Sport) 
after an overnight fast (> 10 h) and in a rested state, to ensure that no significant elevations to 
heart rate would increase blood flow. On arrival to the lab, a 22G indwelling cannula was 
inserted into the antecubital vein for blood collection by a trained phlebotomist, and a baseline 
(BL) blood sample (2 mL) was collected into lithium heparin Vacuette tubes (Greiner Bio-One, 
Kremsmünster, Austria). Immediately after cannulation, the protein source was prepared and 
given to participants who were instructed to consume it within 5 min, sipping slowly 
throughout. Completion of the 5 min period was considered as t = 0. To standardise gastric 
emptying, no other fluid was available for 60 min following consumption; thereafter ad libitum 
water consumption was permitted. Participants then remained resting while 2 mL blood 
samples were collected every 20 minutes over the succeeding three hours. Immediately after 
each blood collection, samples were centrifuged at 1500 xg for 10 min at 4°C. The resulting 
plasma was separated into 500 µL Eppendorf cryotubes and stored at -80°C until required for 
analysis. Whilst at the lab, participants were given a feedback form to complete. The form 
provided four questions related to acceptability and palatability of the protein source in the 
format of a Likert scale (Likert, 1932), and one question with a yes or no response (further 
details can be seen in Chapter Six). Once the three hour period was concluded, the cannula was 




3.5.2 Part A specific protocol 
 
After the consumption of the hydrolysed and non-hydrolysed dairy, and collagen proteins 
(outlined above), participants were required to collect their urine into clean plastic bottles (2 L 
capacity) over a 24 h period, divided into three collection periods (t = 0-6, 6-12 and 12-24 h). 
The subjects also completed 24 h urine collections on 2 baseline (BL) days when no supplement 
was consumed, and normal eating patterns were maintained using breakfast as t = 0 and 
continuing the same collection periods. Participants were instructed to keep urine in a cool, 
dark place and return samples to the laboratory as soon as possible after collection. Urine 
volumes were measured, and aliquots of each sample were stored at -80°C until analysis. Since 
hydroxyproline: creatinine ratio is a commonly accepted way to standardise the reporting of 
hydroxyproline values, hydroxyproline and creatinine were analysed, and the hydroxyproline 
mmol: creatinine mol ratio was calculated.  
 
At the commencement of the study, subjects were instructed by a Sports Dietitian to maintain 
their habitual dietary practices while recording their meal on the night prior to each trial and 
their food and fluid intake during the period of the 24 h urine collection. Food diaries were 
analysed for total protein intake (g/meal and g/day) using dietary analysis software (Foodworks 
v9, Xyris Software, Australia). As the excretion of hydroxyproline has been shown to be 
upregulated for >24 h following exercise (Brown et al., 1997), exercise in the 24 h period prior 
to collection, was recorded by participants in terms of the duration of the bout and a sessional 
rating of perceived exertion (RPE). A standardised metric to describe/compare exercise 




3.5.3 Part B specific protocol 
 
On this occasion, an additional 55mL of blood was collected on three occasions, 40 min after 
the ingestion of three different supplements; a non-hydrolysed collagen (gelatin), a hydrolysed 
collagen (gelita) and a hydrolysed dairy protein (casein). In addition, a BL blood draw was also 
taken on one occasion before any supplements were consumed. After collection, the blood was 
allowed to clot for 30 min at room temperature then centrifuged at 1500 xg for 10 min with the 
resultant serum separated into 2 x ~12 mL, aliquots, under sterile conditions. The samples were 
then stored at -80°C until further analysis. Once all samples were collected, they were then sent 









3.6 Specimen Processing and Analysis 
 
This section will provide extended information in regard to processing and analysis that is not 
available within some, or all, of the Chapters. Where there is extensive information provided 
within the respective Chapters, this information has not been reproduced in this section.  
 
3.6.1 AA analysis of protein sources 
 
Protein sources were analysed for full AA profiles at an independent facility (Australian 
Proteome Analysis Factory, Macquarie University, NSW) using Ultra Performance Liquid 
Chromatography (Waters AccQTag Ultra, Waters Corporation, MA, USA). Where necessary 
(such as for bone broth), prior to analysis, samples were briefly warmed to 37°C to liquefy any 
fatty material and then mixed to provide a homogenous sample. Samples underwent a 24 h 
liquid hydrolysis in 6 M HCl at 100°C and were analysed in duplicate with results provided as 
a mean value (acceptance of variation of 10%). 
 
Hydroxyproline analysis 
Urinary hydroxyproline was measured using a colorimetric hydroxyproline assay kit according 
to manufacturer’s instructions (abcam, Melbourne, Australia). Briefly, in a counter-balanced 
order, 100 µL urine was mixed with 100 µL of 10 N NaOH in a pressure-tight vial and 
hydrolysed at 120°C for 1 hour. Vials were then cooled on ice and neutralised by adding 100 
µL of 10 N concentrated HCl. Samples were then decolourised by adding 4 mg of activated 
charcoal to the neutralised hydrolysate. Vials were then centrifuged at 10,000 xg for 5 min. 
Collected, clarified supernatant was then evaporated in a 96 well plate (Corning, NY, USA) at 
65°C. 100 µL of an oxidation reagent mix was added to each well, and incubated at room 




and incubated at 37°C for an additional 5 min. 50 µL DMAB concentrate solution was then 
added to each reaction well, and the plate was sealed, and incubated at 65°C for 45 min. 
Absorbance was then measured at 560 nm on a microplate reader (FLOUstar omega, BMG 
LABTECH Pty. Ltd., Mornington, Vic, Australia). The hydroxyproline concentration was then 
calculated from a curve of known standards. 
 
3.6.2 Creatinine analysis 
 
Urine was diluted with deionised water 1:20 and then analysed for creatinine by an enzymatic 
colorimetric assay on an automated clinical chemistry analyser (COBAS Integra 400, Roche 
Diagnostics, Risch-Rotkreuz, Switzerland) and the Hyp: Cre mmol: mol ratio was calculated.  
 
3.6.3 Plasma AA 
 
For analysis of AA concentrations in food and plasma, samples were sent to M3 Research Unit 
(Muscle Metabolism Maastricht, Human Movement Sciences, Maastricht University, 
Netherlands) and analysed using liquid chromatograph mass spectrometry (UPLC-MS; 
ACQUITY UPLC H-Class with QDa; Waters, Saint-Quentin, France). Briefly, samples were 
prepared according to manufacturer’s instructions, with an internal standard added. 50 µL of 
plasma was deproteinised using 100 µL of 10% sulfosalicyclic acid with 50 µM of 
metabolomics AA mix standard (Cambridge Isotope Laboratories, Massachusetts, USA). 
Subsequently, 50 µL of ultra-pure demineralised water was added and samples were 
centrifuged. After centrifugation, 10 µL of supernatant was added to 70 µL of Borate reaction 
buffer (Waters, Saint-Quentin, France). In addition, 20 µL of AccQ-Tag derivatising reagent 
solution (Waters, Saint-Quentin, France) was added, and the solution was heated to 55°C for 




Preface to Chapter Four 
 
Chapter Two identified a range of potential sources of collagen precursors within the 
Australian diet. Bone broth is an “in vogue” source of dietary collagen which is touted for its 
benefits in a range of tissues, including ligaments and tendons. The use of food sources to 
provide a therapeutic benefit is of obvious interest for sports nutrition professionals given the 
potential to provide other beneficial nutrients, and to avoid the risk of inadvertent doping. 
However, there is a lack of research substantiating many of the claims surrounding bone broth. 
In particular the AA content of this putative collagenous protein source, and how it compares 
to reference supplements which have preliminary evidence suggesting the capacity to support 
exercise in the upregulation of collagen synthesis in ligaments and tendons. The following 
Chapter (Study 1) sought to determine whether bone broth is comparable to reference 
supplements in its AA content, and whether differences in preparation methods would increase 





Chapter Four: Bone Broth is Unlikely to Provide Reliable 
Concentrations of Collagen Precursors Compared with 
Supplemental Sources of Collagen Used in Collagen Research 
 
Statement of publication 
The chapter is comprised of a currently published manuscript, with slight adjustments made to 
formatting for the purpose of this thesis. A published version is available in the International 
Journal of Sports Nutrition and Exercise Metabolism.  
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of Collagen Precursors Compared With Supplemental Sources of Collagen Used in Collagen 
Research. Int J Sport Nutr Exerc Metab. 2018 Sep 26:1-8. Doi: 10.1123/ijsnem.2018-0139. © 







Intake of dietary sources of collagen may support the synthesis of collagen in varying tissues, 
with the availability of key amino acids being a likely contributor to its effectiveness. This 
study analyzed commonly consumed preparations of bone broth (BB) to assess the amount 
and consistency of its amino acid content. Commercial and laboratory prepared samples, 
made with standardized and variable (non-standardized) protocols were analyzed for key 
amino acids (glycine, lysine, proline, leucine, hydroxyproline and hydroxylysine). The main 
finding of the study was that amino acid concentrations in BB made to a standardized recipe 
were significantly lower for hydroxyproline, glycine, proline; P = 0.003 and hydroxylysine, 
leucine and lysine; P = 0.004 than those provided by a potentially therapeutic dose (20 g) of 
reference collagen supplements (P > 0.05). There was large variability in the amino acid 
content of BB made to non-standardized recipes, with the highest levels of all amino acids 
found within the café prepared varieties. For standardized preparations, commercial BB were 
lower in all amino acids than the self-prepared varieties. There were no differences (P > 0.05) 
in the amino acid content of different batches of BB when prepared according to a 
standardized recipe. If the intake of collagen precursors is proven to support the synthesis of 
new collagen in vivo, it’s unlikely that bone broth can provide a consistently reliable source 
of key amino acids. Focus on the provision of key amino acids from dietary sources should 
continue to focus on the standard sources currently being researched.  






Collagen is the most abundant body protein, constituting around one third of total protein 
stores. Within the extra cellular matrix of musculoskeletal and connective tissues, collagen 
contributes to force transmission and joint stability, providing resistance to forces and sudden 
directional changes that might otherwise contribute to injury (Baar, 2015). Both the overall 
collagen content of the tissue and the cross-linking of collagen molecules contribute to a greater 
level of tissue stiffness and stability (Kadler et al., 2007; Kjaer et al., 2009). Connective tissues 
with a higher cross-sectional area, and presumably higher collagen content and/or density, may 
be more resistant to strain and more capable of withstanding higher loads (Couppe et al., 2008).  
Consistent evidence of a beneficial interaction between exercise and nutrition on skeletal 
muscle protein synthesis has led to explicit recommendations to optimize this process; these 
involve the timing of intake and dose of specific amino acids in combination with exercise, 
with leucine providing a separate stimulus for protein synthesis and other amino acids servicing 
as precursors for the building of the new muscle proteins (Atherton et al., 2012; Phillips et al., 
2011). Whether nutritional strategies can enhance the growth and/or assist in the repair of 
collagenous tissues is currently under investigation and may have implications both within 
ageing populations for the treatment of age related declines in muscle tissue (i.e. sarcopenia) 
(Zdzieblik et al., 2015), and athletic populations for the prevention and treatment of connective 
tissue injury (Baar, 2015, 2017). Although whey protein has been shown to enhance patella 
tendon hypertrophy in young males when combined with a 12 week resistance exercise training 
program (Farup et al., 2014), it is currently unclear whether this resulted from direct 
upregulation of collagen synthesis or in response to hypertrophy of the quadriceps, due to the 
provision of key amounts of the amino acid, leucine. Indeed, according to the ‘leucine’ trigger 
Hypothesis, the provision of targeted amounts (~3 g) of leucine, as found in whey protein, in 




muscle protein in response to exercise.  (Atherton et al., 2017; Phillips, 2014).  Alternatively, 
amino acids abundant in collagen protein, such as proline, and glycine have been shown to be 
essential for the synthesis of new collagen (Li et al., 2018) with in vitro and in vivo work 
demonstrating the potential benefit of glycine and proline availability at times around exercise 
when synthetic machinery is up- regulated. Recently, we reported increases in procollagen I 
Intact N terminal (PINP), following a 3-d protocol involving consumption of 15 g.d-1 of gelatin 
(a dietary form of collagen) and rope-skipping exercise compared to a placebo control. While 
further in vitro work supported these findings, with higher serum concentrations of glycine and 
proline increasing the collagen content and mechanical properties of an engineered ligament 
exposed to a stretch stimulus (Shaw et al., 2017). Meanwhile, other investigations have 
demonstrated the benefit of hydrolyzed collagen supplementation in a range of collagen 
containing tissues (Daneault et al., 2017; Oesser et al., 2016; Oesser et al., 2003; Schunck et 
al., 2013). Although research to date has focused on supplemental and refined sources of 
collagenous proteins, some cultures and exercise groups (e.g. traditional Chinese medicine and 
Cross-fit athletes) are known to consume food forms of collagen for therapeutic purposes 
(Nelson, 2015; Wu et al., 2013). While, it is currently unclear as to which nutrients are 
specifically involved in promoting the health of collagenous tissues, there is also evidence that 
sports nutrition professionals are recommending the intake of collagenous protein sources 
(such as gelatin) to athletes with tendon and ligament injuries to  aid in repair and accelerate 
return to play after injury. The proposed mechanism underpinning such a strategy is that the 
increase in blood concentrations of the amino acids and related compounds found in collagen 
will support an increase collagen synthesis (Baar, 2015). 
 
Bone broth (BB) is a dietary collagen source which has received anecdotal support for a variety 




by simmering bone and cartilaginous meat sources for lengthy periods (> 24 h), purportedly to 
enable collagen protein and bone-related minerals to be released into the liquid (McGruther, 
2014). However, BB composition may vary substantially due to differences in preparation 
protocols, such as the animal source and type of the bones/meat, the method and duration of 
cooking, addition of ingredients that may aid the release of key nutrients from animal tissue 
(e.g. vinegar), and any processing associated with the end product (e.g. dehydration to powder 
form). We hypothesized that even though BB is considered a single foodstuff that can be used 
to provide collagen precursors, variability in its production techniques would lead to significant 
variation in key amino acids.  
 
Accordingly, the aim of the current study was to assess the amino acid composition between 
and within examples of commonly consumed BB preparations. Although, BB is a source of 
nutrients suggested to influence connective tissue health, such as saturated fat and copper (Scott 
et al., 2016), we focused on the provision of amino acids which are putative precursors for 
collagen synthesis (glycine, lysine, proline, and leucine) or indicators of collagen content; 
hydroxyproline and hydroxylysine. We compared both the absolute amount and variability of 
these constituents in a standard serve of bone broth (set at 250 ml) with several supplements 
that could provide a potentially therapeutic dose of collagen precursors. We chose a therapeutic 
dose of 20 g for these reference supplements, noting it to be slightly larger than the 15 g dose 
involved in our earlier studies (Shaw et al., 2017), since amino acid availability has been shown 




4.3 Methods  
 
We identified a range of preparations that represent typical ways in which BB might be 
consumed within the general population, including homemade and commercially prepared 
broths that were made to either standardized or non-standardized protocols. Standardized 
broths were made to the same recipe (i.e. ingredients and cooking techniques) each time they 
were prepared, while non-standardized broths varied by one or more of the following: the 
source of the bone (i.e. chicken vs beef), the type of bone (i.e. standard soup bone vs marrow 
bones), cooking methods (duration of cooking, stove top vs slow cooker, addition of vinegar). 
Table 4.1 summarizes the final range of bone broth samples included in the study, along with 
gelatin and hydrolyzed collagen products which acted as reference supplements. 
 
Samples were prepared or purchased from commercial sources according to the summary 
(Table 4.1.) Each bone broth was prepared or collected on at least two separate occasions to 
produce duplicate or triplicate samples of the standardized recipe. The non-standardized bone 
broths included one which was prepared by a café chef on one occasion and on another by the 
authors according to the “chef provided generic” recipe, and then deliberately manipulated to 
change the type of bones or to remove the fat after cooking. In the case of self-prepared broths, 
the recipe yield was also documented to allow determination of mg of amino acids extracted 
per kg of bone. Two separate samples of gelatin (varying by brand) and collagen peptide 
powder (two different batches) were purchased, as well as one sample of liquid collagen and a 





Table 4.1:  Bone broth sample details and sources. 
Source Type Sample Details 
Standardized bone broth    
Laboratory prepared Chicken bone broth CB Prepared by author (RDA) as per 
standardized recipe below, chicken bones 
  CBv As above + addition of vinegar (2 
tablespoons) 
 Beef bone broth BB Prepared by author (RDA) as per 
standardized recipe below, beef bones 
  BBv As above + addition of vinegar (2 
tablespoons) 
Broth bliss, South Yarra, VIC, AUS Long life liquid chicken 
broth 
BBC Commercial, packaged liquid broth made 
from whole chicken frames and wings 
 Long life liquid beef 
broth 
BBB Commercial, packaged liquid broth made 
from beef marrow bones and joints 
Broth of life, Cromer, NSW, AUS Dehydrated chicken broth 
powder, 
BBC Commercial, powdered broth, made from 
whole chicken frames and reconstituted 
according to instructions (3 g/100 ml) 
 Dehydrated beef broth 
powder 
BBB Commercial, powdered broth made from beef 
marrow bones – neck and leg and 
reconstituted according to instructions (3 
g/100 ml) 
Non-standardized bone broth    
Elemental Cafe, Braddon, ACT, 
AUS 
Café prepared beef broth Ca Commercial broth, prepared by Café chef 
each day “to taste” from a general recipe (see 
below) 
Laboratory replication Café prepared beef broth Ca(2) Prepared by author (RDA) from recipe 
supplied by Café 
 Standardised beef broth 
using different 
ingredients 
BBm(1) Prepared by author (RDA) from standardized 
recipe (below), but using beef marrow bones 
 Beef broth using different 
preparation method 
BBm(2) As above, allowed to cool, and fat scraped 
from the top (to remove fat from the 
solution). 
Reference supplements    
McKenzies, Altona, VIC, AUS Powdered gelatin GEL(1) Commercial gelatin powder used in 




Dr Oetker, Mentone, VIC, AUS Powdered gelatin GEL(2) Commercial gelatin powder used in 
household cooking/food preparation 




PEP Commercial supplement promoted for 
support of connective tissue 
GBR Nutrition, Lancashire, UK Liquid collagen 
supplement 
LCol Commercial supplement promoted for anti-
ageing and joint protection benefit. 60 ml 
liquid used to provide 20 g collagen as per 
manufacturer’s instructions 
Professional whey, NSW, Australia Hydrolyzed collagen 
powder 
HYD Commercial supplement 
Standardized bone broth recipe (adapted from wellnessmama.com) 
Ingredients 
2 carrots, roughly chopped  
2 celery stalks , roughly chopped 
2 medium onion , roughly chopped 
7 garlic cloves , crushed 
1 kg chicken frames + 500 g wing tips (for chicken broth) or  
1.5 kg beef bones (for beef broth) 
2 tablespoons apple cider vinegar 1 teaspoon salt  
Method 
1. Turn on the slow cooker to low 
2. Place vegetables on the bottom of the slow cooker 
3. Lay bones over the top 
4. Top with 2.5 L water, apple cider vinegar and salt 
5. Close the lid of the slow cooker, and cook for 24 h 
6. After 24 h strain the broth through a sieve to remove any 
solids 
Café bone broth recipe (supplied by chef)  
Ingredients 
~5.5 kg beef marrow bones – neck and leg (5.4 kg used in self-
prepared recipe) 





3-6 tablespoons. apple cider vinegar* 
4.8-5.5 L water (enough to cover bones), top up as fluid 
reduces for final yield of 7.5-8 L 
*NB. Amounts not specified, used 1 x Punnett cherry 
tomatoes, and other vegetables as above. 
Method 
1. Place bones in roasting trays between 190-210 degrees for 
20-35 mins, until bones are roasted but not burnt 
2. Remove bones from oven, add to pot with vegetables and 
water 
3. Place pot on the stove and bring to a simmer 
4. Remove from the stove and place into electric oven at ~95 
degrees 
5. Cook for 72 h, checking occasionally to determine if fluid 
requires topping up. 
6. After 72 h, strain liquid, and set in fridge 
7. Place bones back into pot, and cover with water, cook for 
an extra 24 h 
8. Mix with liquid from first batch, place liquid back on the 
stove with extra carrot, onion, celery, bay leaves, thyme and 
peppercorns  
(to taste). 
9. Cook until liquid is reduced back down to 7.5-8 L. 





Once prepared/obtained (see Table 4.1 for further details), BB were mixed to ensure a 
homogenous sample, before transferring 50 mL of each liquid to a collection pot for freezing 
at -20°C. With the exception of the dehydrated bone broth powder, which was prepared 
according to the manufacturer’s instructions and analyzed as a liquid, powdered products were 
measured into 10 g samples. Twelve hours prior to transportation, samples were transferred to 
a -80°C freezer before being couriered on dry ice to an analytical laboratory (Australian 
Proteome Analysis Factory, Macquarie University, Sydney, NSW) where they were stored at 
-20°C freezer until analysis. 
 
Full amino acid profiles were analyzed using Ultra Performance Liquid Chromatography 
(Waters AccQTag Ultra). Where necessary, prior to analysis, BB samples were briefly warmed 
to 37°C to liquefy any fatty material and then mixed to provide a homogenous sample. Samples 
underwent a 24 h liquid hydrolysis in 6 M HCl at 100°C and were analyzed in duplicate with 
results provided as a mean value (acceptance of variation of 10%). For the purposes of this 
study only selected amino acids (glycine, lysine, proline, leucine, hydroxyproline and 
hydroxylysine) are reported. Full amino acid profiles can be found in supplementary Table 
11.2.1. 
 
All data are reported as a range, except where only one sample was analyzed. Data were 
analyzed using GraphPad Prism version 7.00 for Windows (GraphPad Software, La Jolla 
California USA). After visually assessing for normality using a Q-Q plot, a Kruskal-Wallis test 
followed by Dunnett’s multiple comparisons test was utilized to compare the means values 
from standardized and non-standardized bone broths against the reference supplements. 
Unpaired t-tests were used to compare batches of the standardized broths. Statistical 






Table 4.2 summarises the amino acid content per typical serve of product, and where 
applicable, the amount (mg/kg) of amino acid extracted from the bone. Comparisons between 
standardized and non-standardized BB and the reference supplements (Figure 4.1.) revealed 
that standardized preparations were significantly lower in amino acid content than the reference 
supplements (hydroxyproline, glycine, proline; P = 0.003 and hydroxylysine, leucine and 
lysine; P = 0.004), while the non-standardized preparations were similar to the reference 
supplements (P > 0.05). Non-standardized BB had greater variability in amino acid content 
than standardized broths or reference supplements and the highest levels of amino acids across 
all samples were present in the café prepared bone broths, although the exact factors 
contributing to this outcome are unknown (Table 4.2.). For the standardized BB: commercial 
varieties were lower in all amino acids than the self-prepared varieties. There were no 
differences (P > 0.05) in the amino acid content of different batches of the same bone broth 
when prepared according to a standardized recipe. While none of the BB or collagen 
supplements were able to provide a therapeutic dose of leucine; indeed, most were below 500 
mg, and all were below 2 g (Figure 4.1.).   
 
The addition of vinegar did not influence the amino acid content of the broths. Meanwhile the 
source of the bones was associated with differences a higher amino acid content for all amino 
acids for the laboratory-prepared broths (beef > chicken), but not for the commercially sourced 
broths. Differences in the type of bones (long bones containing marrow vs smaller bones) 
altered the amino acid content (“marrow bones” > normal bones), while the removal of the fat 




Table 4.2: Range of amino acid (mg) provided per serve of laboratory prepared and commercial varieties of bone broth and 
reference supplements and per kg of animal tissue for laboratory prepared varieties 
mg of Amino acid provided per serve 
Bone broths-standardized recipe 
Self-prepared Commercial 
 CB BB CBv BBv BBC BBB BOLC BOLB 
No of 
samples 
2 2 2 2 2 2 2 2 
HYP 573-635 918-975 443-610 790-908 385-445 470-500 220-246 230-279 
GLY 1018-1108 1633-1713 780-1063 1405-1598 685-783 830-878 432-477 470-532 
PRO 628-680 1000-1048 480-650 848-968 428-480 503-538 288-316 314-342 
HYL 78-83 125-135 60-80 113-130 55-65 55-58 27-29 29-31 
LYS 288-300 343-368 218-280 293-328 195-203 180-188 186-211 170-195 
LEU 265-268 370-398 190-250 318-353 170-188 178-185 201-218 197-232 
Bone broths – non-standardized recipe Reference supplements 
 Ca Ca(2) BBm(1) BBm(2) GEL PEP Lcol HYD 
No of 
samples 
3 1 1 1 2 2 1 1 
HYP 2825-5450 2250 850 625 2010-2030 2026-2100 1770 2260 
GLY 4900-9450 3925 1500 1100 3610-3642 3726-3694 3204 3830 
PRO 2975-5850 2400 1048 675 2246-2282 2296-2332 2028 2322 
HYL 275-475 250 125 100 186-190 182-186 162 168 
LYS 850-1475 650 275 200 680-610 652 3 552 678 
LEU 850-1650 675 300 225 498-508 504-504 444 532 




mg of Amino acid extracted per kg of animal tissue 
 CB BB CBv BBv Ca(2) BBm(1) BBm(2) 
HYP 3817-4233 6117-6500 2950-4967 5267-6050 10000 5667 4167 
GLY 6783-7383 10883-11417 5200-7083 9367-10650 17444 10000 7333 
PRO 4183-4533 6667-6983 3200-4333 5650-6450 10667 6167 4500 
HYL 517-550 833-900 400-533 750-867 1667 833 667 
LYS 1917-2000 2283-2450 1450-1867 1950-2183 2889 1833 1333 
LEU 1767-1783 2467-2650 1267-1667 2117-2350 3000 2000 1500 






Figure 4.1: Kruskal-Wallis test comparing standardized (Stan) and non-standardized (Non-Stan) broths 














This study addressed the potential role of BB as a dietary source of amino acids necessary for 
collagen synthesis. We compared the content of specific amino acids (glycine, lysine, leucine 
and proline) and collagen components (hydroxyproline and hydroxyproline) within a typical 
serve of homemade and commercial BB preparations in comparison to reference supplements 
which have been used in existing collagen synthesis research. Our chief findings were 1) that 
a typical serve of BB, made according to standardized protocols, provided these constituents 
in amounts that were consistent but below those found in supplemental products supplying a 
20 g therapeutic dose. 2)  While some batches of the non-standardized BB had comparable 
amino acid profiles to supplemental products, their composition was varied (Figure 4.1.). 
Indeed, the variability of the amino acid content of the non-standard broths was greater than 
that of the standardized preparations (Figure 4.2.). 3) BB and supplements targeting collagen 
synthesis are low in leucine, the amino acid that has been proven to promote muscle protein 
synthesis.  Therefore, if a therapeutic dose of 20 g of collagenous protein is proven to support 
the health of collagenous body tissues, it is unlikely that BB could provide a reliable source for 
such treatment due to generally low levels of key amino acids in a standard serve and the 
inconsistency of its ability to provide a therapeutic dose when some, as yet unidentifiable, 
factors are involved in its preparation. Furthermore, all dietary and/or supplemental sources of 
collagenous tissue are inadequate in providing the amino acid known to promote the activation 
of protein synthetic machinery and enhance actual protein synthesis within skeletal muscle. 
While definitive evidence for the effectiveness of specific amino acids on connective tissue 
health and performance is still emerging, we were interested to explore a parallel to the story 
of skeletal muscle, exercise and protein intake. Evidence to support the consumption of protein 
for skeletal muscle growth has evolved through a hierarchy of sources: from purified amino 




(Lunn et al., 2012). Specifically, we were interested to see if a culturally valued food source 
(BB) which has anecdotal support for a variety of health claims (McGruther, 2014) could 
provide a practical form of the nutrient intake recommendations that may emerge from collagen 
research. We recognize that there are other scenarios in which food sources of nutrients are 
unable to support optimal protocols of use. These include creatine supplementation in which 
the typical provision from meat is too low to meet targets for rapid loading (Harris et al., 1992) 
and caffeine, whose concentration in coffee is too variable and unpredictable to make it an 
optimal choice for targeted use as an aid for sports performance (Desbrow et al., 2012) . 
Although findings within the current study indicate that it is possible to obtain leucine, 
collagenous amino acids (glycine, proline and lysine) and other factors (hydroxylated proline 
and lysine), similar to that provided by a 20 g dose of reference supplements promoted for 
collagen therapy, it is challenging to determine which characteristics of ingredient or 
preparation lead to the greater amino acid content. 
 
Our results demonstrate that the source of animal tissue utilized influenced the amino acid 
concentration of the end product, with beef providing higher amino acid concentrations for all 
amino acids than chicken for the standardized laboratory prepared varieties of BB (Table 4.2.) 
irrespective of the volume of animal tissue used. Different characteristics of the bones such as 
amount of meat, fat or marrow remaining on the bone after butchering may have accounted for 
this outcome. For example, marrow is proposed to be a rich source of collagen and therefore 
utilizing bone with more marrow would theoretically result in a higher amino acid 
concentration (McGruther, 2014). Meanwhile, the presence of fat (of which animal skin is a 
rich source) may alter the concentration of amino acids. In the current study, when a BB was 
prepared to a standardized recipe, changing only the type of bone (i.e. marrow vs. standard 




4.2). However, leaving a BB preparation “as is” (with the fat still included) resulted in a high 
concentration of amino acids than when the fat was removed (Table 4.2.).  
 
Recent literature suggests that adding ingredients (i.e. vinegar) suggested to provide a more 
acidic environment to BB, or prolonging the cooking duration, may assist with the extraction 
of nutrients into BB (Hsu et al., 2017). In this instance, the addition of vinegar did not appear 
to have any effect on amino acid content of the broth. However, the BB associated with the 
greatest content of amino acids (Café prepared, non-standardized) was reportedly cooked for 
72 h, in comparison to standardized BB which were cooked for 24 h. This suggests longer 
cooking times may increase amino acid extraction; indeed, when the café prepared broth recipe 
was replicated in the lab under standardized conditions, the amino acid content was lower than 
the purchased form, but higher than that of 24 h-cooked preparations (Table 4.2). This finding 
is supported by the comparison of amino acid content of broths obtained per kg of animal tissue 
used in the recipe (Table 4.2.) and indicates that some unidentified factor may have been 
involved in the preparation of the Café product. 
 
We acknowledge that we have compared the broth contents against a 20 g serve of 
supplemental collagen, a dose currently unproven in the literature as an optimal dose. Indeed, 
the manufacturer’s instructions related to these reference products recommended intakes of 15-
30 g (hydrolyzed collagen) and 10 g (liquid collagen) as a single dose, while our previous study 
which demonstrated benefits of gelatin intake, provided a 15 g dose (Shaw et al., 2017). It 
should be noted, however, that our previous work focused on providing a dose of gelatin that 
could be blinded in comparison to a placebo, rather than the dose providing an optimal amount 
of key amino acids. Nevertheless, previous evidence supports an increasing amino acid 




20 g of our reference collagen supplements as a balance between optimal availability, 
practicality and palatability. Although it could be possible to achieve similar amino acid intake 
by consuming larger volumes of BB, practical considerations may be self-limiting. For 
example, it is unlikely that an athlete would regularly consume 500 ml of beef broth in the 30 
min period prior to exercise should future work show that the combination of increased blood 
content of collagen containing amino acids (through dietary intake) and increased blood flow 
to ligament/ tendon (via exercise) enhance the synthesis of collagen in these tissues. 
 
In conclusion, this study demonstrates that it is possible to consume similar amounts of key 
amino acids found in collagen protein from certain BB preparations in similar amounts as those 
provided in a therapeutic dose of collagen supplements, however it is an unlikely and 
potentially unrepeatable outcome. There is significant variability in the amino acid content of 
various forms of BB, changing according to differences in ingredients and preparation 
techniques. Indeed, the amino acid content of a range of home-made and commercial forms of 
BB were consistently lower than our reference supplements. Whilst a BB prepared in a local 
café was found to provide concentrations of amino acids equal to, or higher than those found 
in the selected reference supplements, we were unable to match these levels when prepared to 
a recipe provided by the café in our laboratory. This suggests that compared to supplemental 
sources of collagen protein it is unlikely that BB will be able to provide a consistently reliable 
and optimal source of collagen-derived amino acids. Furthermore collagenous foods and 






This is the first study to consider the ability of bone broth to provide a potentially therapeutic 
dose of key amino acids to support collagen synthesis, as per the popular claims for this food 
source. 
 
Practical application statement 
Currently available commercial and self-prepared forms of beef broth are unlikely to provide 
a reliable source of key amino acids in doses simulating those supplements specifically 
targeting the support of collagen synthesis. If a therapeutic dose of these amino acids can be 
defined, further work will be needed to find standardized sources capable of replicating these 
amino acid contents. Presently, despite its promoted benefits, bone both does not appear to 
provide a consistent or optimal source of such nutrient support. 
 
Acknowledgments 
This study, funded by a grant administered by the Centre for Exercise and Nutrition, Mary 
Mackillop Institute for Health Research, Australian Catholic University, and provided by the 
ACT Brumbies Super Rugby Team, and was conducted at the Australian Institute of Sport. We 
acknowledge the cooperation of Elemental café, Braddon, ACT, Australia. Amino acid 
analysis was facilitated using infrastructure provided by the Australian Government through 
the National Collaborative Research Infrastructure Strategy (NCRIS).  
 
Author Contributions 
R.D.A, L.M.B and G.C.S were involved in study design, results interpretation, drafting, 






Conflicts of Interest 




Preface to Chapter Five 
 
Hydroxyproline is a metabolite of proline and is a significant component of collagen protein, 
but cannot be incorporated into the synthesis of new collagen. Previously, hydroxyproline has 
been utilised to assess collagen metabolism disease, with the restriction of the intake of dietary 
collagen to prevent an interference with the interpretation of data. For Study 2 (Chapter Five), 
we were interested to determine if hydroxyproline could be utilised as a biomarker of collagen 
intake within “free-living”, healthy, active males. If found to be a sensitive biomarker, urinary 
hydroxyproline could be assessed as a proxy for background intakes of collagen, which are 
otherwise unable to be quantified due to the lack of food composition data on dietary collagen 
sources. This would in-turn allow for more accurate interpretation of dietary intervention 
studies looking to assess the impact of dietary collagen intake on the health and functioning of 





Chapter Five: Urinary Hydroxyproline is Only Suitable as a 
Biomarker for Acute Intake, Up to 6 hr Post ingestion of Collagen 
Proteins in “Free-Living”, Healthy, Active Males 
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Urinary excretion of hydroxyproline (Hyp), abundant in collagen protein, may serve as a 
biomarker of habitual collagen intake, assisting with investigations of the current interest in 
the role of dietary collagen intake in supporting the synthesis of collagenous body tissues. This 
study investigated the time course of urinary Hyp excretion in “free-living”, healthy active 
males following the ingestion of a standardized bolus (20 g) of collagenous (gelatin and gelita) 
and dairy (calcium caseinate and hydrolyzed casein) proteins. Excretion of Hyp was assessed 
over a 24 h period, separated into 0-6, 6-12 and 12-24 h collection periods. Hyp was elevated 
for 0-6 h after consumption of collagen-containing supplements (gelatin, 31.3 ± 8.8 mmol: mol 
and hydrolyzed collagen, 33.7 ± 22.0 mmol: mol vs baseline (BL); 2.4 ± 1.7 mmol: mol and 
2.8 ± 1.5 mmol: mol, p < 0.05) but not for dairy protein supplements (calcium caseinate, 3.4 ± 
1.7 mmol: mol and hydrolyzed casein, 4.0 ± 3.7 mmol: mol, p > 0.05).  Therefore, urinary Hyp 
reflects acute intake of collagenous protein but is not suitable as a biomarker for quantifying 
habitual collagen intake, provided through regular dietary practices in “free-living”, healthy, 
active males. 






Musculoskeletal injuries are a common occurrence within athletic populations and may place 
a significant burden on the professional athlete and/or their respective team (Kreisfeld et al., 
2014). Collagen, which makes up approximately one third of total body protein (Shoulders et 
al., 2009), serves as a key tensile element within connective and structural tissues such as 
muscles, ligaments, tendons and bone, due to cross-linking within its triple helical structure 
(Kadler et al., 2007). Although in its infancy, developing research suggests that it may be 
possible to nutritionally support collagen synthesis, potentially enhancing the growth and/or 
repair of connective tissues (Curtis, 2016). Among the nutrients known to be involved in 
collagen synthesis, there is emerging evidence for the key roles played by amino acids 
abundantly present in collagen protein (such as proline and glycine) as well as unique di- and 
tri-peptides (Baar, 2017; Curtis, 2016; Schunck et al., 2013; Shaw et al., 2017; Smith et al., 
2007). This has contributed to the marketing of “collagen support” products for 
tendon/ligament health or repair, with guidance that athletes should consume supplemental or 
dietary sources of collagen, peptides and specific amino acids in concert with exercise that 
stimulates blood flow to the specific tissues (Baar, 2017). Furthermore, it has been suggested 
that hydrolyzed collagen may be superior to un-hydrolyzed forms in its role in collagen 
metabolism and provide a more timely dose of amino acids and/or peptide (Schunck et al., 
2013). Although further evidence is needed to support the benefits of these strategies, adjunct 
research, and research tools, are needed to understand background dietary intakes of 
collagenous proteins. A sensitive and reliable biomarker of habitual collagen intake would 
allow for improved epidemiological research investigating correlations between connective 
tissue health and optimal intakes in various populations. Current consumer preferences within 
Western societies (such as Australia) for leaner, filleted cuts suggest that the intake of collagen 




derived gelatin in food technology as a texture modifier is widespread but unquantified. Indeed, 
even the most comprehensive food composition databases do not provide complete information 
of collagen, gelatin, or hydroxyproline (Hyp) content in commonly consumed foods (Gomez-
Guillen et al., 2011; Khong et al., 2016; USDA ARS, 2018). This renders the use of dietary 
analysis for identifying habitual or period-specific intakes of collagenous proteins to, at best, a 
qualitative tool.  
 
Hyp, a metabolite of proline which constitutes ~ 14% of the total amino acid content of collagen 
protein, has historically been measured in urine to measure collagen turnover and/or 
perturbations to collagen metabolism (Prockop et al., 1961). In such cases, collagen intake prior 
to testing is restricted to prevent its contribution to Hyp excretion from interfering with the 
validity and interpretation of data (Sjoerdsma, 1965). More recently, exercise has been 
suggested to lead to acute collagen protein turn-over which may lead to a transient increase in 
the excretion of Hyp (Tardioli et al., 2012). However, to date, no studies have determined if 
urinary Hyp is a reliable and valid biomarker of habitual or an acute intake of collagen in “free-
living” individuals, engaging in normal dietary and exercise practices. Accordingly, the aims 
of the current study were to determine the time course of urinary Hyp excretion over a 24 h 
period following the intake of 20 grams of either collagen or dairy proteins, and a habitual diet 
to determine whether urinary Hyp is a suitable marker of habitual or acute intake of dietary 






Subjects and study overview 
Eight healthy, male subjects (31 ± 5 years; 79 ± 10 kg body mass) with no current collagen-
related disease or known collagen or milk protein allergies were recruited for the study. 
Approval was granted by the Australian Institute of Sport Ethics Committee (20170607) and 
written consent was received from participants prior to commencing the study. A randomized, 
cross-over design was utilized, with at least 48 h between trials. 
 
Supplement selection, preparation and consumption 
The current study was carried out during part of a larger research project investigating plasma 
amino acid availability after the consumption of various protein sources (Alcock et al., 2019). 
For the current study data were collected after the consumption of four different protein 
sources, and two occasions where a normal breakfast was consumed (BL) in a counterbalanced, 
randomized order, with a minimum of 48 h washout period between trials. The protein sources 
included two collagen supplements: gelatin (McKenzie’s gelatin, Altona, VIC, Australia), and 
a hydrolyzed collagen powder (Tendeforte, Gelita, Eberbach, Germany), and two dairy protein 
supplements that did not contain any collagen: calcium caseinate and hydrolyzed casein (both 
from Professional whey, NSW, Australia). Participants reported to the laboratory between 5-7 
am after a > 10 h overnight fast and were given five minutes to consume 20 g of supplement 
dissolved in 300 mL of warm water. To standardize gastric emptying, no further fluid was 
allowed for 60 minutes after the supplement ingestion and no food was consumed, or exercise 
performed for 3 h, after which participants returned to their normal dietary and exercise habits. 
The dose of 20 g was chosen to build on our previous work (Shaw et al., 2017) and to increase 
the availability of key amino acids as per other dosing studies (Ichikawa et al., 2010; Imaoka 




Analysis Factory, Macquarie University, Sydney, NSW) for levels of Hyp via Ultra 
Performance Liquid Chromatography (Waters AccQTag Ultra, Waters Corporation, MA, 
USA).  
 
Urine collection and analysis 
Following the ingestion of the supplement, urine was collected into clean plastic bottles (2 L 
capacity) for a period of 24 h, divided into three collection periods (t = 0-6, 6-12 and 12-24 h).  
The subjects also completed 24 h urine collections on 2 baseline (BL) days when no supplement 
was consumed, and normal eating patterns were maintained using breakfast as t = 0 and 
continuing the same collection periods. Subjects were instructed to keep urine in a cool, dark 
place and return samples to the laboratory as soon as possible after collection. Urine volumes 
were measured, and aliquots of each sample were stored at -80°C until analysis. Urinary Hyp 
was measured using a colorimetric hydroxyproline assay kit, according to manufacturer’s 
instructions (abcam, Melbourne, Australia). Since the Hyp: creatinine ratio is a commonly 
accepted way to standardize the reporting of Hyp values Hyp: Cre, creatinine (Cre) was 
analyzed on a COBAS Integra 400 (Roche Diagnostics, Risch-Rotkreuz, Switzerland) and the 
Hyp: Cre mmol: mol ratio was calculated.  
 
Food, fluid and exercise diaries 
At the commencement of the study, subjects were instructed by a Sports Dietitian to maintain 
and record habitual dietary and exercise practices for specific periods. Participants were 
instructed to record their meal on the night prior to each trial, and to record their food and fluid 
intake during the period of the 24 h urine collection. Food diaries were analyzed for total 
protein intake (g/ meal and g/day respectively) using dietary analysis software (Foodworks v9, 




following exercise (Brown et al., 1997), exercise in the 24 h period prior to collection, was 
recorded by participants in terms of the duration of the bout and a sessional rating of perceived 
exertion (RPE). A standardized metric to describe/compare exercise sessions was then 
calculated multiplying these factors (Foster et al., 2017).  
 
Statistics 
We assumed that a 5 mg change in urinary Hyp excretion represented a minimal worthwhile 
change based on previous variability estimates of Hyp excretion (Prockop et al., 1961). The 
simulated power to detect a significant effect while allowing for a 5% Type I error rate based 
on 1000 replications of our study design with 8 participants was calculated to be 94. The data 
were analyzed with a General Linear Mixed Model using the R package lme4 (Bates et al., 
2015; R Core Team, 2017). A random intercept for subjects was included to account for intra-
individual dependencies and inter-individual heterogeneity. This also allowed for individual 
baseline adjustment. All models were estimated using Restricted Maximum Likelihood. 
Assumptions of normality and homoscedasticity were assessed via visual inspection of residual 
QQ-plots. The plots showed signs of heavy tails in the distribution, but this was deemed to be 
within the margin of deviation to which the model is known to be robust (Jacqmin-Gadda et 
al., 2007). To account for a potential distributional impact, confidence intervals were generated 
using a bootstrapping procedure (B. et al., 1994). P-values were obtained using Type II Wald 
F tests with Kenward-Roger degrees of freedom as implemented in the R package car (Fox et 
al., 2011). Results are reported as mean estimates and 95% confidence intervals. 
 
A Pearson’s correlation was performed to determine the association between exercise in the 24 
h prior to urine collection and the 0-6 h excretion of urinary Hyp. Differences in protein intake 




analyzes were made using GraphPad Prism version 7.00 for Windows (GraphPad Software, La 
Jolla California, USA). 
5.4 Results 
 
Collagen containing supplements provided 2010 and 2026 mg of Hyp for gelatin and 
hydrolyzed collagen, respectively. Full amino acid profiles are available in Supplementary 
table 11.2.1. Hyp was not detected in the dairy protein supplements. The excretion of Hyp 
normalized to creatinine is displayed in Figure 5.1. Urinary Hyp remained stable for both BL 
measures throughout all of the collection periods (3.0 ± 0.9 mmol: mol). Hyp was elevated for 
0-6 h following the consumption of collagen proteins (gelatin: 31 ± 8.8 and hydrolyzed 
collagen 33.7 ± 22.0 mmol: mol) compared to BL values of the same time period (2.6 ± 0.2 
mmol: mol) (p < 0.05). Furthermore, there was considerable variability in the excretion of Hyp 
between individuals ranging from 22.9 to 47.5 mmol: mol and 2.0 to 50.5 mmol: mol, 0-6 h 
after the consumption of gelatin and hydrolyzed collagen, respectively These levels returned 
to BL values by the 6-12 h collection period (p > 0.05). Dairy protein supplements (calcium 
caseinate and hydrolyzed casein) did not elevate Hyp excretion at any time point compared to 
BL values (p > 0.05). There was no difference in urinary Hyp excretion between participants 
for any of the BL measures (p > 0.05). 
 
Dietary protein intake (night before and day of urine collection) and sRPE are displayed in 
Table 5.1. There was no difference in protein intake the night before, or the day of urine 
collections for any conditions (p > 0.05). Although there was large variation in sRPE across 
different conditions exercise in the 24 h prior to urine collection was not correlated with the 0-
6 h excretion of Hyp for either dairy supplements, collagen containing supplements, or BL 



















Figure 5.1: Urinary excretion of hydroxyproline (normalized to creatinine) over 0-6, 6-12 and 12-24 hours 
after the consumption of a habitual breakfast (BL1 and BL2) or 20 grams of either collagen containing 
(gelatin & hydrolyzed collagen) or, dairy (calcium caseinate & hydrolysed casein) supplements.  Line shows 
median, boxes represent 25th-75th percentiles and whiskers show maximum and minimum values. * P< 0.05 
compared to 0-6 h BL1 and BL2.
Table 5.1: Dietary protein intake and exercise 
 Protein intake Exercise (n = 8) 
 Day of urine collection 
Night prior to urine 
collection 
In the 24 h prior 
to urine collection 
Mean ± SD Grams/kg BM/day Grams/day Grams/meal  sRPE x duration  
BL1 
1.8 ± 0.7 (n=7) 146 ± 62 (n=7) 60 ± 27 (n=7) 
175 ± 300 
BL2 
1.6 ± 0.4 (n = 7) 127 ± 36 (n=7) 51 ± 19 (n=7) 
707 ± 616 
Calcium caseinate 
1.7 ± 0.5 (n=7) 138 ± 49 (n=7) 62 ±16 (n=7) 
405 ± 562 
Hydrolysed casein 
2.0 ±0.7 (n =6) 159 ± 37 (n=6) 68 ±17 (n=7) 
444 ± 689 
Gelatin 
1.6 ±0.5 (n=6) 121 ± 35 (n=6) 62 ± 38 (n=6) 
647 ± 1167 
Hydrolysed 
collagen  
2.0 ±0.6 (n=7) 158 ± 47 (n=7) 68 ± 22 (n=5) 




5.5 Discussion  
 
Our findings demonstrate that urinary Hyp is elevated for the period of 0-6 h after ingesting a 
20 g dose of collagen in supplemental form (~ 2000 mg of Hyp), with levels returning to BL 
within 12 h. There was no difference in the excretion of Hyp when dairy protein supplements 
or when a “normal breakfast” was consumed. Additionally, there was no difference in protein 
intake for either the night prior to or the day of urine collections for any of the collection 
periods, which would indicate normal dietary intake of protein was not responsible for the 
differences observed in urinary excretion of Hyp. Our results showed no association between 
exercise in the previous 24 h period and the 0-6 h Hyp excretion for either BL measures or 
when a dairy or collagen protein was consumed. Therefore, in practical terms, while urinary 
Hyp may serve as a suitable biomarker for the ingestion of a single large serving (>20 g) of 
collagenous protein for 0-6 h post ingestion in free-living individuals, on waking, urinary Hyp 
is unlikely to be a suitable measure of habitual intake or collagen consumed > 6 h prior. 
Additionally, a 24 h urine collection is only likely to document the intake of a substantial dose 
of collagen consumed within a relatively short period before collection, which is unlikely to be 
achievable through normal dietary sources (e.g. meat) (USDA ARS., 2018).  
 
Of interest, we found considerable inter-individual variability in the excretion of Hyp 0-6 h 
after the consumption of collagen proteins. While it has been suggested that exercise may 
increase collagen turnover, and thereby the excretion of Hyp (Brown et al., 1997), despite the 
large variability in the exercise patterns reported by individuals during the collection periods,  
we did not find any association between exercise over the 24 h prior to urine collection and the 
excretion of Hyp in the following 0-6 h. Similarly, although previous data suggests that smaller, 
regular intake of collagenous proteins may lead to a cumulative rise of plasma Hyp (Knight et 




urinary Hyp. This suggests habitual intake of collagenous protein sources in our population 
were not substantial enough to influence Hyp excretion. Indeed, current consumer trends 
indicate a preference for meats void of large amounts of collagenous tissue, containing ~ 0.1 
mg/ 100 g of Hyp (USDA ARS, 2018; Wong et al., 2013). It is possible that individual 
differences in capacity to metabolize collagenous protein exists and may account for the 
differences of excretion found within individuals (Gardner, 1988). This may be an important 
area for further study, as difficulty in metabolizing collagen proteins consumed specifically for 
health and rehabilitation purposes may affect the availability of amino acids proposed to play 
a role in the synthesis of new collagen.  
 
In summary, while urinary Hyp is a suitable biomarker of bolus collagen intake for up to 6 h 
after its consumption, Hyp is not suitable as a sensitive biomarker for habitual intake of dietary 
collagen in “free-living” individuals. 
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Preface to Chapter Six 
 
As outlined in Chapter Two, there is evidence that nutrition plays a supportive, rather than 
central role in the synthesis of collagen protein within ligaments and tendons. However, it has 
been suggested that hydrolysed forms of proteins are superior to their non-hydrolysed 
counterparts because they deliver potentially beneficial peptides to the target tissue in a more 
rapid and pronounced manner. Thus, the premise of the following Chapter (Study 3) was to 
provide information on the plasma AA responses to the consumption of a selection of dairy 
and collagen protein sources. A direct comparison between hydrolysed and non-hydrolysed 
forms of some proteins was planned to determine whether the form influenced the apparent 





Chapter Six: Plasma Amino Acids after the Ingestion of Dairy 
and Collagen Supplements, in Healthy Active Males 
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Introduction: Recent evidence suggests that the consumption of essential amino acids (AA) 
and/or those abundantly present in collagen may have the capacity to influence the synthesis 
of new collagen in ligaments and tendons, when tissue perfusion is optimised (e.g. during 
exercise). However, little is currently known about the bioavailability of these AAs in blood 
after the consumption of various collagen and diary protein sources: such information is needed 
to develop potentially useful dietary and supplement intake strategies.  
Objectives: The aim of the current study was to characterise blood AA concentrations in 
response to consumption of collagen and dairy protein sources; specifically, maximum 
concentrations, the timing of maximum concentration, and total (area under the curve) 
exposure above baseline.  
Methods: A 20 g serve of various dairy and collagen proteins, and a 300 mL serve of bone 
broth were consumed by healthy, recreationally active males after an overnight fast. Blood 
samples were drawn every 20 min for a total of 180 min, for analysis of plasma AA 
concentrations. Total AA, essential AA and collagen specific AAs were analysed for maximum 
concentration, timing of peak, and area under the curve.  
Results: In general, protein intake was associated with a similar increase in total and collagen 
specific AAs, except for collagen proteins being a superior source of glycine (683 ± 166 
µmol/L) compared to 260 ± 65 µmol/L for dairy proteins (P <0.0001), whilst dairy proteins 
were a superior source of leucine (267 ± 77 µmol/L) compared to 189 ± µmol/L for collagen 
proteins (P <0.04). Although there were several differences in the bioavailability of hydrolysed 
compared to non-hydrolysed proteins, this only reached statistical significance within the dairy 
proteins, but not for collagen proteins. 
Conclusions:  The intake of collagen proteins result in higher plasma peaks of glycine, whilst 




support further investigations, and identification of key AAs that may support exercise in the 
synthesis of collagen.  







Literature suggests that ligaments and tendons are similar to muscle in being dynamic 
structures that respond to mechanical loading with tissue hypertrophy (Couppe et al., 2013; 
Kongsgaard et al., 2007; Zhang et al., 2015). Larger tissues with more densely packed collagen 
fibrils have a greater capacity to withstand force, and thereby exert greater injury protection 
(Galloway et al., 2013). On the other hand, smaller tissues with disorganised collagen fibrils 
have been associated with higher injury risk, such as the development of tendinopathies 
(Couppe et al., 2013). Although the amino acids (AAs) required for myofibrillar tissue 
formation have been well documented (Morton et al., 2015; Morton et al., 2018; Phillips, 2006; 
Phillips, 2014; Phillips et al., 2011), evidence regarding the potential role of collagen 
precursors (e.g. proline, glycine and lysine) and/or stimulatory AAs (e.g. leucine) in the 
synthesis of new collagen in ligaments and tendons is still emerging. Furthermore, the 
requirement for an appropriate exercise stimulus to support tissue perfusion appears essential 
(Baar, 2019; Curtis, 2016; Kjaer et al., 2015; Langberg et al., 2001).  
 
Leucine, an essential amino acid (EAA), has been the subject of extensive research for its role 
in stimulating myofibrillar protein synthesis (Morton et al., 2018). Leucine exerts its effect on 
the mammalian target of rapamycin (mTOR), which results in a signalling cascade leading to 
the synthesis of myofibrillar protein in muscle tissue (Dodd et al., 2012). In the context of 
connective tissue, work undertaken in an animal model has suggested an increase in collagen 
synthesis in the deep digital flexor tendon of malnourished rats in association with a leucine-
rich diet, and further enhanced when combined with physical stimulation (Barbosa et al., 2012). 
Similarly, in humans, the ingestion of leucine-rich whey protein, coupled with resistance 
training, has been shown to lead to patellar tendon hypertrophy, with the proximal cross-




et al., 2014), but no change in distal or mid tendon CSA. However, it is highly plausible that 
this increase occurred secondary to a distinct increase in the size of the quadriceps muscle, 
acting as a stimulatory load on the tendon (Kjaer et al., 2009).   
 
In addition to the stimulatory role of leucine on the protein synthetic machinery, it is likely that 
other AAs, such as those found in large quantities in collagen protein (e.g. glycine, proline and 
lysine) play a role in the synthesis of new collagen. Proline is a conditionally essential amino 
acid (CEAA), which plays a role in the formation and structural integrity of collagen fibrils (Li 
et al., 2018). Indeed, in older individuals, ingestion of leucine and proline in the form of casein 
protein, in combination with resistance training, resulted in a trend towards a higher fractional 
synthetic rate of collagen compared to whey protein (Dideriksen et al., 2011). In an engineered 
ligament model, it has been shown that the addition of 50 µM proline with 50 µM ascorbic 
acid, to a media rich in AAs such as leucine and glycine, increased ligament collagen content 
from 1.34% ± 0.2% to 8.34% ± 0.37% (Paxton et al., 2010). More recently, work from our 
group has shown that the consumption of 15 g of dietary collagen; one hour prior to intermittent 
exercise led to an increase in procollagen I N-terminal propeptide (P1NP), compared to a 
placebo control (Shaw et al., 2017). Additionally, an in vitro arm of the same study, displayed 
an increase in the collagen content and mechanical properties of an engineered ligament treated 
with serum obtained post ingestion of dietary collagen (Shaw et al., 2017). Thus, it is plausible 
that a combination of EAA, to upregulate synthetic machinery, and CEAA to supply AA 
building blocks is required during the synthesis of collagen protein. Although these findings 
are promising, it remains unclear as to the value of hyper-aminoacidemia in the synthesis of 
new collagen, and whether these amino acids work in isolation or synergistically.  
 




peptides in a range of collagen containing tissues, including increased collagen synthesis 
(Daneault et al., 2017; Schunck et al., 2013), improved body composition (Oertzen-Hagemann 
et al., 2019; Zdzieblik et al., 2015), reduced pain (Clark et al., 2008; Oesser et al., 2016; Praet 
et al., 2019) and the slowing of degenerative diseases such as osteoarthritis (Bello et al., 2006; 
Van Vijven et al., 2012). It has been suggested that hydrolysis of collagen protein prior to 
ingestion allows two and three amino acid peptides to pass across the mucosal barrier equating 
to a higher expression and therefore biosynthesis within the tissue matrix (Aito-Inoue et al., 
2007). This was illustrated in a recent study whereby the consumption of hydrolysed collagen 
proteins resulted in a higher bioavailability of AAs compared to non-hydrolysed collagen 
protein and a placebo control (Skov et al., 2019). Furthermore, it has recently been shown that 
the consumption of collagen peptides resulted in a higher expression of collagen signalling 
proteins, compared to a placebo control (Oertzen-Hagemann et al., 2019). 
 
Accordingly, we aimed to determine the bioavailability [i.e. timing, maximum concentration, 
and area under the curve (AUC)] of TAA, EAA and key AAs proposed to support the synthesis 
of new collagen, after the consumption of a selection of hydrolysed and non-hydrolysed 
collagenous, and dairy proteins, and a collagenous food source. This data would be of benefit 
to allow further investigations into a range of practical questions: 
1. The optimal food source/supplement, AA and/or combinations of AAs that may 
support exercise in increasing collagen synthesis.  
2. The optimal timing to consume this food source/ supplement and/or AA(s) prior to an 
exercise bout.  
3. Whether there is increased bioavailability from the consumption of hydrolysed vs non-




6.3 Materials and methods 
 
Subjects and ethics  
Fifteen healthy, recreationally active, male subjects (30 ± 5 years; 80 ± 8 kg BM) with no 
current collagen-related disease or known protein allergies were recruited for the study. The 
current study formed part of a larger study, which necessitated a male subject population given 
the influence of female sex hormones of ligament health (Stijak et al., 2015). Sample size was 
chosen using power estimation determined in previous, similar studies (Burke et al., 2012; van 
Loon et al., 2000). The Human Ethics Committee of the Australian Institute of Sport granted 
approval for this study (20170607) and written informed consent was received from 
participants prior to its commencement. The protocol was registered with the Australian New 
Zealand Clinical Trials Registry (ANZCTR12617000923369). 
 
Protein source and preparation 
Four collagen and two high leucine dairy protein sources were selected for the study. These 
included a hydrolysed and non-hydrolysed collagen powder: Gelita (Pep) and gelatin (Gel) 
respectively; a hydrolysed and non-hydrolysed dairy protein supplement: calcium caseinate 
(Cas) and hydrolysed casein (HCas) respectively; a liquid collagen supplement (LCol) and one 
collagenous food source: bone broth (BBr). Further details of these protein sources can be seen 
in Table 6.1. We chose a standard dose of 20 g for all powdered supplements and 60 mL of 
liquid collagen (equivalent to 20g of collagen protein as per manufacturer information). This 
dose was slightly higher than used in previous work (Shaw et al., 2017), due to the benefits 
associated with to increased amino acid availability (Imaoka et al., 1992; Iwai et al., 2005). 
The BBr used in this study was chosen on the basis of the results of our previous work (Alcock 
et al., 2018) in which this preparation was found to have a higher protein content than other 




(further details of the broth used in this study; “chef prepared bone broth” are available 
elsewhere; Alcock et al., 2019). Furthermore, we decided on a 300 mL serve as a representative 
portion size that would be practical to consume within the prescribed time-period, as we would 
not ascertain total protein content of this broth prior to commencing the study. Analysis of the 
batch actually consumed in this study, subsequent to the trials, found that it was considerably 
higher than expected. Nevertheless, by purchasing a bulk volume of the broth (5 L) and mixing 
it well before dividing it into 300 mL serves, we achieved consistency between the serves 
consumed by subjects. 
 
To maintain consistency across all experimental protocols, all protein sources were served 
warm, and in/with the same amount of fluid (300 mL) achieved via the addition of water. 
Supplements were provided in a counter-balanced, randomised fashion, with at least 48 h 
between trials. All protein sources were assessed for full amino acid profiles analysed using 
Ultra Performance Liquid Chromatography (Waters AccQTag Ultra) (Australian Proteome 
Analysis Factory, Macquarie University, Sydney, NSW). 
 
Experimental protocol and analysis 
Participants fasted overnight (> 10 h) prior to attending the laboratory at the Australian Institute 
of Sport between 5:30 and 7 am. On waking, participants were allowed to consume 250 mL of 
water to ensure adequate hydration for the blood collections but instructed to arrive to the lab 
in a rested state to avoid significant elevations to heart rate that would increase blood flow. On 
arrival, a 22G indwelling cannula was inserted into the antecubital vein for blood collection by 
a trained phlebotomist, and a baseline (BL) blood sample was collected. Immediately after, the 
protein source was prepared and given to participants who were instructed to consume it within 




standardise gastric emptying, no other fluid was available for 60 min following consumption, 
and then ad libitum water consumption was permitted. Immediately after the consumption of 
the protein source, participants were asked to fill out a feedback form (as outlined below). 
Blood samples were then collected every 20 min for 180 min into 2 mL lithium heparin 
Vacuette tubes (Greiner Bio-One, Kremsmünster, Austria). Immediately after each blood 
collection, samples were centrifuged at 1500 xg for 10 min at 4°C. The resulting plasma was 
separated and stored at -80°C until further analysis. Once the 180 min period was concluded 
the cannula was removed and participants were allowed to leave the laboratory. 
 
Once all plasma samples were collected, they were transported to Maastricht University for 
analysis of full amino acid profiles using liquid chromatograph mass spectrometry (UPLC-MS; 
ACQUITY UPLC H-Class with QDa; Waters, Saint-Quentin, France). Briefly, samples were 
prepared according to manufacturer’s instructions, with an internal standard added. 50 µL of 
blood plasma was deproteinised using 100 µL of 10% sulfosalicyclic acid (SSA) with 50 µM 
of metabolomics amino acid mix standard (MSK A2) (Cambridge Isotope Laboratories, 
Massachusetts, USA). Subsequently, 50 µL of ultra-pure demineralized water was added and 
samples were centrifuged. After centrifugation, 10 µL of supernatant was added to 70 µL of 
Borate reaction buffer (Waters, Saint-Quentin, France). Twenty µL of AccQ-Tag derivatising 
reagent solution (Waters, Saint-Quentin, France) was then added, and the solution was heated 
to 55°C for 10 min. Of this 100 µL derivative, 1 µL was injected and measured using UPLC-
MS. 
  
Due to the interests of this study, we have reported concentrations of TAA, EAA and a selection 




proline, glycine, lysine and leucine) (Baar, 2017; Dideriksen et al., 2011; Farup et al., 2014; 
Shaw et al., 2017).  
 
Protein source acceptability  
The feedback form completed by subjects immediately after consuming a test product provided 
four questions in the format of a Likert scale (Likert, 1932), and one question with a yes or no 
response. The questions are outlined in Table 6.3 and included questions related to acceptability 
and palatability. While we acknowledge that this is not a validated questionnaire, it was 
intended that this feedback would provide practical insight into the use of this product for 
connective tissue health purposes.  
 
Statistics 
Trapezoidal rule (Yeh, 2002) adjusted to baseline concentration was applied to calculate the 
area under curve (AUC) of the amino acid concentration. Statistical analysis were performed 
using GraphPad Prism version 7.00 for Windows (GraphPad Software, La Jolla California, 
USA). Data were checked for normality using a D’Agostino & Pearsons normality test. A 
repeated-measures One-way ANOVA by General Linear Models (GLM) was used to compare 
the effects of different supplements on outcome variables (plasma amino acid content for: 
baseline; BL, observed maximum concentration; Cmax Obs, timing of peak; Tmax and AUC). 






Total protein and amino acid content of selected collagen and dairy proteins 
The composition per serve of the protein sources (total protein, TAA, EAA and selected AAs) 
is displayed in Table 6.1. Full amino acid profiles are available as supplementary material (see 
supplementary table 11.2.2). The supplements (Cas, HCas, Gel, Pep and LCol) provided 19.3 
± 0.8 grams protein per 20 gram serve, whereas BBr provided 52.2 grams of protein per 300 
mL serve. Per serve, BBr contained the highest levels of all selected AAs, with the exception 
of leucine, which was provided in the highest amount in the dairy protein supplements, HCas 
and Cas at ~1540 mg per serve. AA profiles of proline, glycine, lysine and leucine of protein 
sources of similar derivatives (e.g. dairy and collagen proteins), were comparable in their 
amino acid content. Liquid collagen provided the lowest levels of all AA among the collagen 
protein sources in this study.  
 
Observed maximum concentration (Cmax Obs) 
Figure 6.1. displays the time course of the appearance of TAA, EAA, and the selected AAs in 
the plasma over 180 min. Kinetic parameters of TAA, EAA and selected AAs after the 
consumption of collagen and dairy protein sources are displayed in Table 6.2., as means and 
SD.  There were no differences in BL levels for TAA, EAA or any of the AAs between protein 
sources (P > 0.2).  
 
In terms of TAA, Cmax Obs was similar for all protein sources, except for Cas which was 
significantly lower (P < 0.04) than all protein sources and LCol which was significantly lower 
than Pep (P = 0.03).  HCas was significantly higher for Cmax Obs for EAA than all other protein 
sources (P <0.0001) while Cas was only higher than BBr and LCol (P < 0.04). There was no 




of proline was similar (P > 0.1) for all protein sources other than Cas, which was significantly 
lower than the others (P < 0.001). HCas provided the highest Cmax Obs for lysine compared to 
all other protein sources (P < 0.002). Collagen proteins provided a higher Cmax Obs for glycine 
compared to Cas and HCas (P <0.0001) while there was no difference between the dairy protein 
sources (P = 0.8). Meanwhile, HCas provided the highest Cmax Obs of leucine compared to all 
collagen proteins (P = 0.0001) and Cas also had a higher Cmax Obs for leucine than these 
products (P < 0.04). However, differences in Cmax Obs for leucine between any of the collagen 
proteins failed to reach significance (P > 0.06).  
 
Timing of maximum concentration (Tmax) 
Results of Tmax in Table 6.2., illustrate a similar time course for TAA for all products except 
an earlier peak with HCas than BBr and Gel (P < 0.02). There was no difference in Tmax of 
EAA with all protein sources peaking between ~ 30 and 50 min (P > 0.1). Tmax of proline for 
BBr was slower than all other protein sources (P < 0.002). Although the time to peak for proline 
was slower for the non-hydrolysed proteins compared to the hydrolysed proteins, this did not 
reach statistical significance (P > 0.05). BBr was the slowest to peak for glycine, and was 
significantly slower than Pep and LCol (p <0.001). The Tmax of glycine for Gel was also found 
to be slower than for Pep (P = 0.04). There was no difference in Tmax for leucine between any 
of the protein sources, with all peaking between ~ 30 to 50 min (P > 0.04). The only difference 
for lysine Tmax was a quicker peak with BBr than HCas (P = 0.001).  
 
Area under the curve (AUC) 
Figure 6.2 displays the AUC of amino acid concentrations in plasma after consumption of the 
protein sources. BBr provided the highest AUC for TAA at 91029 ± 29630 µmol/L/180 min, 




µmol/L/180 min and 36042 ± 12833 µmol/L/180 min, respectively (P < 0.0001)] but not 
significantly different to any of the collagen protein supplements [77052 ± 24304, 84664 ± 
20582 and 71882 ± 19085 µmol/L/180 min for Gel, Pep and LCol, respectively (P > 0.2)]. 
However, as seen in Figure 6.1., plasma AAs after consumption of BBr remained elevated at 
the completion of 180 min, particularly for proline and glycine. Cas provided the lowest AUC 
for TAA, and was significantly lower than all collagen supplements (P <0.0002), but not HCas 
(P = 0.6). Although hydrolysed supplements appeared to have a higher AUC for TAA than 
their non-hydrolysed counterparts, this was not statistically different for either collagen or dairy 
proteins (P > 0.6). Collagen proteins had a higher AUC than dairy proteins for TAA (81157 ± 
8419 and 31654 ± 6206 µmol/L/180 min, respectively, P <0.0001). 
 
HCas provided the highest AUC for EAA at 55992 ± 15675 µmol/L/180 min, which was 
significantly greater than all other protein sources (P<0.003), except Cas which provided an 
AUC for EAA of 39587 ± 18573 µmol/L (P = 0.2). The AUC for EAA of Cas, was only 
significantly higher than LCol and Pep which provided 8806 ± 16410 and 12238 ± 13682 
µmol/L/180 min, respectively (P < 0.006). The lowest AUC of EAA was provided by LCol at 
8806 ± 16410 µmol/L/180 min, but this was not different to the other collagen protein sources 
(P > 0.8).  
 
In terms of individual AA, the AUC of lysine was greater for HCas than Gel, Pep and LCol 
[AUC of 11187 ± 2764 µmol/L/180 min compared to 7003 ± 4340, 6310 ± 2714 and 5729 ± 
3290 µmol/L/180 min, respectively (P <0.008)]. For leucine, dairy proteins had a higher AUC 
than all collagen proteins at 10187 ± 3023 µmol/L/180 min and 746 ±1043 µmol/L/ 180 min 
respectively (P < 0.001). Meanwhile, HCas provided a higher AUC for leucine than Cas (P = 




13547 ± 3450 µmol/L/180 min, for Gel, Pep and LCol respectively P < 0.01), and glycine 
[(48563 ± 4429 and -1863 ± 2255 µmol/L/ 180 min (P <0.0001).]  
 
Collagen and dairy protein acceptability and palatability 
Responses to the questions around acceptability and palatability for each protein source are 
displayed in Table 6.3. LCol had the highest scores individually, and on average, while HCas 
was rated the lowest. Despite these differences between products, only 53% of participants 
reported being willing to pay the specified price for either product. Meanwhile, the non-
hydrolysed supplements (which were also the lowest in cost; Table 6.1.), scored 93% for 




Table 6.1: Details of collagen and non-collagen (dairy) protein sources, and collagen specific amino acid profiles per serve of 
select food/supplement. 



































Chef made bone 
broth 
Abbreviation Cas HCas Gel Pep LCol BBr 
Serve 20 grams 20 grams 20 grams 20 grams 
60 mL 
(equivalent to 20 
grams) 
300 mL 
Cost per serve $ 0.70 $ 1.24 $ 0.74 $ 3.00 $ 5.37 $ 4.50 
Manufacturer 
stated total protein 
per serve (g) 
20 20 20 20 20 N/A 
Actual measured 
total protein per 
serve (g)* 
19.2 19.2 20.1 20.6 17.9 52.2 
TAA per serve 
(mg)* 
19172 19378 20108 20594 178928 52260 
EAA per serve 
(mg)* 
8306 8368 4944 5858 4392 13320 
Proline per serve 
(mg)* 
2038 2060 2664 2722 2406 6420 
Glycine per serve 
(mg)* 
360 354 4750 4904 4212 11760 
Lysine per serve 
(mg)* 
1422 1468 696 746 630 1740 
Leucine per serve 
(mg)* 
1782 1786 588 584 516 1710 
EAA: Essential Amino Acids; TAA: Total Amino Acids 
* Calculation based on free amino acid molecular weight 






Table 6.2: Kinetic parameters of total, essential, and collagen specific, amino acid concentration in plasma after the 
consumption of collagen and dairy protein sources. Data presented as mean ± SD. 




2156 ± 234 2233 ± 403 2155 ± 308 2178 ± 331 2151 ± 325 
2254 ± 
392 




3012 ± 407 3725 ± 641 3525 ± 631 3710 ± 670 3445 ± 641 
3552 ± 
561 








998 ± 116 1044 ± 170 1030 ± 135 1017 ± 148 1000 ± 147 
1074 ± 
142 











































273 ± 31 369 ± 65 269 ± 52 271 ± 50 262 ± 48 272 ± 41 P <0.0001 












230 ± 31 351 ± 59 184 ± 29 190 ± 34 181 ± 30 203 ± 28 P  <0.0001 
 
Tmax min  
(min/max) 
47 ± 36 29 ± 10 36 ± 23 29 ± 31 33 ± 41 33 ± 12 P = 0.3768 
 
 
Table 6.3: Likert scale of protein source feedback and palatability. Data presented as median (range). 
Question 
(1-7) 
Cas HCas Gel Pep LCol BBr 
Significan
ce  
Serve size 20 g 20 g 20 g 20 g 60 mL  300 mL 
P < 0.001 
1 4 (1-7) 3 (1-5) 4 (1-7) 5 (2-7) 6 (307) 5 (2-7) 
P < 0.001 
2 6 (3-7) 5 (2-6) 6 (2-7) 6 (2-7) 7 (4-7) 6 (2-7) 
P = 0.032 
3 6 (2-7) 5 (1-7) 6 (2-7) 6 (2-7) 7 (5-7) 6 (2-7) 
P = 0.044 
4 6 (3-7) 4 (1-7) 6 (1-7) 6 (2-7) 7 (4-7) 6 (2-7) 
P = 0.006 
5 (% Yes) 93 53 93 60 53 73 
- 
*Question 1: The palatability (taste, texture) of the product was acceptable 
*Question 2: The volume of the product (300mL) was acceptable to consume in the time specified (5 mins) 
*Question 3: The volume of the product would be acceptable to consume within 20-40 minutes prior to exercise 
*Question 4: I would be willing to consume this product at least twice a day as part of a rehabilitation program 
**Question 5: Would you be willing to pay the specified amount for one serve of the product if it was beneficial to connective 
tissue health? 
1 = strongly agree, 7 = strongly disagree 
* Out of 1 (strongly agree) to 7 (strongly disagree) 





Figure 6.1: Time course of plasma amino acid concentrations over 180 min after the consumption of 





Figure 6.2: Area under the concentration – time curve (AUC) of plasma amino acids over 180 minutes 
after the consumption of dairy and collagen protein sources. Middle line shows mean, boxes represent 




6.5 Discussion  
 
A number of AAs have been suggested to play a complementary role in the synthesis of 
collagen in ligaments and tendons, when combined with an appropriate mechanical stimulus 
(Baar, 2017). There is emerging evidence that the ingestion of key AAs (including proline, 
glycine, lysine and leucine), or combinations thereof, provide enhanced availability to support 
the synthesis of collagen when combined with an appropriate exercise protocol (Scott et al., 
2016). Accordingly, the aim of the present study was to characterise the bioavailability (e.g. 
timing of appearance, maximum concentration, and AUC) of TAA, EAA and key AAs that 
may be involved in the synthesis of collagen, after the ingestion of a selection of collagen and 
dairy protein sources.  
 
In general, plasma AA responses reflected the AA profiles of the consumed supplement, except 
in the case of the casein, and bone broth. These both resulted in a lower and more prolonged 
appearance of AAs in the blood over the 180 min following consumption (See Table 6.1. and 
6.2. and Figure 6.2.). This is likely due to various components known to slow gastric emptying 
such as the fat content of the BBr (Lin et al., 1996), and the clotting of casein in the stomach 
after ingestion (Boirie et al., 1997). However, it is also plausible that the delayed gastric 
emptying of BBr may be related to the volume was consumed. As can be seen in Figure 6.1., 
the plasma concentration of AAs after consumption of BBr remained elevated at the 180 min 
mark, and most likely would have continued to be available at a higher amounts in the blood 
beyond the 3 hours that were monitored for this study.  
 
It has been proposed that AAs play a supportive, rather than stimulatory role in the synthesis 
of collagen within ligaments and tendons (Baar, 2017; Babraj et al., 2005a; Shaw et al., 2017). 




an upregulation of collagen synthesis for a period of up to 72 h (Langberg et al., 2000). Exercise 
results in an increase in hormones that have been shown to stimulate the synthesis of collagen 
in connective tissue (e.g. growth hormone, and insulin-like growth factor 1) (West et al., 2015). 
As ligaments and tendons are poorly vascularised tissues, it may be sensible to isolate the 
provision of AAs to scenarios involving the exercise-induced enhancement of blood flow 
(Henning Langberg et al., 1999). Therefore protein sources that achieve higher AA peaks over 
a shorter period of time (e.g. HCas) may be considered optimal, whereas a slower release of 
key AAs over an extended period of time (e.g. with BBr) may not be as easily matched to 
enhanced tissue blood flow. Literature to date suggests that there is dose related response to 
the key AA involved in the synthesis of collagen. Indeed, Shaw et al. (2017) illustrated that a 
15 g dose of gelatin resulted in an increased availability of AAs and collagen synthesis than a 
5 g dose, resulting in improvements to tissue mechanics in engineered ligaments in vitro. Peak 
blood concentrations of glycine and proline in the current study (~650-750 and 350-450 
µmol/L, respectively) were slightly higher than those reported in previous work (i.e. 448 ± 165 
and 238 ± 77 µmol/L in (Shaw et al., 2017). This is to be expected given the slightly higher 
dose within our current protocol. However, others have shown similar plasma values after the 
ingestion of 35 grams of collagenous protein (Skov et al., 2019) which they suggest shows an 
upper threshold to the AA availability of collagen proteins. In general since all AAs appeared 
to peak between 30 and 60 mins (Table 6.2.), the consumption of ~ 20 grams of protein within 
the 30 – 60 mins prior to exercise would ensure the optimal availability of AAs at a time when 
synthetic machinery is upregulated, and tissue perfusion supported (H. Langberg et al., 1999; 
Langberg et al., 2001; Langberg et al., 2000). It should be noted, however, that whether the 
increased availability of AAs within the plasma results in an increased availability of AAs 
around the target tissue (e.g. the peritendinous fluid), where it as able to be utilised and 




While the maximum concentrations of total AA present within the plasma after the ingestion 
of collagen and high leucine dairy proteins were comparable, dairy proteins provided a larger 
Cmax Obs and AUC of leucine, while hydrolysed casein provided a higher Cmax Obs  of EAA 
than both dairy and collagen proteins, and collagen proteins were superior in terms of glycine. 
Such differentiation mean that no protein source was superior in terms of all AAs that are 
potentially implicated in collagen synthesis. If subsequent research identifies the benefits of 
EAA as well as collagen precursors (e.g. proline and glycine), a case could be made for the 
consistent intake of EAA (i.e. the current guidelines for regular intake of high-quality protein 
sources over the day), with a supplemental and/or food source of collagenous protein consumed 
at key periods i.e. prior to exercise. The lack of such a pattern may also detract from the health 
of connective tissues.  
 
It has been proposed that hydrolysed proteins are superior to non-hydrolysed forms in 
providing a higher AA bioavailability; more specifically, being able to reach a target tissue 
more quickly and with a higher peak concentration (Aito-Inoue et al., 2007; Koopman et al., 
2009; Skov et al., 2019). Within the present study, the plasma characteristics of hydrolysed and 
non-hydrolysed dairy proteins showed some differences, but these were not seen with the 
collagen proteins. Our findings are similar to the study of Koopman and co-workers where 
ingestion of 35 grams of hydrolysed casein protein resulted in an increased bioavailability and 
incorporation rate of AAs into skeletal muscle protein than intact casein (Koopman et al., 
2009). However, while another more recent study showed that the ingestion of 35 grams of 
enzymatically hydrolysed collagen resulted in a higher bioavailability of several AAs 
compared to non-enzymatically hydrolysed collagen (Skov et al., 2019), we did not find any 




possible that differences in processing methods accounted for this finding as it has been 
suggested to influence digestibility and therefore bioavailability of AAs (Dallas et al., 2017). 
 
In terms of the limitations of this study, we acknowledge that the questionnaire relating to 
acceptance and palatability of the protein sources used in this study was not a validated tool. 
Nevertheless, it provided insight into factors that are likely to affect the compliance of use of 
protein sources of potential benefit for collagenous tissues. Indeed, it indicated that despite the 
superiority of HCas over Cas in terms of AA availability, its poor scores for taste/texture are 
likely to affect consumer uptake and compliance with regular use. On the other hand, non-
hydrolysed supplements scored well in terms of acceptability in taste and cost; this makes 
gelatin a potentially useful product since it provided similar peak and total AA exposure than 
other collagen products. Furthermore, our inability to measure the composition of the protein 
sources actually used in this study until after its conduct meant that we relied on previously 
collected data, or that stated by the manufacturer which differed to the final measured content 
(Table 6.1.). The subsequent discovery of the higher protein of this broth makes it difficult to 
compare the bioavailability based on their actual protein intake. However, since the serves used 
in this study are the commonly consumed or recommended amounts of these protein sources, 
it did allow real-life insight into the AA profiles.  
 
In summary, our study characterised the blood AA profiles following the intake of a range of 
dairy and collagen supplements providing 20 g of protein, and a common serve of beef broth 
of higher total protein. While protein sources of similar origin contained a comparable total 
AA profile, consumption of dairy proteins provided a more pronounced amount of EAA and 
leucine than collagen sources, with hydrolysed casein showing increased bioavailability of 




glycine, with small differences between hydrolysed and non-hydrolysed forms. Although the 
total AA content of the beef broth was greater, a lower and more sustained blood AA profile 
seems likely. This information may help to inform protocols for achieving ideal blood AA 
responses once the optimal support for the synthesis of collagenous tissues is identified. 
However, the cost and palatability of these dietary and supplement sources should be 
considered.  
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Preface to Chapter Seven 
 
 
As outlined in Chapter Two, previous studies have demonstrated that the consumption of 
collagenous protein (in concert with an exercise stimulus) can result in an increased collagen 
content and improved tissue mechanics in an in vitro engineered ligament model. The final 
Chapter (Study 4) aimed to build on this work using information obtained within the initial 
studies of the thesis including the timing and appearance of AAs after the consumption of a 
selection of collagen and dairy proteins. A previously established engineered ligament model 
was updated with the consideration that the usual media used in this protocol is four times more 
concentrated than physiological serum levels and may, therefore, not represent the in vivo 
environment experienced by tendons and ligaments. Thus, an additional aim of the study was 
to determine the true effect of the differing AA responses to the intake of collagen and dairy 





Chapter Seven: The Consumption of Collagen and Dairy Proteins 
Does Not Affect Material and Mechanical Properties of 
Engineered Ligaments Treated With a Media Reflective of 
Fasting Physiological Amino Acids. 
 
 
The chapter is comprised of a paper in preparation for publication in The American Journal 





7.1 Abstract  
 
Background: Three-dimensional (3D) cell culture models present an opportunity to measure 
changes to dense connective tissues as a result of nutritional interventions, without the need for 
invasive techniques such as biopsy. However, this methodology may not be representative of 
in vivo synthesis due to supra-physiological levels of several amino acids (AA) proposed to be 
implicated in the synthesis of collagen. 
Objectives: The aim of this study was to measure changes in material and mechanical 
properties of 3D engineered ligaments within a physiologically relevant media, combined with 
serum collected after the consumption of collagen and dairy proteins.  
Design: Serum obtained from individuals after the consumption of 20 grams of collagen and 
dairy proteins, was added to a media developed to reflect physiological levels of AAs and 
utilized to treat 3D engineered ligaments. Once fully formed (8 - 10 days after plating), 
ligaments were treated for an additional 6 days in the serum media, after which time ligaments 
were tested for material and mechanical properties.  
Results: Despite differences in the AA profiles of the plasma after the consumption of collagen 
and dairy proteins (P < 0.007), there were no significant differences in collagen content (P = 
0.09), collagen % dry mass (P = 0.3), CSA (P = 0.2), MTL (P = 0.2), UTS (P = 0.3), or modulus 
(P = 0.5) for any of the treatment groups.  
Conclusions: Enhanced AA availability did not improve mechanical or material properties of 
3D engineered ligaments treated with a media reflective of physiological AA availability.   







A wide range of factors have been shown to influence the health and function of dense 
connective tissues including mechanical stimulus (Bohm et al., 2015), menstrual cycle phase 
(Morrison et al., 2015), inflammation (Tang et al., 2018) and metabolic disease (Abate et al., 
2013). Collagen, the main protein present within these tissues, is integral to their health and 
functioning. Conditions which lead to perturbations in the production of collagen protein (e.g. 
Ehlers-Danlos syndrome) result in tissues with poor integrity that are prone to injury 
(Myllyharju et al., 2009). Furthermore, it has been suggested that tendinopathies are 
accompanied with a lower collagen content and/or disruptions to mechanical properties, 
compared to healthy tendons (Arya et al., 2010; Couppe et al., 2013).  
 
While the impact of mechanical stimulus on collagen production and/or alterations to 
mechanical properties of collagen containing tissues has been thoroughly explored, there is 
only a small amount of research available seeking to determine whether nutrition may also 
impact material and/or mechanical properties of collagen containing tissues. Promising 
candidates include essential amino acids (EAAs) (e.g. leucine) (Barbosa et al., 2012; 
Dideriksen et al., 2011; Farup et al., 2014; Kato et al., 2016), those enriched in collagen protein 
(e.g. proline and glycine) (Baar, 2019; Barbul, 2008; Li et al., 2018; Paxton et al., 2012; Shaw 
et al., 2017; Vieira et al., 2015), or a combination of both (Dideriksen et al., 2011). Meanwhile, 
hydrolysed collagen and/or peptide formulations have shown promise in a range of collagen 
containing tissues including the reduction of joint and tendon pain (Oesser et al., 2016; Praet 
et al., 2019). Hydrolysed collagen formulations are suggested to have a higher bioavailability 
of bi- and tri- hydroxyproline containing peptides (e.g. gly-pro-hyp), resulting in an increased 




of collagen (Aito-Inoue et al., 2007; Koopman et al., 2009; Oertzen-Hagemann et al., 2019; 
Schunck et al., 2013; Skov et al., 2019). While there is some support for these claims, more 
work is necessary before they merit implementation in resource-intensive longitudinal studies 
of ligament and tendon health. 
 
The slow regenerative capacity of dense connective tissues (Heinemeier et al., 2013) renders 
research on connective tissue health/function as lengthy and challenging. Indeed, the only 
direct measure of both the synthesis and incorporation of collagen into dense connective tissue 
requires a biopsy of the tendon with the incorporation of isotopically labelled AAs (Smith et 
al., 2007). However, invasive measures to collect data on dietary interventions within athletic 
populations whom are heavily reliant on the day to day functioning of such tissues are not 
appropriate, as they can take a significant period to heal. In the absence of a non-invasive and 
precise measure of collagen synthesis and its incorporation into connective tissues, an in vitro 
three dimensional (3D) engineered ligament model has recently been developed (Paxton et al., 
2010). Through the use of this model, in vivo conditions as a result of exercise and/or nutrition 
interventions can tested in in vitro environments. This allows interventions to be undertaken in 
a well-controlled environment and reduces the premature need for invasive measures such as 
biopsies. Utilising this model, it has been shown that ligaments treated with serum obtained 
from exercising individuals resulted in an enhanced collagen content and mechanical 
properties, compared to ligaments treated with serum obtained from sedentary individuals 
(West et al., 2015). More recently engineered ligaments exposed to serum obtained after the 
ingestion of 15 g of supplemental gelatin, resulted in an increased collagen content and 
improved tissue mechanics compared to 5 g of an isocaloric placebo (Shaw et al., 2017). 
Although these findings are indeed promising, the application of such findings to “real world” 




Indeed, the media [Dulbecco's Modified Eagle Medium (DMEM)], that is traditionally utilised 
in the development and treatment of 3D cell cultures contains up to four times the fasting 
physiological levels of specific AAs, such as leucine and glycine (Alcock et al., 2019; Sarwar 
et al., 1991; Yao et al., 2017). Although necessary for the success of in vitro models, such high 
levels of nutrients may provide an artefact compared to real-life in vivo models where these 
tissue types are known to be poorly vascularised and may not receive such high levels of 
nutrient availability (Boushel et al., 2000a; Bray et al., 2002). Accordingly, the aim of the 
current study was to develop engineered ligaments according to established methods (Paxton 
et al., 2010), and once fully formed, treat them with a media reflective of physiological levels, 
with the addition of serum obtained from human participants after the interventions of interest. 
The specific targets of this work were the consumption of a standardised amount of hydrolysed 
and non-hydrolysed collagen proteins, and a high leucine hydrolysed dairy protein. It was 
hypothesised that this would allow for a more physiologically relevant interpretation of the 
influence of various protein sources on the mechanical and material properties of engineered 
ligaments.  
7.3 Subjects and Methods 
 
Subjects and blood collection 
Eight healthy, recreationally active males (29 ± 6 years; 81 ± 4 kg BM) with no known protein 
allergies or collagen related disease were recruited for the study. The sample size was chosen 
using similar power size estimations as outlined in (Shaw et al., 2017). The Australian Institute 
of Sport (AIS) human ethics committee granted ethics approval (#20170607) and written 
consent was received from participants prior to commencement of the study. This study was 
conducted as part of a larger investigation, with the entire study protocol submitted to the 




Subjects arrived at the Australian Institute of Sport physiology laboratory after an overnight 
fast (> 10 h) on 4 separate occasions, with at least 48 h separating trials. On arrival, a cannula 
was placed into the antecubital vein of the arm, and an initial 2 mL blood sample was collected 
into lithium heparin collection tubes (Becton, Dickinson and Company, Franklin Lakes, New 
Jersey, United States) for baseline (BL) plasma amino acid analysis. On one occasion only for 
each participant in random order an additional 51 mL blood sample was collected into 6 x 8.5 
mL serum-separator tubes (Becton, Dickinson and Company, Franklin Lakes, New Jersey, 
United States) for the treatment of BL ligaments. Immediately after the BL blood collections, 
subjects were given the treatment to consume and then instructed to rest for 40 minutes, at 
which time a 2 mL blood sample was collected into lithium heparin collection tubes for plasma 
amino acid analysis and a 51 mL blood sample was taken for the treatment of the engineered 
ligaments. The time of blood collection was chosen in light of the results of an earlier study 
which identified the plasma concentrations of TAA peak at this time (Alcock et al., 2019). 
Blood was immediately centrifuged (1500 x g; 4°C; 10 min) and the resulting plasma was 
separated and stored at -80°C for later plasma amino acid analysis. Meanwhile, the blood for 
the engineered ligament testing was allowed to clot, before centrifuging, processing and storage 
using aseptic technique. The resulting serum was frozen at -80°C until all samples were 
collected. The samples were then transported to the University of California, Davis for use in 
engineered ligament treatment. 
 
Supplement selection and preparation. 
Three supplements were chosen for the study; two collagen based supplements including a 
readily available commercial variety of ground porcine collagen (partially hydrolysed) 
(Gelatin; McKenzies, Altona, VIC, Australia), and a specific collagen peptide powder 




(Hydrolysed Casein; Professional Whey, NSW, Australia) was also chosen. In a recent study 
by our group we determined that whilst the three supplements chosen in the current study had 
a similar bioavailability of TAAs and proline, the collagen supplements provided a 
significantly higher amount of glycine, whilst hydrolysed casein provided a significantly higher 
amount of leucine at the timing of the peak (Alcock et al., 2019). Thus by choosing these 
supplements we were able to further explore the impact of specific AAs proposed to play a role 
in collagen synthesis. Although we did not find any difference in the availability of the AAs 
between hydrolysed and partially hydrolysed collagen supplements, within the current we were 
interested to determine if other factors that we did not capture such as peptide bioavailability 
may result in improved ligament outcomes. A 20 gram dose for each supplement powder was 
chosen to optimise AA availability (Alcock et al., 2019; Imaoka et al., 1992; Iwai et al., 2005). 
The supplements were mixed with 300 mL lukewarm water, and subjects were instructed to 
consume the liquid within 5 minutes.  
 
Amino acid composition of protein sources 
All protein sources were assessed for full amino acid profiles analysed using Ultra Performance 
Liquid Chromatography (Waters AccQTag Ultra) (Australian Proteome Analysis Factory, 
Macquarie University, Sydney, NSW). 
 
Plasma amino acid content  
Plasma samples were transported to Maastricht University for analysis of full amino acid 







Engineered ligament formation 
Primary human anterior cruciate ligament (ACL) cells were isolated from a young, male donor 
(18 y old) post-mortem, and used to construct engineered ligaments using a protocol approved 
by the Institutional Review Board at University of California, Davis. Cells were collected as 
described previously (Paxton et al., 2010). The ACL cells were expanded in DMEM growth 
media containing 10% foetal bovine serum and 1% penicillin and frozen at -200°C. When 
required, frozen cells were thawed, expanded in growth media, and passaged at least five times 
prior to the formation of the engineered ligaments. Engineered ligaments were formed as 
described previously (Paxton et al., 2010). Constructs were grown for 8-10 days in feed media 
containing 2 mL DMEM, 200 µM ascorbic acid, 50 µM proline and 3 ng/mL TGF- β per 
construct. 
 
Engineered ligament treatment and analysis 
Once constructs were formed fully, they were treated for 6 days with the media that was 
developed by diluting the DMEM media, and adding back in the relevant AAs to mimic 
physiological levels (Sarwar et al., 1991). The composition of the developed media can be 
found in Supplementary Table 11.2.3, and included 100 mL DMEM, 400 mL PBS, 1800 mg 
glucose, 9 mg glycine, 1% penicillin, 80 mg calcium chloride, 39 mg magnesium sulphate, 200 
µM ascorbic acid, 50 µM proline, 3 ng/mL TGF- β and 50 mL treatment serum collected from 
participants. A minimum of 3 constructs per condition were treated, with the mean being used 
for analysis. The tissue engineer treating the ligaments was blinded to the serum treatments.  
 
After treatment, constructs were tested as described previously (Paxton et al., 2010). 
Ligaments’ width and length were measured using digital callipers and cross-sectional area 




motor and force transducer and stretched using a custom LabView program (National 
Instrument) at a rate of 0.4 mm/s until failure. Maximal tensile load (MTL), ultimate tensile 
stress (UTS) and modulus (stiffness) were calculated. Once tensile testing was completed, 
ligaments were analysed for hyp content, from which collagen content was determined (Paxton 
et al., 2010). Briefly, constructs were hydrolysed in 6 N HCl for 3 hours and dried at 120°C. 
The resulting sample was resuspended in hyp buffer consisting of citric acid, acetic acid, 
sodium acetate and sodium hydroxide solution (approximate pH 6 - 6.5). An aliquot was diluted 
1:20, combined with 150 μL of 14.1 mg/mL chloramine-T solution and incubated for 20 
minutes at room temperature. Subsequently, aldehyde-perchloric acid was added and incubated 
for 15 minutes at 60°C and cooled for 10 minutes at room temperate. 200 μL of each sample 
was added to a 96 well plate and absorbance was read at 550 nm.  
 
Statistics 
Although a sample size of 8 subjects was intended, a vial of serum for one participant was 
contaminated during transportation. Therefore, this subject was excluded from the study. 
Statistical analysis was performed using GraphPad Prism version 7.00 for Windows (GraphPad 
Software, La Jolla California, USA). Prior to analysis, data was assessed for normality using a 
D’Agostino & Pearson’s normality test. Engineered ligament data were normalised to baseline 
values and then analysed using a linear mixed model with Tukey’s post hoc analysis. 
Differences in amino acid content of supplements was compared using a one-way ANOVA (if 
a full data set was available) or mixed-effect analysis with Tukey’s post hoc analysis. 
Correlations between plasma amino acid concentrations and ligament outcomes were assessed 







Amino acid content of protein sources 
The AA content of the various protein sources have been reported elsewhere (Alcock et al., 
2019). Although there were similarities in TAA concentrations, the dairy protein contained 
higher levels of EAA, leucine and lysine, whilst the collagen proteins were superior sources of 
glycine. Hydroxyproline and hydroxylysine were not detected in the dairy supplement. There 
was no significant difference in proline content between the protein sources. 
 
Amino acid availability in the plasma  
Plasma AA data are displayed in Table 7.1. Plasma AA concentrations were significantly 
higher for TAA, EAA, lysine and proline after the consumption of all supplements at 40 min 
compared to BL (P < 0.003). Compared to BL measures, the ingestion of the collagen 
supplements led to significantly higher plasma concentration of glycine (P < 0.007), after 40 
min, while the ingestion of hydrolysed casein led to a significantly higher plasma concentration 
of leucine and lysine at 40 min compared to BL (P < 0.0001). Across plasma concentrations at 
40 min; the ingestion of collagen supplements led to significantly higher plasma concentrations 
of glycine, hydroxylysine and hydroxyproline compared to hydrolysed casein (P < 0.002). 
Meanwhile, the ingestion of hydrolysed casein led to substantially higher plasma 
concentrations of EAA and leucine compared to collagen supplements (P < 0.0001), and higher 
plasma lysine (P = 0.02). There were no difference between collagen supplements in terms of 
AA availability at 40 min after their ingestion (P > 0.1). 
 
Collagen content and mechanics of engineered ligaments 
There was no difference in collagen content (P = 0.09), collagen % dry mass (P = 0.3), CSA 




(Figure 7.1). However, there was considerable inter-individual variability within these 
measures which is illustrated by individual data points in Figure 7.1. 
 
Correlation of amino acid availability and material and mechanical properties 
There was a weak inverse correlation between collagen % dry mass and plasma EAA (r = -
0.46, P = 0.05), and proline (r = -0.47, P = 0.001). There were no other correlations found 
between plasma AA concentrations and collagen content (P > 0.2), collagen % dry mass (P > 




Table 7.1: Amino acid content (mg) per 20 gram serving of dairy and collagen proteins, and plasma amino acid concentrations 40 min after their consumption, presented as mean ± 
SD. 
Supplement Hydrolysed casein powder Powdered gelatin Hydrolysed collagen peptide powder 














Plasma concentration  
(µmol/L) 
 - BL 40 min - BL 40 min - BL 40 min 
TAA 19378 2193 ± 244 3629 ± 455 20108 2111 ± 324 3399 ± 615 20594 2143 ±489 3695 ± 919 
EAA 8368 998 ± 112 1849 ± 159˟^ 4944 972 ± 140 1281 ± 241 5858 1008 ±206 1281 ± 241 
Pro 2060 178 ± 33 386 ± 64 2664 160 ± 49 336 ± 95 2722 163 ± 68 425 ± 144 
Gly 354 234 ± 38 225 ± 45 4750 232 ± 38 635 ± 173* 4904 222 ± 51 744 ± 248* 
Lys 1468 172 ± 28 331 ± 52 ˟^ 696 174 ± 35 263 ± 46 746 178 ± 42 279 ± 56 
Leu 1786 139 ± 21 329 ± 30 ˟^ 588 172 ± 29 172 ± 29 584 147 ± 35 182 ± 38 
Hyl N.D. N.D. N.D. 210 N.D. 17 ± 3* 208 N.D. 22 ±10* 
Hyp N.D. 18 ± 9 19 ± 8 2330 20 ± 11 139 ± 42* 2434 17 ± 6 197 ± 105* 
TAA: Total amino acids, EAA: Essential amino acids, Pro: Proline, Gly: Glycine, Lys: Lysine, Leu: Leucine, Hyl: Hydroxylysine, Hyp: Hydroxyproline, N.D.: Not detected. 
Note: Cysteine and tryptophan have not been included in analysis, which account for < 5% in total. mg per serve calculated based on free amino acid molecular weight. 





Figure 7.1: Material and mechanical properties of engineered ligaments treated with serum obtained 
after the consumption of collagen and dairy proteins, and a physiologically relevant media. Column 
shows mean, lines represent SD and shapes represent individual data points. All data are normalised to 





The main finding of the current study was that, despite differences in blood AA availability 
following the ingestion of dairy and collagen proteins, we failed to find significant differences 
in the material or mechanical properties of the engineered ligaments when they were exposed 
to this nutrient support. Furthermore, there was only a weak inverse correlation between plasma 
EAA and proline and collagen % dry mass, while there were no other correlations between 
plasma AA concentrations and ligament properties. These findings are in contrast to previous 
work by our group in which we found enhanced collagen content in engineered ligaments 
treated with normal DMEM and serum collected after the ingestion of increasing amounts of 
gelatin (Shaw et al., 2017). 
 
Although the recent development of 3D models have allowed for insight into the impact of 
various nutrition and exercise interventions without the need for invasive techniques, there is 
criticism as to their “real-world” applicability, particularly in terms of the composition of media 
utilised to grow and treat the constructs (Ackermann et al., 2019; McKee et al., 2017; Ravi et 
al., 2015; Yao et al., 2017). Indeed, DMEM was initially developed to supply cancer cells with 
nutrients essential for their continuous proliferation (Ackermann et al., 2019). As such, DMEM 
contains nutrients in supra-physiological levels including glucose, minerals such as calcium 
and phosphorus, and AAs such as leucine and lysine (Ackermann et al., 2019; Yao et al., 2017). 
Our study followed the concept implemented by several other researchers of manipulating 
constituents of the media to be more reflective of physiological levels (Baar, 2015; Cantor et 
al., 2017; Paxton et al., 2010; Vande Voorde et al., 2019), with the specific focus on AAs that 






Proline and ascorbic acid 
Although DMEM contains supra-physiological levels of some nutrients, others, such as 
proline, and ascorbic acid are not present in the media. Proline constitutes a large component 
of collagenous protein and has been shown to be essential for collagen production (Wu et al., 
2011). Meanwhile, ascorbic acid is an essential cofactor for prolyl-4-hydroxylysase, which 
catalyses the formation of hydroxyproline. Therefore, deficiencies in the intake of ascorbic acid 
interferes with the development of collagen protein and leads to poor connective tissue strength 
(Boyera et al., 1998; Peterkofsky, 1991). In optimising the engineered ligament model, Paxton 
et al. (2010), determined that the addition of  proline (50 µM), and ascorbic acid (50 µM) led 
to  an increased collagen content and strength in their constructs (Paxton et al., 2010). Later, 
Hagerty et al. (2012), determined that the addition of 200 µM ascorbic acid and other growth 
factors led to further increases in the collagen content of engineered ligaments. Furthermore, 
recent work by our group determined that the intake of increasing amounts of gelatin led to an 
increased proline availability, potentially leading to collagen content of the engineered 
ligaments (Shaw et al., 2017). Although in the current study we allowed our base media to 
contain optimal amounts of  ascorbic acid and proline levels associated with the viability of 
engineered ligaments (West et al., 2015), we still expected to see differences in blood proline 
concentrations following the intake of our experimental supplements. In fact, there was no 
difference in availability of proline between protein sources after consumption. Thus, it is 
possible that the lack of additional availability differences in proline and/or ascorbic acid from 
the intake of collagen and dairy proteins led to the lack of differences seen in material and 
mechanical properties of the engineered ligaments. It is also possible that the addition of these 
components to the media had such a large impact on the outcome measures, that any subtle 
differences due to other AA concentrations in the subjects’ plasma were unable to be detected. 




key determining factors that accounted for the lack of differences seen within the ligament 
properties despite receiving different levels of other AAs within the treatment media.  
 
Glycine 
Glycine is an important AA in collagen synthesis protein, providing ~ 1/3 of the protein  content 
of a collagen molecule (Li et al., 2018). Although glycine has been defined as a non-essential 
AA (NEAA), it has been suggested that its biosynthesis within the body does not meet the 
demands for collagen synthesis requirements in all scenarios (Meléndez-Hevia et al., 2009; 
Wang et al., 2013). In addition, glycine has been shown to exert a range of anti-inflammatory 
effects in a range of tissues including the liver, kidney, heart, intestine and skeletal muscle in 
varying states of disease and malnutrition (Zhong et al., 2003). In an animal model, a high 
glycine diet has been shown  to  increase collagen synthesis in an inflamed deep digital flexor 
tendon (DDFT), to a similar degree to that of a non-inflamed DDFT (Vieira et al., 2015). Within 
the current study, plasma glycine concentrations at the time point of sampling for the ligament 
treatment (40 min post-ingestion) were 744 ± 248 and 635 ± 173 µmol/L for hydrolysed 
collagen, and gelatin, respectively; this is similar to the concentrations reported in our previous 
study for the high (15 g; 687 µmol/L) gelatin dose (Shaw et al., 2017). We note, therefore, that 
our higher doses of collagen proteins (20 g) did not appear to result in increased availability of 
glycine, suggesting a threshold in regard to the amount of gelatin that is able to be absorbed or 
possibly utilised. However, we acknowledge that blood concentrations provide a blunt 
snapshot of the dynamic kinetics between appearance and tissue uptake of nutrients. 
Furthermore, we note that the serum used to treat the engineered ligaments was obtained at a 
time point informed by an earlier part of data collection of the larger study as the mean time to 
reach peak plasma AA concentrations and further data collection/analysis showed variability 




concentration of glycine was not captured for all individuals within the current study. This also 
provides a case for further work to determine differences in BL levels and/or absorption of key 
AAs that may be associated with collagen synthesis in dense connective tissues.  
 
Hydroxyproline and hydroxylysine 
Other AAs of quantitative importance in collagen proteins, but absent within the dairy proteins 
include glycine, hydroxyproline and hydroxylysine. Hydroxyproline and hydroxylysine are 
metabolites unique to collagen protein and are produced during the process of collagen 
synthesis (Shoulders et al., 2009). Within the current study, both were found to be present in 
plasma following the consumption of collagen-derived protein supplements (Table 7.1.). 
Although they contribute to the strength and rigidity of formed collagen molecules, our current 
understanding is that plasma hydroxyproline and hydroxylysine are incapable of being 
incorporated into new collagen (Shoulders et al., 2009; Sjoerdsma, 1965; Yamauchi et al., 
2012). Therefore, differences in their bioavailability should have little influence on the collagen 
content or mechanical properties of engineered ligaments, unless they have a unique bioactive 
role that may upregulate the synthesis of collagen in certain tissues as has been previously 
suggested (Edgar et al., 2018; Matsuda et al., 2006; Rutherfurd-Markwick, 2012; Schunck et 
al., 2013). 
 
Essential AAs and leucine 
EAAs are necessary for the maintenance and integrity of muscle tissue and inadequate intakes 
lead to perturbations of growth and development and lean mass atrophy (Hou et al., 2015). 
Considerable attention has focused on the role of one particular EAA, leucine for its role in 
stimulating myofibrillar protein synthesis via the mammalian target of rapamycin (Dodd et al., 




with an appropriate exercise stimulus (Phillips, 2014; Phillips et al., 2011). In extension of their 
importance in myofibrillar protein synthesis, researchers have sought to determine whether 
EAA may also play a role in the synthesis of collagen with equivocal results. Barbosa et al., 
(2012) reported increased collagen content and tissue mechanics of the digital flexor tendon, 
amplified by exercise, when malnourished rats consumed a high leucine diet. However, these 
results were not seen in a nutrient replete cohort (Barbosa et al., 2012), and a separate study 
involving rodents failed to see an increase in skeletal muscle collagen when leucine enriched 
EAA was consumed immediately, and 1 day, after exercise (Kato et al., 2016). In the current 
investigation, although the ingestion of hydrolysed casein resulted in a higher plasma 
availability of leucine compared to the intake of collagen derived proteins, this increased 
availability did not result in any differences in material or mechanical properties of the 
engineered ligaments. This suggests that leucine may not play a critical role in collagenous 
protein synthesis within the engineered ligament model compared to that which is well-
established in myofibrillar proteins (Churchward-Venne et al., 2012; Dodd et al., 2012). 
 
Hydrolysed and non-hydrolysed collagens 
Suggestions that hydrolysed protein sources are superior to whole protein sources due to higher 
bioavailability and bioactive functions (Aito-Inoue et al., 2007; Iwai et al., 2005) have not been 
well documented within the literature. In the present study, we did not see any differences in 
apparent availability (i.e. higher or more rapidly achieved increased in blood concentrations) 
of any AAs between the hydrolysed, and partially hydrolysed collagen protein sources at the 
chosen timepoint of 40 min post-ingestion (Table 7.1). Although we did not measure peptide 
availability, if there was a significant biological effect of hydrolysed collagen on collagen 
synthesis compared to the partially hydrolysed collagen, we would then expect to see 




their consumption, however this was not the case (Figure 7.1). This suggests that within the 
current study hydrolysed collagen was not superior to partially hydrolysed collagen in terms of 
general bioavailability or impact on collagen synthesis.  
 
Individual variability 
As was evidenced in Table 7.1, there was between-subject variability in plasma AA response 
to the consumption of dairy and collagen protein sources, suggesting differences in individual 
capacity to digest, absorb and/or the transportation of varying protein sources. Furthermore, 
although the loss of one subject’s data weakened the study power and our ability to probe 
individual “responsiveness”, there was a visual difference in the inter-individual results around 
the material and mechanical properties of the engineered ligaments (Figure 7.1). However, 
there were only weak inverse correlations found between plasma EAAs and proline and 
collagen % dry mass. Thus, differences in AA availability between individuals were potentially 
too small to equate to significant differences in material or mechanical properties, or the 
particular AAs which presented differences in availability were not implicated in collagen 
synthesis. 
 
Limitations and future directions 
There were several limitations to the current study. The desired sample size was not achieved 
due to an accident in the sample handling; this reduced the statistical power of the study and 
decreased the likelihood of detecting real-world significance. Further the inter-individual 
variability suggested that other factors such as exercise habits, hormonal milieu and/or regular 
dietary intake may influence an individual’s AA concentrations in response to an ingested 
protein dose. In addition, although all plasma/serum was obtained after an over-night fast, with 




of subjects during this preparation phase. Differences in background diet and exercise, as well 
as other unidentified factors may have contributed to the considerable inter-individual 
variability in the changes in the properties of the engineered ligaments following our 
interventions. Although it is difficult to ascertain what led to the lack of differences in the 
material and mechanical properties of engineered ligaments, it is possible that low levels of 
AAs present in the treatment media did not support the optimal growth of the engineered 
ligaments as is necessitated in cell-culture work (Yao et al., 2017). As such, it is possible that 
other components of the development media i.e. the fibrinogen gel may have been broken down 
and utilised as an additional source of AAs to support ligament growth. Another limitation of 
the current study was that although proline was reduced when initially diluting the media, we 
decided to follow the standard media enrichment protocol whereby 50 µM of proline was added 
to the growth and treatment media (Hagerty et al., 2012). Had we not added extra proline to 
the treatment media, we may have seen slight differences in the material and/or mechanical 
properties of the engineered ligaments as a result of differences in proline availability after the 
consumption of the protein sources. Although we adapted our treatment media to simulate 
physiological values for serum AA concentrations, it may be more appropriate to match the 
composition of the media to that of peritendinous fluids after the consumption of specific 
protein sources and/or AAs. However, to our knowledge this information is not yet available, 
thus would be of benefit for future research. Further research on manipulations of treatment 
media is needed to find a balance between mimicking in vivo conditions and supporting the 
viability of in vitro work. It is possible that if there we had more participants, and thereby 
power to the current study, this may have overcome differences in inter-individual variability, 
and led to significant outcomes. A final limitation to the current study, is that no comparison 
between characteristics of the engineered tissues from pre- to post-treatment could made due 






Although several AAs have been proposed to influence collagen synthesis, the differences in 
concentrations of AAs in the plasma at 40 min post consumption of a hydrolysed diary and 
collagen protein, and a non-hydrolysed collagen protein, in addition to a media to reflect fasted, 
rested physiological levels did not influence the material or mechanical properties of 
engineered ligaments. Despite these findings, this study highlights several challenges in 
utilising in vitro cell culture models to investigate conditions found in vivo models. Thus, care 
should be taken when translating findings obtained from cell culture work to whole body 
outcomes. Furthermore, extraneous variables such as habitual protein intake, exercise, and 
potentially the ability to digest/absorb proteins should be considered where possible.  
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8.1 General Discussion and Summary 
 
Maintaining the health and function of dense connective tissues is of obvious interest to all 
populations. As discussed in Chapter One, the incidence and cost of connective tissue injury is 
of significant concern to all exercising individuals from recreational, to elite athletes. 
Furthermore, given the potentially slow rate of turnover of these tissue types, injuries can 
require lengthy rehabilitation periods to ensure full recovery. Therefore, strategies that can 
enhance the strength and/or accelerate healing of dense connective tissues would be of 
significant value (Baar, 2015).  
 
Early research on the synthesis of collagen in ligaments and tendons investigated whether  
EAAs, such as leucine, would extend their role in the synthesis of myofibrillar protein to the 
dense connective tissues (Scott et al., 2016). However, it remains unclear whether the intake of 
leucine beyond that of dietary sufficiency for normal growth and development is of benefit to 
ligaments and tendons. Separate lines of investigation of the strategic intake of the AAs that 
make up the bulk of collagen protein (e.g. glycine and proline) have shown promise in 
introductory models involving cell cultures (Paxton et al., 2010; Shaw et al., 2017). However, 
confirmation of the transferability of these findings to “real-world” conditions requires further 
investigation involving in vivo protocols. 
 
As discussed in Chapter Two, longitudinal intervention studies pose significant challenges, 
including the lengthy intervention period required to observe meaningful changes in ligaments 
and tendons, and the difficulty of measuring the synthesis and incorporation of collagen into 
these tissues. Furthermore, the initial scoping activities associated with this body of work 




after the consumption of various protein sources and the lack of ability to control or measure 
background intake of collagenous protein. The combination of this uncertainty with the level 
of resourcing required for a lengthy intervention study led to the decision that the priority needs 
in this area were to systematically determine and confirm the best candidates for a chronic 
supplementation study, and to identify any factors that might confound the outcomes or the 
interpretation of the data. Thus, the intention of this thesis was to create a foundation of 
information that could assist in the future implementation of more invasive quantitative 
intervention study. The specific areas investigated within this thesis and the outcomes of these 
investigations are outlined in Figure 8.1. The main findings of these studies are:  
1) Bone broth, a source of collagen-derived protein, commonly used in various sporting 
and/or interest groups (e.g. Cross-fit, and traditional Chinese medicine) has a widely 
variable AA composition, which is likely to be associated with differences in 
preparation methods (e.g. animal and/or bone type, cooking time etc.). The principle 
cause of this variability was not obvious and therefore, could provide confounding 
factors for future studies. On this basis, bone broth should not be considered a consistent 
and therapeutically beneficial source of collagen-specific AAs.  
2) Urinary hydroxyproline is not suitable as a sensitive biomarker of habitual collagen 
intake in “free-living”, healthy, active males, as it is rapidly excreted from the body 
(within ~ 6 h), and there is large inter-individual variation potentially due to differences 
in collagen digestion and/or collagen turnover.  
3) In contrast to the claims of superior bioavailability of commercial hydrolysed collagen 
protein formulas (e.g. Gelita Tendoforte) compared to partially-hydrolysed collagen 
sources (e.g. gelatin), plasma AA responses to the consumption of several collagen-
derived proteins was similar. The consumption of dairy-based and collagenous proteins 




bioavailability of EAAs and leucine after the consumption of dairy proteins, and higher 
concentrations of glycine associated with collagen-derived protein.  
4) The treatment of engineered ligaments with serum collected in response to the 
consumption of collagen and dairy proteins, and a media to reflect physiological 
nutrient levels did not result in any significant differences in collagen content or 
mechanical properties. The reason for this outcome is largely unknown but may be due 
to insufficient AA availability in the treatment media, or due to the lack of differences 
in the proline content between the dietary treatments. This study illustrates the 
limitations and care that needs to be taken when designing and utilising an in vitro 
model to infer in vivo outcomes.  
Overall, these findings highlight the complexity of research within this area and that careful 
consideration is necessary prior to engaging in costly, complex and lengthy intervention studies 
aiming to increase our knowledge of nutrition support for dense connective tissues.  
 
8.1.1 Thesis outcomes 
 
Chapter Four (Study 1) summarises an investigation to determine whether a food source of 
collagen, bone broth, would provide specific AAs in amounts that are similar to reference 
supplements currently involved in collagen research. This aligns with the “food first” approach 
of sports nutrition professionals and recognises that the provision of nutrient needs through 
food sources has the capacity to meet several sports specific and health goals simultaneously 
while avoiding the risk of inadvertent doping associated with supplement use (Geyer et al., 
2008). A variety of bone broth sources were assessed, including both commercial and home-
made varieties, with both standardised and non-standardised recipes. The home-made varieties 
of bone broth included a number of preparation methods claimed to extract higher levels of key 




types. Analysis of the broths showed consistency in the AA composition of batches prepared 
to the same recipe (made by the author) but inconsistencies between batches prepared 
according to different recipes. However, although a bone broth prepared by an external source 
(i.e. the “chef prepared bone broth”) contained comparable (although highly variable) amounts 
of key AAs to the reference supplements, a further batch prepared by the author to the same 
recipe was unable to match the level of AAs.  There was no consistency across factors involved 
in the different preparation methods of home-made bone broths to explain the differences in 
the AA content. This led to the conclusion that bone broth is too variable in composition to be 
utilised therapeutically for the purpose of supporting collagen synthesis in ligaments and 
tendons. We recognise that there was a practical limit to the number of variations in both broth 
recipes that could be included in the study. Therefore, it is plausible that different types of 
bones and/or cooking methods may achieve increased levels of AAs in some bone broths, and 
therefore increase the suitability of this food source if prepared to a known and standardised 
recipe. Nevertheless, the variability in AA content and the general findings of insubstantial 
amounts of potentially important AAs reduces the widespread viability of bone broth as a 
vehicle for supplying doses associated with therapeutic uses. 
 
Chapter Five (Study 2) was undertaken in recognition of the lack of data on the background 
intake of collagen-derived protein in the Australian diet, due to the lack of information on the 
collagen content of various food sources. The inability to account for background dietary intake 
of nutrients may confound the validity of research on dietary support for the 
health/performance of dense connective tissues, both in epidemiological settings and in the 
standardisation of intervention studies (Weaver et al., 2017). Hydroxyproline is a metabolite 
of proline, which is released during collagen breakdown but not incorporated into new collagen 




as a marker of hydroxyproline excretion, secondary to the breakdown of collagen proteins in 
the body (Prockop et al., 1961). As the urinary excretion of hydroxyproline is increased after 
the consumption of dietary collagen, when this method is used to screen for the presence of 
conditions with atypical collagen breakdown, the intake of collagenous food sources is usually 
restricted to prevent interference with the validity and interpretation of data (Prockop et al., 
1961). However, no studies have sought to determine whether urinary hydroxyproline could 
be indicative of dietary collagen intake in “free-living” individuals, and the time course of its 
appearance within the urine after its intake. The results of this study showed that urinary 
hydroxyproline (standardised to creatinine excretion) was increased for up to six hours 
following the consumption of a large bolus of collagen proteins (31 ± 8.8 mmol: mol after the 
consumption of gelatin and 33.7 ± 22.0 mmol: mol after the consumption of hydrolysed 
collagen). However, usual dietary intake (i.e. a normal breakfast) failed to create a detectable 
change in urinary concentrations. Furthermore, there was also considerable variability between 
individuals, ranging from 22.9 to 47.5 mmol: mol and 2.0 to 50.5 mmol: mol, 0-6 h after the 
consumption of gelatin and hydrolysed collagen, respectively. This variability could not be 
accounted for with the measured variables. Indeed, there was no association found between 
general protein intake or exercise performed and the excretion of hydroxyproline. Therefore, 
other factors must influence urinary hydroxyproline concentrations between, and within, 
individuals. This might include individual capacity to digest collagen protein (Gardner, 1988), 
which has implications in terms of how these individuals may respond to dietary interventions 
utilising collagen protein.  
 
Previous literature suggests that, unlike other tissues with high rates of turn over (e.g. bone, 
and muscle), nutrition is likely to play a supportive, rather than stimulatory role, in collagen 




likely due to dense connective tissue being reliant on mechanical stimulus in order to facilitate 
growth, and the need to encourage blood flow (through exercise) through tissues which are 
otherwise poorly vascularised, in order to improve AA availability at the site of the tissue. 
Therefore, Chapter Six (Study 3) aimed to answer several questions with regard to the 
bioavailability of AAs after the consumption of various collagen and dairy protein sources. 
These included the timing and magnitude of peak blood concentrations of the AAs putatively 
involved in the synthesis of collagen; such information would help to inform prescriptions for 
the optimal timing and amount of the protein source(s) prior to exercise. Furthermore, given 
the lack of clarity around which AAs are involved in enhancing the synthesis of collagen (see 
section 2.8, we endeavoured wished to determine blood AA profiles following the intake of a 
protein dose considered to be of therapeutic value for collagen synthesis as well as a commonly 
consumed serve of bone broth (although there were limitations using this approach; see section 
8.3). 
 
It has been suggested that hydrolysed collagen proteins are superior to intact, partially or non-
hydrolysed collagen proteins. Such formulations are proposed to have a more pronounced and 
rapid ability to appear in the blood and reach the target tissue, as well as providing 
physiological functions beyond that of the whole, intact proteins (Aito-Inoue et al., 2007; Edgar 
et al., 2018; Matsuda et al., 2006; Oesser et al., 2003; Rutherfurd-Markwick, 2012). The use of 
these hydrolysed collagen formulations that contain bioactive peptides have been reported to 
enhance the health/function of collagen-containing tissues within the body, with outcomes 
ranging from reduced joint pain, to improved body composition (Edgar et al., 2018; Oertzen-
Hagemann et al., 2019; Oesser et al., 2016; Oesser et al., 2003; Praet et al., 2019; Schunck et 
al., 2013; Zdzieblik et al., 2015). However, these products have not been compared to other 




provided higher plasma EAA, and leucine concentrations, while collagen proteins provided 
higher plasma glycine concentrations. Meanwhile, although increased bioavailability (i.e. 
greater AA appearance in blood following intake of the protein) was observed with the 
hydrolysed dairy proteins compared to non-hydrolysed dairy proteins this difference was not 
seen between the hydrolysed and non-hydrolysed collagen formulas. This finding contrasted 
with the results of other similar studies, and may have resulted from differences in processing 
methods to hydrolyse protein sources (Dallas et al., 2017).  
 
Chapter Seven (Study 4) was informed by the first part of the data collection for study 3 (part 
A), in which 8 of the 15 subjects’ plasma was analysed for AA bioavailability after the 
consumption of collagen and dairy protein sources (refer to Chapter Three). This allowed an 
indication of when AAs were at their peak in the blood, which would inform when to obtain 
the blood used to treat the engineered ligaments. Three supplements were utilised for this study 
including a hydrolysed and partially hydrolysed form of collagen protein, and a hydrolysed 
dairy protein. Engineered ligaments were grown from human fibroblasts in a full strength 
media for 8-10 days, and treated with serum collected from the participants after the 
consumption of dairy and collagen proteins and mixed into a more physiologically reflective 
media (Sarwar et al., 1991) for 6 days. This media was manipulated as the full strength media 
utilised to develop and treat engineered ligaments contains concentrations of AAs four times 
that which is found in the blood (Yao et al., 2017). Therefore, it is not reflective of “real-world” 
AA availability within the body, and in particular within these tissue types which are known to 
be poorly vascularised (Boushel et al., 2000a; Boushel et al., 2000b; Bray et al., 2002; Petersen 
et al., 1999). After treatment, the ligaments were tested for material and mechanical properties 
using a variety of methods. However, there were no significant differences in collagen content 




unable to ascertain what led to the lack of significant findings, however it could have been 
attributable to a lack of AA availability within the treatment media that was purposefully 
diluted, or that there was equivalent proline availability across all treatments. It was also 
possible that the addition of ascorbic acid may have reduced the likelihood of detecting small 
differences in ligament properties. Finally, there was also considerable inter-individual 
variability, which may have been confounded by other variables not captured within this study. 
Whilst we were unable to ascertain what led to either the lack of significant findings or 
individual variability, this study does illuminate potential challenges of this model in its 
application to in vivo conditions.  
 
Therefore, collectively, this body of work was able to fill in several literary gaps and provide 
further insight into methodological considerations that will assist in the development of further 
research and ultimately a well-designed intervention study. However, several other gaps were 
highlighted, and further highlights the difficulty undertaking research within this area.  
 
8.2 Limitations and Considerations 
 
It is important to recognise the global limitations of this body of work, by summarising and 
integrating the limitations of the separate studies. Study 1 aimed to investigate the diversity in 
the amino acid content of different types and batches of bone broth. Although we tried to 
include a large range in the types of broth, there are a multitude of different combinations of 
individual meat types and/or meat products, amounts of ingredients, the inclusion or exclusion 
of varying ingredients, such as vinegar, and treatment of the end product (e.g. with, or without 
fat, strained, or unstrained and so forth). Had we included a greater range of collagenous-rich 




reach higher amounts of collagen precursors, comparable to the doses present in the reference 
supplements. Indeed, we note that the café-provided bone broth was able to match, and even 
exceed, the level of AAs in the reference supplements; presumably, this was attributable to 
some unidentified component of preparation. Furthermore, the dose of reference supplements 
(20 grams), may be higher than the optimal dosage, meaning that we may have overlooked the 
benefits of some broth sources.   
 
In Study 2, we used 20 g doses of collagen-rich protein supplements to assess urinary 
hydroxyproline excretion as a potential biomarker of its intake. Although we concluded that 
spot collections of urine provide only a short-term observation of a relatively substantial dietary 
intake (e.g. 20 grams of collagen powder), further interrogation could include analysis of the 
response to different dietary protein sources and its interaction with a range of different factors 
such as individual body composition/lean mass or volume, intensity and mode of exercise that 
may contribute to the individual variability of urinary hydroxyproline excretion. It should be 
noted that due to challenges with data collection for dietary intake records, the sample size on 
some occasions was reduced to 5. This reduced our ability to determine if any of these factors 
had a significant impact on hydroxyproline excretion. However, given that hydroxyproline 
appeared to be excreted within a 6-hour period, it is unlikely that dietary intake the night prior 
(> 6 hours) would have had an impact. Furthermore, given that hydroxyproline excretion was 
not significantly increased on days where the collagen supplement was not consumed, it is 
unlikely that protein intake during the day would have had any correlation with hydroxyproline 
excretion, unless of course a substantial source of dietary protein intake came from collagenous 





As outlined in Chapter Three, the data collection for Study 3 was split into two phases and 
participant cohorts. This was necessary to enable the proposed studies to be completed in a 
timely manner. More specifically, in utilising this systematic approach, it enabled information 
from the first eight participants to inform data collection for the final study: to determine the 
time point of peak AA concentrations at which the large blood sample, needed for the 
engineered ligament protocol, would be drawn. This occurred before receiving the complete 
data set from the chemical analysis of the AA and protein content of the study food sources, 
bone broths and reference supplements was received. We were reliant on using the initial 
analyses, and manufacturer-derived information on the protein content, of the doses of the 
liquid collagen and bone broth used in Study 3. In some cases, the actual AA content deviated 
from our expectations/initial data. This prevented us from being able to truly compare the 
bioavailability of true 20-gram protein serves of these products. Due to financial constraints 
and limits to the volume of blood that could be collected from subjects over multiple trials in 
a short time frame (particularly the 51 ml sample), we were restricted to collecting blood at 20 
min intervals for a total of three hours only. It is possible that more regular sample collection 
and/or for a longer period of time, may have given more accurate outcome measures, such as 
time to peak, and AUC. Furthermore, it is possible that had we engaged in more than one data 
collection for each protein source per participant, we may have seen differences in intra-
individual variability on different days. This may have had implications for the ensuing study. 
 
Finally, with regard to the cell culture work undertaken in Study 4, there is a considerable time 
required from passaging cells to growing the optimal set of at least 4 engineered ligaments per 
individual per treatment (approximately 4 – 6 months). This meant that there was insufficient 
time to develop another set of ligaments to be treated with full-strength media, against which 




been compared. Perhaps the most significant limitation was the decision to adhere to previous 
protocols including standardised addition of proline and ascorbic acid to treatment media. This 
may have reduced the likelihood to observe any differences resulting from the treatments per 
se, given that both proline and ascorbic acid are heavily involved in collagen production 
(Barbul, 2008; Boyera et al., 1998).  
 
8.3 Future Research Directions 
 
This body of work was able to address several gaps in the current literature including: a) 
whether a common food source of collagen, currently used by several cultural populations is 
able to provide a reliable and therapeutically beneficial amount of key AAs proposed to be 
involved in the synthesis of collagen; b) whether it is possible to use urinary hydroxyproline as 
a suitable biomarker of collagen intake in “free-living”, healthy, active males and; c) the 
bioavailability of AAs after the consumption of various collagen and dairy protein sources, 
including intact, hydrolysed and partially hydrolysed forms. Although the final study did not 
have the intended outcome and allow for the interpretation of the various treatments, it did 
highlight the challenges in the transferability of these models to “real-world” conditions. As a 
result of these findings, several future research directions require further investigation (Figure 
8.1.). These include:  
1) The analysis of the collagen content of various food sources, including varying cuts of 
meat and offal determined through the analysis of their hydroxyproline content, to allow 
for the development of more detailed nutrient composition tables for the quantification 
of collagen intake in dietary intake studies. This could provide added rigidity to studies 




2) Further investigations into individuals’ ability to digest collagen proteins, including 
those consuming a vegetarian diet, and the impact of these differences on various 
outcomes such as collagen synthesis and incorporation, and/or dense connective tissue 
health. 
3) Investigations into whether athletes have a higher rates of collagen turnover compared 
to sedentary individuals and whether different tissues within the body have higher rates 
of collagen turnover. 
4) Investigations as to the optimal dosage of collagen, whether there is a threshold in 
regards to bioavailability after the consumption of collagen proteins, and whether this 
is dependent on body mass. 
5) Investigations into whether regular, consistent intake of collagen results in increased 
availability of AAs in the blood, and the impact that this might have on dense 
connective tissue material and its’ mechanical properties. 
6) Microdialysis study investigating the availability of key nutrients and presence of 
biomarkers of collagen turnover in peri-tendinous fluid after the consumption of 
collagen. 
7) Engineered ligament/cell culture studies mimicking in vivo conditions, including 
proline and ascorbic acid consumed, rather than added to the treatment media. 
8) Engineered ligament/cell culture studies mimicking in vivo conditions, compared to 
traditional conditions (e.g. physiologically relevant compared to full strength media), 
and whether increased EAA content with media matched to peritendinous fluid (as 
above) would have an impact. 
9) Engineered ligament/cell culture studies treated with individual AAs, and/or 
combinations thereof in order to determine which AA/combination of AAs are involved 




10) Validation of assessment techniques for collagen synthesis and integration in dense 
connective tissues in vivo. 
11)  Further investigations into gender differences for connective tissue health/function and 
injury risk as a result of fluctuations in sex hormones, and the nutritional management 
of these potential differences.  









Table 8.1: Recommendations for intervention study for increasing collagen synthesis and integration in dense connective tissues. 
Component of study design Methodological considerations Other considerations 
Participant selection and 
recruitment  
 Should initially consist of male participants given the effect of female sex hormones on dense connective tissue 
health and injury risk. 
 Should be athletes who utilise explosive movements or are prone to connective tissue injury given nature of sport 
and/or separate athletes in different positions.   
 Responders vs. non-responders should be assessed through the excretion of hydroxyproline or blood availability of 
AAs after the consumption of protein sources in order to assist the interpretation of research outcomes.  
 Exclusion criteria includes low or non-meat eaters; not recommended as this may impact on collagen digestion.  
 Need to quantify or standardise exercise habits. 
 Use power calculation as minimum number of participants required with an additional 10-20% in case of any data 
loss. 
 Should utilise trained population as it is likely that athletes have higher rate of collagen turnover than sedentary 
individuals (need further studies to confirm).  
Likely need to determine other factors that may 
increase or decrease hydroxyproline excretion 
between individuals and/or differences in ability 
to metabolise collagenous proteins 
Length of intervention  Minimum of 6 months.  
 This may depend on the dense connective tissue being targeted e.g. those with higher turnover compared to those 
with lower turnover.  
Cost will likely affect how long the study can be 
undertaken.  
Dietary intervention and adjunct 
measures 
 Bioactive peptide formula vs hydrolysed collagen vs gelatin (need further studies to confirm). 
 Compare against placebo (e.g. vegetarian collagen as this is void of collagen specific AAs), also compare against 
high leucine protein sources.  
 Document vitamin C intake and assess within the blood. Recommend dietary adequacy rather than supplemental 
forms.  
 May be worth utilising single AAs and/or combinations thereof (need further studies to confirm) 
 Consume within 40-60 mins prior to exercise as per AA paper dependant on AA targeting.  
 Standardised diet likely not possible given the length of the study, therefore, dietary intake should be monitored, 
suggested, and/or repeated where possible. 
 Protein intake in particular should be consistent between individuals to ensure adequate availability of EAAs. 
 Minimum EI should also be recommended to ensure prevention of LEA which may impact on connective tissue 
health. 
 Challenges in measuring dietary intake, need 
to utilise several adjunct measures, and 
ensure participants comply and do not lose 
food diaries. 
 Athlete compliance also needs to be taken 
into consideration and should also form part 
of data collection. 
Exercise Protocol  6 minutes skipping protocol added to athlete’s current training? 
 Imbed connective tissue specific programming for participants to encourage blood flow to the target tissue, and/or 
increase or decrease tissue mechanics. 
Must control/document exercise undertaken 
outside of study, or give strict protocols. 
Assessment of collagen turnover 
(synthesis and breakdown), 
incorporation into target tissue and 
functional outcomes 
In lieu of direct measures (i.e. biopsy) several measures are necessary, including biomarkers (preferentially at the site of 
the tissue of interest), and changes to tissue size.  
Need to complete micro dialysis study to confirm 
availability of AAs and biomarkers at the target 




8.4 Practical Implications 
 
The potential to have a positive impact on the health/function of ligaments and tendons is of 
obvious interest, and therefore, perhaps prematurely, several guidelines have surfaced around 
the intake of collagen, with the intention to prevent, or accelerate healing from, soft tissue 
injuries. Presently, as a result of in vitro and in vivo work, it is recommended that 15 grams of 
gelatin, with a source of vitamin C be consumed 1 hour prior to exercise to assist in the 
upregulation of collagen synthesis and to improve tissue mechanics. Furthermore, several 
groups have recommended that hydrolysed/bioactive peptide formulations be consumed, as 
they have better bioavailability and bioactivity than non-, or partially hydrolysed forms. 
Meanwhile, others have recommended the consumption of bone broths for connective tissue 
support. The studies contained within this thesis have found that 20 grams of collagenous 
proteins achieved higher plasma AAs than those found in previous work utilising 15 grams, 
thus it is possible that consumption at this amount is of further benefit in regards to increasing 
the synthesis of collagen in dense connective tissue. However, we were unfortunately unable 
to confirm this with the in vitro work performed as part of this thesis, thus it has been 
recommended as an area for further research (see section 8.3). It was also discovered that, in 
the case of a hydrolysed peptide formula, and a non-hydrolysed collagen, there was no 
difference in amino acid bioavailability. Although there was a higher bioavailability of AAs in 
hydrolysed, compared to non-hydrolysed, dairy proteins, the low scores in regard to 
acceptability/palatability meant that it is unlikely to be consumed, even for the benefit of 
connective tissue health.  
 
In regard to the non-hydrolysed collagen (gelatin), as it is considered a food product, there is 
also low risk of inadvertent doping with the consumption of this product. Furthermore, it is 




This was reflected in palatability/acceptability scores in study 2. Meanwhile, bone broth was 
found to be too variable in its AA content, and therefore, would not likely be able to 
consistently provide adequate levels of AA to support collagen synthesis/incorporation. 
Although it is not yet established whether outcomes determined in vitro will be reflected in 
vivo, given the potential of consumed collagen to increase the synthesis of collagen in dense 
connective tissue, the recommendations that have eventuated from this thesis for dense 
connective tissue health/injury prevention and/or to assist in tissue rehabilitation are as follows:  
 During periods of connective tissue repair, consume 15-20 grams of collagen protein 
(either gelatin or hydrolysed collagen), 40 – 60 minutes prior to any exercise that will 
encourage/support blood flow to the target tissue, and “switch-on” synthetic machinery. 
o As collagen is metabolised and excreted within 6 hours; intake at least two times 
per day is potentially of further benefit than intake once per day. 
 Given the anti-inflammatory properties of glycine, that is highly available within 
collagen protein sources, collagen intake may also assist with pain management in 
chronically inflamed dense connective tissues and/or joint pain. 
 In times of increased metabolism (e.g. post-surgery), dietary adequacy of vitamin C and 
protein should be encouraged, with collagen precursors consumed as soon as possible 
after surgery. 
 Within athletes, inadequate protein intake may put them at risk of connective tissue 
injury due to the poor availability of AAs necessary for the synthesis of collagen 
(particularly if they are found to have higher turnover rates of collagenous tissues). 
Thus, regular and adequate intake of protein should be encouraged. 
 Whether collagen supplementation is useful as a preventative measure is currently 
unknown, however in athletes who have higher rates of exercise, and potentially a 




collagen rich food sources within the diet may be of benefit, and are likely of low risk, 
particularly when consumed as a food source. 
 Further, in athletes who have had previous connective tissue injury, utilising collagen 
daily may be of benefit, given dietary intake may be insufficient to support collagen 
containing tissues, and there may be a higher requirement within these athletes. It is 
possible that regular intake may also increase individual’s capacity to digest these 
protein sources, thus regular intake may also assist with increased bioavailability. 
 Gelatin may be a preferential option in some groups given its equivalent bioavailability 
to hydrolysed-collagen, reduced risk of inadvertent doping, and increased acceptability 
and palatability.  
8.5 Conclusion 
 
Although further work is necessary to confirm the outcome of dietary collagen and/or high 
leucine dairy proteins on dense connective tissue health/performance in vivo, this body of work 
provides a significant contribution to the literature. Furthermore, this work also highlights 
limitations and/or considerations in regard to the applicability of in vitro work to in vivo 
conditions when utilising a cell culture model. Ultimately, this thesis provides relevant 
information that will assist in the development of a well-designed intervention studies and 








When you commence a PhD, you are told that you will complete it and become an expert in 
your field of research. You start with this false confidence that even though it is incredibly 
difficult when you start, in a mere three years you will emerge as an expert researcher (a.k.a., 
a butterfly), complete with a super hero ability to foresee any difficulties or limitations that 
may arise in future research. Three and a half years on, I feel as though I have more questions 
than when I started, and I have realised that the beauty in research is not when everything runs 
smoothly and you get the outcome that you are looking for, it is when things don’t go to plan 
that you experience the most learning and growth. In essence, it made me realise that I am still 
a caterpillar, waiting to get my wings. It has also made me realise that no matter how much 
control you think you have, there are some aspects of research that you just can’t control. 
Instead, you are forced to go with the flow, and be comfortable in the uncontrollable mess that 
is sometimes characteristic of both life and research.   
 
Perhaps naively, upon commencing this thesis, I had thought that everything would run 
smoothly, with a clear progression of questions that would be answered, which would 
ultimately lead to the implementation of a well-designed and well-controlled intervention 
study. However, upon thoroughly immersing myself in the literature, in addition to discussions 
with several experts within the field, it soon became clear that this would not be the case. For 
example, within dense connective tissue research, the only direct way to measure not only the 
synthesis, but also incorporation of collagen into these tissues is through biopsy. However, 
although not documented within the literature, anecdotally, there are reports of ongoing tendon 
pain/ damage in utilising the biopsy technique. So, the next step was to find a non-invasive way 
to measure changes to collagenous tissues. After leveraging some of the expertise at the now 
disbanded AIS, and playing around with ultra-sound machines. I was on my way to discuss the 




asking the question “so what do these outcome measures actually mean”, and being met with 
a “well we don’t actually know that yet”, I realised, it was probably best to look for a plan C. 
Enter the “micro dialysis study” idea which involved an initial meeting with several experts at 
the AIS. However, this was another technique which required specific expertise, along with 
purpose-built tubes to enable the correct particles to be able to be obtained from the dialysate 
(i.e. collagen synthesis biomarkers; PINP and PICP). After a few weeks of researching this 
potential option I/we were met with another dead end. Although this was frustrating and felt 
like a purposeless exercise, I now appreciate that value of these so called “dead-ends”, and the 
role that they play in your future research planning. 
 
In regard to the studies that were eventually decided on, and undertaken, there were also several 
difficulties/considerations which emerged. During the entirety of the thesis, two days per week 
were involved in servicing a professional rugby union team. It was intended that this would 
serve two purposes; to assist in the funding of the research studies contained within this thesis, 
and, to have a captive audience of which to implement phase 5; the intervention study. 
However, this did create some difficulty in regard to time constraints, and therefore, as outlined 
in Chapter Three, several data collections were completed in an over-lapping manner 
(specifically studies 2-4). Whilst this did reduce the total time commitment, cost, staff and 
participant burden, and avoided the need to recruit 3 different participant groups, it did restrict 
how data was able to be obtained, in the fact that we decided on utilising the one 
methodological protocol for several studies. Further, on some occasions, due to time constraints 
it meant that some trials had to be commenced prior to getting “the full picture” (e.g. total 





Finally, the last study was commenced without a full understanding of cell-culture work which 
resulted in a considerable amount of limitations, and potentially a “non-significant finding”. 
However, it wasn’t until I physically went to the laboratory at University of California, Davis, 
and developed and treated the engineered ligaments myself, and completed the entire study, 
that I would have a complete understanding of the complexity of this work.  
 
To conclude, whilst this PhD has taught me that although you can be incredibly thorough in 
your planning, there are some lessons in research that you won’t be apparent until you go 
through those perceived failures. However, as aforementioned, it is during those times where 
you experience the most growth. To quote the great Thomas Edison: “I have not failed, I have 
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11.2 Supplementary Tables 
 
11.2.1: Supplementary for study 1. Range of Amino acid (mg) provided per serve of laboratory prepared and commercial 
varieties of bone broth and reference supplements and per kg of animal tissue for laboratory prepared varieties 
 
mg of Amino acid provided per serve  
Bone broths-standardized recipe  
Self-prepared Commercial  
 CB BB CBv BBv BBC BBB BOLC BOLB 
 
No of samples 2 2 2 2 2 2 2 2  
HYP 573-635 918-975 443-610 790-908 385-445 470-500 220-246 230-279 
 
GLY 1018-1108 1633-1713 780-1063 1405-1598 685-783 830-878 432-477 470-532 
 
PRO 628-680 1000-1048 480-650 848-968 428-480 503-538 288-316 314-342 
 
HYL 78-83 125-135 60-80 113-130 55-65 55-58 27-29 29-31  
LYS 288-300 343-368 218-280 293-328 195-203 180-188 186-211 170-195 
 
LEU 265-268 370-398 190-250 318-353 170-188 178-185 201-218 197-232 
 
HIS 110-180 150-163 100-115 133-145 88-93 95-98 71-78 71-84 
 
TAU 0-43 N.D. 35-38 N.D. 35-40 N.D. 15-17 3-3 
 
SER 210-230 363-368 170-218 308-345 170-185 183-190 139-151 153-162 
 
ARG 525-550 790-813 400-540 675-770 345-385 383-410 281-312 281-288 
 
ASP 483-533 720-740 385-500 600-670 365-380 365-378 299-319 288-321 
 
GLU 950-1025 1330-1360 745-960 1108-1278 678-740 738-740 507-557 521-564 
 
THR 188-195 243-253 143-185 205-233 135-140 118-123 135-147 125-146 
 
ALA 593-640 900-915 453-603 755-858 403-448 453-478 291-318 319-325 
 
TYR 70-75 100-113 55-73 85-95 53-58 48-50 72-80 64-82 
 





VAL 188-193 290-308 255-280 130-138 38-148 138-148 154-165 153-178 
 
ISO 143-145 188-193 105-135 150-170 95-100 90-95 126-134 112-134 
 
PHE 173-180 258-273 130-173 223-248 120-128 125-133 133-144 130-147 
 
Total protein (g)         
 
Bone broths – non-standardized recipe Reference supplements  
 Ca Ca(2) BBm(1) BBm(2) GEL PEP Lcol HYD  
No of samples 3 1 1 1 2 2 1 1  















HYL 275-475 250 125 100 186-190 182-186 162 168 
 
LYS 850-1475 650 275 200 680-610 652 3 552 678 
 
LEU 850-1650 675 300 225 498-508 504-504 444 532 
 
HIS 275-525 175 75 75 134-140 152- 158 132 98 
 
TAU N.D. N.D. N.D. N.D. 0-80 N.D. N.D. N.D. 
 
SER 950-1700 750 325 225 668-672 692-702 582 656 
 















THR 550-1000 450 200 150 356-358 352-354 306 382 
 





TYR 225-300 175 100 50 88-102 112-114 42 32 
 





VAL 725-1400 575 250 175 444-450 474 396 506 
 
ISO 450-875 350 150 125 292- 300 250-252 264 292 
 





11.2.2: Supplementary for Study 3. Amino acid profiles of select food/supplements (mg/serve) 
 Cas HCas Gel Pep LCol BBr 
Hyp N.D. N.D. 2330 2434 2052 5910 
Gly 360 354 4750 4904 4212 11760 
Pro 2038 2060 2664 2722 2406 6420 
Hyl N.D. N.D. 210 208 186 570 
Lys 1422 1468 696 746 630 1740 
Leu 1782 1786 588 584 516 1710 
His 546 480 140 158 132 450 
Tau N.D. N.D. N.D. N.D. N.D. N.D. 
Ser 1086 1088 668 702 582 1680 
Arg 706 700 1584 1652 1380 3840 
Asp 1212 1238 1072 1088 1996 2970 
Glu 3930 4040 1956 1970 1788 5670 
Thr 810 812 356 352 306 990 
Ala 540 540 1694 1678 1530 4560 
Tyr 994 990 102 114 42 360 
Met 550 554 160 154 138 420 
Val 1234 1242 450 474 396 1260 
Iso 986 986 300 252 264 810 
Phe 976 978 388 402 336 1140 
Total protein 
(g) 
19.2 19.4 20 20 17.9 52.2 
HYP: Hydroxyproline; GLY: Glycine; Pro: Proline; HYL: Hydroxylysine; Lys: Lysine; Leu: Leucine; HIS: Histidine; TAU: 
Taurine; SER: Serine; ARG: Arginine; GLU: Glutamic acid; THR: Threonine; ALA: Alanine; TYR: Tyrosine; MET: Methionine; 




mg of Amino acid extracted per kg of animal tissue 
 CB BB CBv BBv Ca(2) BBm(1) BBm(2) 
HYP 3817-4233 6117-6500 2950-4967 5267-6050 10000 5667 4167 
GLY 6783-7383 10883-11417 5200-7083 9367-10650 17444 10000 7333 
PRO 4183-4533 6667-6983 3200-4333 5650-6450 10667 6167 4500 
HYL 517-550 833-900 400-533 750-867 1667 833 667 
LYS 1917-2000 2283-2450 1450-1867 1950-2183 2889 1833 1333 
LEU 1767-1783 2467-2650 1267-1667 2117-2350 3000 2000 1500 
HIS 
733-783 1000-1083 667-767 883-967 778 500 500 
TAU 
0-283 N.D. 233-250 N.D. N.D. N.D. N.D. 
SER 
1400-1533 2417-2450 1133-1450 2050-2300 3333 2167 1500 
ARG 
3500-3667 5267-5417 2667-3600 4500-5133 6778 4500 3333 
ASP 
3217-3550 4800-4933 2567-3333 40000-4467 5889 3833 2833 
GLU 
6333-6833 8867-9067 4967-6400 7383-8517 10889 7167 5167 
THR 
1250-1300 1617-1683 950-1233 1367-1550 2000 1333 1000 
ALA 
4267-3950 6000-6100 3017-4017 5033-5717 8889 5167 3833 
TYR 
467-500 667-750 367-483 567-633 778 667 333 
MET 
650-683 767-817 517-683 633-767 889 500 333 
VAL 





950-967 1250-1283 700-900 1000-1133 1556 1000 833 
PHE 
1150-1200 1717-1817 876-1150 1483-1650 2222 1500 1000 
Abbreviations 
HYP: Hydroxyproline; GLY: Glycine; Pro: Proline; HYL: Hydroxylysine; Lys: Lysine; Leu: Leucine; HIS: Histidine; TAU: 
Taurine; SER: Serine; ARG: Arginine; GLU: Glutamic acid; THR: Threonine; ALA: Alanine; TYR: Tyrosine; MET: 
Methionine; VAL: Valine; ISO: Isoleucine; PHE: Phenylalanine; N.D.: Not detected. 
 
 
11.2.3: Supplementary Table for Study 4.  mg per litre of amino acids in diluted DMEM media. 
Amino acids DMEM media Population means 
Final concentration of 
diluted media 
Leucine 105 19 21 
Glycine* 30 24 24 
Proline* 0 30.2 30.2 
Lysine* 146 38.5 38.6 
Arginine 84 20.3 20.4 
Cysteine 63 6 12.6 
Glutamine 584 90 116.8 
Histidine 42 18.8 18.8 
Isoleucine 105 9 21 
Methionine 30 5 6 
Phenylalanine 66 14 14 
Serine 42 4 8.4 
Threonine 95 18 19 
Tryptophan 16 17 3.2 
Tyrosine 104 15 20.8 




Other Components added to diluted media 
Glucose - - 3,600 
Magnesium sulphate - - 78 
Calcium chloride - - 160 




11.3 Ethics Approval, Participant Information Forms and Informed 
Consent 
The following ethics approval relates to all studies contained within this thesis, and was 
submitted as a complete project  
 












11.3.3 Information to participants  
Research Title:  
The impact of different Proline and Glycine containing test foods and supplements on serum amino acid and 
peptide availability in healthy active males 
 
Principal Researcher:  





Prof. Louise Burke, Australian Institute of Sport 
0422635869 
Louise.Burke@ausport.gov.au 








We would like to invite you to participate in this postgraduate research project. You should only participate if you 
want to; choosing not to take part will not disadvantage you in any way. Before you decide whether you want to 
take part, it is important for you to understand, why the research is being done and what your participation will 
involve. Please take time to read the following information carefully and discuss it with others if you wish.  Ask 
us if there is anything that is not clear or if you would like more information. 
Background: 
Specific amino acids (i.e. Proline and Glycine) and/or sequences of these amino acids (i.e. peptides) play a 
supportive role in the synthesis of collagen, the predominant protein found within connective tissues, such as 
ligaments and tendons. Recent work by our team has shown a dose response relationship between amino acid 
availability, collagen content and tissue mechanics within engineered ligaments following the ingestion of Gelatin 
(a food form of collagen). However, it is not currently known whether other foods/supplements containing 
relevant amino acids/ peptides have the potential to support collagen synthesis. Furthermore, the bioavailability 
(i.e. timing and peaks of appearance within the blood) of varying collagen and non-collagen containing food 
sources is currently unknown. 
Aim: 
The aim(s) of this research project is to assess; 
1. The bioavailability (appearance within the blood) of amino acids after consumption of collagen and non-
collagen containing food sources and supplements. 
2. Whether urinary hydroxyproline (HYP) may be used as an indicator of dietary collagen intake 






This study will help to provide information around the optimal food source/supplement and its’ bioavailability 
(timing and peaks of appearance within the blood), to support the health/ function of connective tissues. 
Additionally, it may also assist in the development of a validated food frequency questionnaire to assess intake of 
dietary sources of collagen. 
What is involved? 
Note: There are three “parts” to this study (as per the aims outlined above), which will completed in 2 separate 
study groups. The total time commitment will be identical in each group, however in group 1 aims 1 and 2 will 
be explored and in group 2, aims 1 and 3 will be explored.  
Part 1: A total of 7 trials will be undertaken in fasted, rested conditions with a 48 hour wash-out period between 
trials. Participants will arrive on testing days following an overnight fast (10 h). Participants will be cannulated 
and a baseline (BL) blood sample collected (2 ml). The participants will then consume the test food (as described 
below) and blood samples (2ml) will be obtained every 20 minutes over the Proceeding 3 hours for plasma amino 
acid assessment.  
Participants will ingest 7 different Proline, Glycine and/or Leucine containing test foods (specifically whey protein 
powder, skim milk powder, casein protein powder, hydrolysed collagen powder, liquid gelatin, solid gelatin 
powder and a bone broth).  
Participants will ingest an amount of product equivalent to 20 g protein. Where food protein concentrations are 
small and doses required to provide 20 g are impractical to consume within 5 minutes, an amount to an acceptable/ 
practical volume (i.e. 300ml) will be prescribed. After cannulation, and an initial blood draw is taken for baseline 
measures, participants will commence consumption of the specified food/supplement and encouraged to finish 
within 5 min. Fluid volume associated with product intake will be standardised to 300ml. No further fluid intake 
will be allowed for 60 min after ingestion of test food to standardise gastric emptying rates. While food will be 
withheld until completion of the trial. 
Once the final blood sample is collected, the cannula will then be removed and pressure applied to the insertion 
site, after which participants will then be provided with a meal. The participant will be free to go and will return 
to the lab for subsequent testing after 48 h washout.  
It is anticipated there will be time commitment at the lab of approximately 3.5 hours. However, participants 
are free to bring outside work and have access to wireless internet. 
Part 2: Participants will be required to collect urine samples for 24 hours on 6 different occasions (2 baselines in 
the week prior to commencing the study on any day they wish, and for 4 of the test foods – these will be 
randomised in order). All of the urine MUST be collected at the following time points 0-6h after the test food (or 
breakfast on BL days), 6-12h after the test food (or breakfast on BL days), and 12-24h after the test food (or 
breakfast on BL days). A 24hr food and exercise diary, and information on food and fluid intake the night prior 
to urine collection will be required, which will then be verified by a trained Dietitian on the subsequent testing 
day. It is imperative that all urine is stored in a cool/dry place throughout collection. 
Part 3: Participants will follow the same protocol as per part 1, with an additional 55ml of blood collected at BL 
and at the time point associated with the Proline and Glycine plasma peak after ingesting the supplement. This 
blood collection will occur for 3 of the 7 foods described above (no more than 75mls of blood will be taken in 1 
day).  
Supplements/Medication use  
The supplements to be utilised within this research project are currently classified under the AIS Sports 
Supplement Framework as group C supplements. Further information can be found at: 
https://www.ausport.gov.au/ais/nutrition/supplements/groupc  
The following supplements will be used: 
1. Gelita Tendoforte: www.gelita.com 
2. Professional Whey Hydrolysed casein: www.Professionalwhey.com.au 
3. Professional Whey Calcium caseinate: www.Professionalwhey.com.au 





Who we are recruiting? 
Healthy, active males, aged 18-40 years old, without a known food allergy or intolerance to pig and/or beef 
gelatin, milk and/or milk products and/or chicken/beef/seafood, non-diabetics and individuals without current 
tendinopathies. 
Adverse Effects and Withdrawal: 
Although it is expected that this study be low risk if you do happen to suffer any adverse reactions to cannulation, 
or the supplement/food sources provided the project doctor, will assess your symptoms and provide appropriate 
support. You will have the right to withdraw from the study at any stage. 
Confidentiality: 
Confidential information will be kept by the principal investigator in a lockable filing cabinet and in a personal 
computer protected by password. In addition, the participants will be identified by number only. All address lists 
will be kept securely in the primary investigator’s care and only be available to the primary investigator and 
appropriate co-researchers. The presentation of results will not make reference to individual participants when 
the data are published. The raw data will be retained by the principal investigator for five years in a secure 
cabinet at the Australian Institute of Sport. At the conclusion of this five year period all material containing 
confidential information will be destroyed. 
Ethics Approval: 
The project set out in the attached application, including the adequacy of its research design and compliance 
with recognised ethical standards, has the approval of the Australian Institute of Sport (AIS). If you have any 
concerns, please contact the secretary of the AIS Ethics Committee on 02 6214 1577. 
Further information: 
Please contact Rebekah Alcock at  Rebekah.Alcock@ausport.gov.au or 0476291511 if you have any questions, 




11.3.4 Informed consent form 
Project Title: The impact of collagen and non-collagen containing food sources and supplements on plasma 
amino acid response, in-vitro collagen synthesis and mechanical properties in an engineered ligament. 
Principal Researchers: Rebekah Alcock, AIS 
Nicolin Tee, AIS 
Greg Shaw, AIS 
Louise Burke, AIS 
This is to certify that I,       hereby agree to participate as a volunteer in a scientific 
investigation as an authorised part of the research program of the Australian Sports 
Commission under the supervision of     . 
The investigation and my part in the investigation have been defined and fully explained to me 
by       and I understand the explanation. A copy of the procedures of this investigation and 
a description of any risks and discomforts has been provided to me and has been discussed in 
detail with me. 
 I have been given an opportunity to ask whatever questions I may have had and all such questions and 
inquiries have been answered to my satisfaction. 
 I understand that I am free to deny any answers to specific items or questions in interviews or questionnaires. 
 I understand that I am free to withdraw consent and to discontinue participation in the project or activity at 
any time, without disadvantage to myself. 
 I understand that I am free to withdraw my data from analysis without disadvantage to myself. 
 I understand that any data or answers to questions will remain confidential with regard to my identity. 
 I certify to the best of my knowledge and belief, I have no physical or mental illness or weakness that would 
increase the risk to me of participating in this investigation. 
 I am participating in this project of my (his/her) own free will and I have not been coerced in any way to 
participate. 
 I have read and understand the product and policy information provided to me on surrounding the use of 
supplements/medications within the study (where applicable) 
 
Privacy Statement: The information submitted will be managed in accordance with the 
ASC Privacy Policy. 
□ I consent to the ASC keeping my personal information.  
Signature of Subject: _______________________________ Date: ___/___/___ 
I, the undersigned, was present when the study was explained to the subject/s in detail and to 
the best of my knowledge and belief it was understood. 






11.4 Likert Scale for Supplement Palatability and Acceptability 
 
Please fill out the following questionnaire in relation to the supplement/food product that you just consumed: 
  Strongly disagree                              Neutral                                     Strongly agree 








       








       










       





per day as 
part of a 
rehabilitation 
program 
       
5 Would you be willing to pay the 







11.5 Urine Collection Instructions Sheet 
 
In order to assess the excretion of the urinary marker hydroxyproline (an amino acid which may be able to be 
used as a marker for intake of collagen containing food sources), we are collecting urine on 6 occasions – 2 
baseline (on any day in the week before commencing the study), and with the intake of 4 foods (2 that contain 
collagen and 2 that don’t – these will be randomised in order). 
Please ensure you have a 10 hour fast (no food and keep fluid intake the night prior consistent - document on the 
next page), empty bladder on waking, then start collection after you have consumed breakfast or the test 
supplement. You will receive 3 bottles on each occasion labelled as followed: 
 Time of commencement: Please document the time you finish your breakfast/ test supplement – this is when 
your 0-6h period (as described below commences). 
 0-6h: This is the 6 hour period after consumption of the food on the allocated collection day, and may be after 
breakfast on BL day. 
 6 – 12h: This is from 6 to 12 hours (inclusive) after consumption of the food on the allocated collection day, and 
from 6-12h (inclusive) after breakfast consumption. 
 12 – 24h: This is from 12 hours up until the equivalent time once your collection time commenced the first day 
i.e. if you finished the food/breakfast on the day prior at 7am, you should collect until 7am the following day. 



















   



















   



















   





















   



















   

















    
 
Please collect all urine excreted into the bottles provided – the easiest way may be to keep the bottles next 




11.6 24 Hour Food, Fluid and Exercise diaries  
 
The purpose of collecting data around your intake and exercise will enable a better understanding of the factors 
that may have an impact of the excretion of hydroxyproline. It is imperative that these diaries are as 
comprehensive as possible, if you have any questions please contact Rebekah Alcock at 0476 291 511 or 
Rebekah.Alcock@ausport.gov.au. 
Please read the instructions thoroughly before commencing: 
Instructions  
1. Please document every food and liquid that you consume, and any exercise that you do within the 24h period 
that coincides with your urine collection 
2. Ensure that you document as much information as possible, including any toppings/ additions. For example; 
- Burgen bread, soy and linseed, 2 slices with 2 tsp meadowlea canola spread 
- Yoghurt – Yoplait vanilla 175 grams  
- 250 gram rump steak, fat removed, cooked in 1tblsp olive oil 
3. Utilise measuring cups and/or spoons where possible to weigh out amounts. 
4. Note the weight or volume of items that come in packages, and how much you consumed. 
5. If you are consuming mixed dishes, please include the recipe and the amount that you consumed of each 
component i.e. spaghetti bolognaise (500 grams lean mince, 140 grams tinned tomatoes, 2 beef stock cubes, 2 
tblsp tomato paste, 500 grams penne pasta) – consumed 1 cup sauce, 2 cups pasta (cooked), 1 tbs parmesan 
cheese. 
6. Please document the amount of exercise, including any warm-ups and cool downs – including HR if possible. 
7. Please document total fluid intake as accurately as possible – including all water consumed. 
The below may assist you in documenting amounts where scales/measuring-ups are not available: 
1 closed fist = 1 cup i.e. cereal, fruit, salad, pasta 
1 palm = 100 grams meat  
1 cupped hand = ½ cup i.e. pasta, rice, beans 
2 cupped hands = 85 – 100 grams (i.e. popcorn, chips, pretzels) 




Example food diary 
Meal/Time Food/ fluid Quantity Comments 
Breakfast 08:30am Toast (multigrain) – Burgen brand  
Meadowlea canola spread  Vegemite  
 
Water 
2 pieces  
 
2 tbslp canola spread  
2 tblsp vegemite 
 
1 x 250ml glass 
 







Lunch 1:00pm Bread (Burgen soy and linseed) 
Mixed lettuce leaves 








30 grams (3 thin slices) 
 
Afternoon tea 3:00pm Uncle Toby’s muesli bar forest fruit flavour 1 bar  
Dinner 6:00pm Rump steak 
Mashed potato (3 whole potatoes, ½ cup 
milk, 1 tblsp butter)  
Peas 




½ cup  
Lean steak, cut off the fat 
 
  
Dinner + fluid intake the night prior to urine collection day – please aim to consume at least 2.5L of water 
Please allow at least 10 hours with no food intake (prior to the test food/breakfast) and document all fluid intake 
Meal/Time Food/ fluid Quantity Comments 
Dinner    
Dessert    
Supper    
Fluid intake    
    
    
    




Food/fluid intake on urine collection day – please aim to consume at least 2.5L of water 
Meal/Time Food/ fluid Quantity Comments 
    
    
    
    
    
    
    
    





Exercise the day prior to urine collection Date 
Exercise  Time Type/ intensity/ duration (include reps/ sets where possible) 









Exercise the day of urine collection Date 
Exercise  Time Type/ intensity/ duration (include reps/ sets where possible) 












End of Document 
 
